Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:lead diacetate
go back to main search page
Accession:CHEBI:31767 term browser browse the term
Definition:A lead coordination entity in which a central lead(2+) atom is coordinated to two acetate ions.
Synonyms:exact_synonym: bis(acetato-kappa(2)O,O')lead;   lead(2+) acetate;   lead(II) acetate
 related_synonym: Blei(II)-azetat;   Bleidiacetat;   Bleidiazetat;   Bleizucker;   Formula=2C2H3O2.Pb;   Formula=C4H6O4Pb;   InChI=1S/2C2H4O2.Pb/c2*1-2(3)4;/h2*1H3,(H,3,4);/q;;+2/p-2;   InChIKey=GUWSLQUAAYEZAF-UHFFFAOYSA-L;   SMILES=CC1=[O][Pb]2(O1)OC(C)=[O]2;   lead acetate;   lead acetate (anhydrous);   plumbous acetate;   salt of Saturn;   sugar of lead
 xref: Beilstein:1099661;   Beilstein:6919265;   CAS:301-04-2;   Gmelin:1042008;   Gmelin:21797;   Gmelin:327405;   KEGG:D01945
 xref_mesh: MESH:C008261
 xref: PMID:25042713;   PMID:4470991


show annotations for term's descendants           Sort by:
 
lead diacetate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin affects expression
decreases expression
EXP lead acetate affects the expression of A2M mRNA
lead acetate results in decreased expression of A2M mRNA
CTD PMID:21864555 PMID:22641619 NCBI chr 4:154,309,426...154,359,138
Ensembl chr 4:154,309,426...154,359,137
JBrowse link
G Aadat aminoadipate aminotransferase increases expression EXP lead acetate results in increased expression of AADAT mRNA CTD PMID:22641619 NCBI chr16:32,832,001...32,868,680
Ensembl chr16:32,832,061...32,868,702
JBrowse link
G Aars1 alanyl-tRNA synthetase 1 increases expression EXP lead acetate results in increased expression of AARS mRNA CTD PMID:11578147 NCBI chr19:43,193,264...43,215,281
Ensembl chr19:43,193,257...43,215,281
JBrowse link
G Abca1 ATP binding cassette subfamily A member 1 increases expression EXP lead acetate results in increased expression of ABCA1 mRNA; lead acetate results in increased expression of ABCA1 protein CTD PMID:29908845 NCBI chr 5:69,857,717...69,983,042
Ensembl chr 5:69,857,771...69,983,015
JBrowse link
G Abcc1 ATP binding cassette subfamily C member 1 increases expression
affects export
EXP
ISO
lead acetate results in increased expression of ABCC1 mRNA; lead acetate results in increased expression of ABCC1 protein
ABCC1 protein affects the export of lead acetate
CTD PMID:23274417 PMID:24598511 PMID:27236077 NCBI chr10:549,537...672,235
Ensembl chr10:549,883...672,196
JBrowse link
G Abce1 ATP binding cassette subfamily E member 1 increases expression EXP lead acetate results in increased expression of ABCE1 mRNA CTD PMID:11578147 NCBI chr19:31,867,960...31,892,863
Ensembl chr19:31,867,981...31,892,863
JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 increases expression EXP lead acetate results in increased expression of ABCG2 mRNA CTD PMID:22641619 NCBI chr 4:88,765,441...88,890,268
Ensembl chr 4:88,832,178...88,890,621
JBrowse link
G Abhd15 abhydrolase domain containing 15 increases expression ISO lead acetate results in increased expression of ABHD15 mRNA CTD PMID:22609695 NCBI chr10:62,643,453...62,648,844
Ensembl chr10:62,643,453...62,648,844
JBrowse link
G Acan aggrecan increases expression
multiple interactions
ISO lead acetate results in increased expression of ACAN mRNA
BMP2 promotes the reaction [lead acetate results in increased expression of ACAN mRNA]; lead acetate promotes the reaction [BMP2 results in increased expression of ACAN mRNA]
CTD PMID:17805416 NCBI chr 1:140,762,758...140,824,441
Ensembl chr 1:140,762,758...140,824,441
JBrowse link
G Acat1 acetyl-CoA acetyltransferase 1 decreases expression ISO lead acetate results in decreased expression of ACAT1 mRNA CTD PMID:21829687 NCBI chr 8:58,166,990...58,195,884
Ensembl chr 8:58,166,990...58,195,884
JBrowse link
G Acat2 acetyl-CoA acetyltransferase 2 decreases expression ISO lead acetate results in decreased expression of ACAT2 mRNA CTD PMID:21829687 NCBI chr 1:47,972,399...47,992,654
Ensembl chr 1:47,972,399...47,992,653
JBrowse link
G Ace angiotensin I converting enzyme affects expression EXP lead acetate affects the expression of ACE mRNA CTD PMID:21864555 PMID:22641619 NCBI chr10:94,170,766...94,213,831
Ensembl chr10:94,170,766...94,187,822
JBrowse link
G Ace2 angiotensin I converting enzyme 2 decreases expression ISO lead acetate results in decreased expression of ACE2 mRNA CTD PMID:22613225 NCBI chr  X:32,050,734...32,095,860
Ensembl chr  X:32,049,931...32,096,016
JBrowse link
G Acer2 alkaline ceramidase 2 increases expression EXP lead acetate results in increased expression of ACER2 mRNA CTD PMID:22641619 NCBI chr 5:105,230,540...105,279,732
Ensembl chr 5:105,230,580...105,279,731
JBrowse link
G Ache acetylcholinesterase decreases expression
decreases activity
increases activity
multiple interactions
ISO
EXP
lead acetate results in decreased expression of ACHE protein
lead acetate results in decreased activity of ACHE protein
lead acetate results in increased activity of ACHE protein
Biological Factors inhibits the reaction [lead acetate results in decreased activity of ACHE protein]; ferulic acid inhibits the reaction [lead acetate results in increased activity of ACHE protein]; Plant Preparations inhibits the reaction [lead acetate results in decreased activity of ACHE protein]
puerarin inhibits the reaction [lead acetate results in decreased expression of ACHE protein]
CTD PMID:23501611 PMID:25322819 PMID:30703413 NCBI chr12:22,472,358...22,477,052
Ensembl chr12:22,472,358...22,478,753
JBrowse link
G Acin1 apoptotic chromatin condensation inducer 1 decreases expression ISO lead acetate results in decreased expression of ACIN1 mRNA CTD PMID:20542052 NCBI chr15:33,288,369...33,333,256
Ensembl chr15:33,288,374...33,333,417
JBrowse link
G Acot7 acyl-CoA thioesterase 7 increases expression ISO lead acetate results in increased expression of ACOT7 mRNA CTD PMID:21829687 NCBI chr 5:169,357,582...169,450,215
Ensembl chr 5:169,357,517...169,450,219
JBrowse link
G Acsm3 acyl-CoA synthetase medium-chain family member 3 affects expression EXP lead acetate affects the expression of ACSM3 mRNA CTD PMID:21864555 NCBI chr 1:189,514,504...189,541,233
Ensembl chr 1:189,514,553...189,541,224
JBrowse link
G Acsm5 acyl-CoA synthetase medium-chain family member 5 decreases expression EXP lead acetate results in decreased expression of ACSM5 mRNA CTD PMID:22641619 NCBI chr 1:189,240,955...189,270,422
Ensembl chr 1:189,233,141...189,272,172
JBrowse link
G Actb actin, beta affects expression ISO lead acetate affects the expression of ACTB protein CTD PMID:20797405 NCBI chr12:13,715,843...13,718,813
Ensembl chr12:13,715,843...13,718,841
JBrowse link
G Acvrl1 activin A receptor like type 1 increases expression ISO lead acetate results in increased expression of ACVRL1 mRNA CTD PMID:22609695 NCBI chr 7:142,769,942...142,787,336
Ensembl chr 7:142,776,252...142,787,335
JBrowse link
G Acyp2 acylphosphatase 2 decreases expression ISO lead acetate results in decreased expression of ACYP2 mRNA CTD PMID:20542052 NCBI chr14:114,891,245...115,052,497
Ensembl chr14:114,891,246...115,052,450
JBrowse link
G Adam19 ADAM metallopeptidase domain 19 decreases expression ISO lead acetate results in decreased expression of ADAM19 mRNA CTD PMID:22613225 NCBI chr10:31,146,107...31,240,582
Ensembl chr10:31,146,107...31,240,582
JBrowse link
G Adam1a ADAM metallopeptidase domain 1a increases expression EXP lead acetate results in increased expression of ADAM1A mRNA CTD PMID:22641619 NCBI chr12:40,533,731...40,536,632
Ensembl chr12:40,533,632...40,536,620
JBrowse link
G Adam2 ADAM metallopeptidase domain 2 increases methylation EXP lead acetate results in increased methylation of ADAM2 gene CTD PMID:29571894 NCBI chr15:42,708,536...42,751,281
Ensembl chr15:42,708,387...42,751,330
JBrowse link
G Adam32 ADAM metallopeptidase domain 32 increases expression EXP lead acetate results in increased expression of ADAM32 mRNA CTD PMID:22641619 NCBI chr16:71,889,035...71,999,151
Ensembl chr16:71,889,235...71,999,148
JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 decreases expression EXP lead acetate results in decreased expression of ADAMTS1 mRNA CTD PMID:22641619 NCBI chr11:25,342,119...25,350,938
Ensembl chr11:25,342,126...25,350,974
JBrowse link
G Adamts15 ADAM metallopeptidase with thrombospondin type 1 motif, 15 decreases expression ISO lead acetate results in decreased expression of ADAMTS15 mRNA CTD PMID:22613225 NCBI chr 8:31,977,001...32,000,378
Ensembl chr 8:31,977,001...32,000,378
JBrowse link
G Adamts20 ADAM metallopeptidase with thrombospondin type 1 motif, 20 increases expression EXP lead acetate results in increased expression of ADAMTS20 mRNA CTD PMID:22641619 NCBI chr 7:135,465,021...135,630,941
Ensembl chr 7:135,466,884...135,630,654
JBrowse link
G Adamts4 ADAM metallopeptidase with thrombospondin type 1 motif, 4 increases expression EXP lead acetate results in increased expression of ADAMTS4 mRNA CTD PMID:22641619 NCBI chr13:89,622,996...89,632,485
Ensembl chr13:89,622,632...89,634,419
JBrowse link
G Adamtsl1 ADAMTS-like 1 increases expression ISO lead acetate results in increased expression of ADAMTSL1 mRNA CTD PMID:20542052 PMID:22613225 NCBI chr 5:103,789,443...104,753,866 JBrowse link
G Adcy8 adenylate cyclase 8 increases expression ISO
EXP
lead acetate results in increased expression of ADCY8 mRNA CTD PMID:11578147 PMID:20542052 NCBI chr 7:105,353,883...105,593,372
Ensembl chr 7:105,353,913...105,592,804
JBrowse link
G Adcyap1 adenylate cyclase activating polypeptide 1 decreases expression ISO lead acetate results in decreased expression of ADCYAP1 mRNA CTD PMID:22613225 NCBI chr 9:121,705,897...121,725,736
Ensembl chr 9:121,706,979...121,725,716
JBrowse link
G Adgre4 adhesion G protein-coupled receptor E4 affects expression ISO lead acetate affects the expression of ADGRE4 mRNA CTD PMID:21829687 NCBI chr 9:8,056,034...8,200,262
Ensembl chr 9:8,052,210...8,198,800
JBrowse link
G Adgrf2 adhesion G protein-coupled receptor F2 increases expression EXP lead acetate results in increased expression of ADGRF2 mRNA CTD PMID:22641619 NCBI chr 9:20,898,943...20,948,284
Ensembl chr 9:20,917,673...20,950,386
JBrowse link
G Adgrg6 adhesion G protein-coupled receptor G6 increases expression EXP lead acetate results in increased expression of ADGRG6 mRNA CTD PMID:22641619 NCBI chr 1:8,593,342...8,751,540
Ensembl chr 1:8,593,075...8,751,198
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing decreases expression EXP lead acetate results in decreased expression of ADIPOQ mRNA CTD PMID:11578147 NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
JBrowse link
G Adipor2 adiponectin receptor 2 increases expression ISO lead acetate results in increased expression of ADIPOR2 mRNA CTD PMID:21829687 NCBI chr 4:151,412,135...151,480,108
Ensembl chr 4:151,414,684...151,428,894
JBrowse link
G Adk adenosine kinase decreases expression ISO lead acetate results in decreased expression of ADK mRNA CTD PMID:20542052 NCBI chr15:3,033,535...3,435,888
Ensembl chr15:3,033,495...3,435,888
JBrowse link
G Adora1 adenosine A1 receptor multiple interactions
increases expression
EXP [lead acetate co-treated with Morphine] results in increased expression of ADORA1 mRNA; [lead acetate co-treated with Morphine] results in increased expression of ADORA1 protein; [lead acetate results in increased expression of ADORA1 protein] which results in increased abundance of Adenosine
lead acetate results in increased expression of ADORA1 mRNA; lead acetate results in increased expression of ADORA1 protein
CTD PMID:20932874 PMID:26478469 NCBI chr13:51,042,111...51,076,913
Ensembl chr13:51,042,248...51,076,852
JBrowse link
G Adpgk ADP-dependent glucokinase decreases expression EXP lead acetate results in decreased expression of ADPGK mRNA CTD PMID:22641619 NCBI chr 8:64,088,871...64,116,832
Ensembl chr 8:64,088,913...64,116,832
JBrowse link
G Adra1d adrenoceptor alpha 1D increases expression ISO lead acetate results in increased expression of ADRA1D mRNA CTD PMID:22613225 NCBI chr 3:124,129,558...124,145,566
Ensembl chr 3:124,129,558...124,145,566
JBrowse link
G Adra2b adrenoceptor alpha 2B increases expression ISO lead acetate results in increased expression of ADRA2B mRNA CTD PMID:21829687 NCBI chr 3:119,805,941...119,809,987
Ensembl chr 3:119,805,941...119,809,987
JBrowse link
G Adtrp androgen-dependent TFPI-regulating protein increases expression ISO lead acetate results in increased expression of ADTRP mRNA CTD PMID:22609695 NCBI chr17:22,619,913...22,688,296
Ensembl chr17:22,619,891...22,688,307
JBrowse link
G Aebp1 AE binding protein 1 increases expression EXP lead acetate results in increased expression of AEBP1 mRNA CTD PMID:22641619 NCBI chr14:86,101,253...86,111,323
Ensembl chr14:86,101,277...86,111,306
JBrowse link
G Ahnak AHNAK nucleoprotein increases expression ISO lead acetate results in increased expression of AHNAK mRNA CTD PMID:21829687 NCBI chr 1:225,184,883...225,429,638
Ensembl chr 1:225,184,939...225,215,015
JBrowse link
G Ahr aryl hydrocarbon receptor increases expression
multiple interactions
EXP
ISO
lead acetate results in increased expression of AHR mRNA; lead acetate results in increased expression of AHR protein
[Cadmium Chloride co-treated with Benzo(a)pyrene co-treated with lead acetate] results in increased activity of AHR protein; [lead acetate co-treated with Benzo(a)pyrene] results in increased activity of AHR protein; [sodium arsenite co-treated with Benzo(a)pyrene co-treated with lead acetate] results in increased activity of AHR protein
CTD PMID:17576166 PMID:29502740 NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
JBrowse link
G Ahsp alpha hemoglobin stabilizing protein affects expression EXP lead acetate affects the expression of AHSP mRNA CTD PMID:22641619 NCBI chr 1:199,720,038...199,721,010
Ensembl chr 1:199,720,038...199,721,010
JBrowse link
G Aif1 allograft inflammatory factor 1 increases expression
multiple interactions
ISO
EXP
lead acetate results in increased expression of AIF1 mRNA
[lead acetate co-treated with Morphine] results in increased expression of AIF1 mRNA
CTD PMID:21829687 PMID:26478469 NCBI chr20:5,161,350...5,167,176
Ensembl chr20:5,161,333...5,166,448
JBrowse link
G Aifm1 apoptosis inducing factor, mitochondria associated 1 affects expression
multiple interactions
decreases expression
EXP
ISO
lead acetate affects the expression of AIFM1 protein
[lead acetate results in increased abundance of Lead] which results in increased expression of AIFM1 protein; PPIF protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of AIFM1 protein]
lead acetate results in decreased expression of AIFM1 mRNA
CTD PMID:18618274 PMID:23146751 PMID:31874198 NCBI chr  X:135,304,063...135,343,062
Ensembl chr  X:135,304,066...135,343,087
JBrowse link
G Aipl1 aryl hydrocarbon receptor-interacting protein-like 1 decreases expression EXP lead acetate results in decreased expression of AIPL1 mRNA CTD PMID:22641619 NCBI chr10:58,599,690...58,631,194
Ensembl chr10:58,599,856...58,608,907
JBrowse link
G Akap7 A-kinase anchoring protein 7 increases expression ISO lead acetate results in increased expression of AKAP7 mRNA CTD PMID:22609695 NCBI chr 1:21,129,213...21,263,850
Ensembl chr 1:21,141,970...21,263,850
JBrowse link
G Akap8 A-kinase anchoring protein 8 increases methylation EXP lead acetate results in increased methylation of AKAP8 gene CTD PMID:29571894 NCBI chr 7:14,323,298...14,339,953
Ensembl chr 7:14,324,104...14,351,918
JBrowse link
G Akr1c2 aldo-keto reductase family 1, member C2 increases expression ISO lead acetate results in increased expression of AKR1C2 mRNA CTD PMID:22839698 NCBI chr17:69,388,337...69,435,160
Ensembl chr17:69,388,335...69,404,341
JBrowse link
G Akr7a3 aldo-keto reductase family 7 member A3 increases expression EXP lead acetate results in increased expression of AKR7A3 mRNA CTD PMID:22641619 NCBI chr 5:157,801,120...157,813,756
Ensembl chr 5:157,801,163...157,813,756
JBrowse link
G Akt1 AKT serine/threonine kinase 1 increases phosphorylation
multiple interactions
ISO
EXP
lead acetate results in increased phosphorylation of AKT1 protein
Genistein inhibits the reaction [lead acetate results in increased phosphorylation of AKT1 protein]
CTD PMID:24530660 PMID:26542248 PMID:26797587 NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
JBrowse link
G Akt2 AKT serine/threonine kinase 2 increases expression
decreases expression
ISO
EXP
lead acetate results in increased expression of AKT2 mRNA
lead acetate results in decreased expression of AKT2 mRNA
CTD PMID:22609695 PMID:30980912 NCBI chr 1:84,400,939...84,451,223
Ensembl chr 1:84,411,726...84,450,162
JBrowse link
G Alad aminolevulinate dehydratase decreases expression
multiple interactions
decreases activity
EXP
ISO
lead acetate results in decreased expression of ALAD protein
Ditiocarb inhibits the reaction [lead acetate results in decreased activity of ALAD protein]; ferulic acid inhibits the reaction [lead acetate results in decreased activity of ALAD protein]; indium trichloride promotes the reaction [lead acetate results in decreased activity of ALAD protein]; lead acetate promotes the reaction [indium trichloride results in decreased activity of ALAD protein]; Vitamin E inhibits the reaction [lead acetate results in decreased activity of ALAD protein]
Curcumin inhibits the reaction [lead acetate results in decreased activity of ALAD protein]
CTD PMID:1032310 PMID:2177232 PMID:2604901 PMID:7084431 PMID:22362014 PMID:23292317 PMID:24345272 PMID:24970117 PMID:25322819 NCBI chr 5:78,368,867...78,379,206
Ensembl chr 5:78,368,867...78,379,346
JBrowse link
G Alas2 5'-aminolevulinate synthase 2 increases expression EXP lead acetate results in increased expression of ALAS2 mRNA CTD PMID:22641619 NCBI chr  X:23,167,576...23,187,356
Ensembl chr  X:23,167,696...23,187,341
JBrowse link
G Alb albumin increases expression
multiple interactions
EXP lead acetate results in increased expression of ALB mRNA; lead acetate results in increased expression of ALB protein
[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate co-treated with Mercuric Chloride co-treated with chromium trioxide co-treated with nickel chloride co-treated with manganese chloride co-treated with ferric chloride] results in decreased expression of ALB protein
CTD PMID:17657459 PMID:21549428 PMID:22641619 NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
JBrowse link
G Alcam activated leukocyte cell adhesion molecule increases expression ISO lead acetate results in increased expression of ALCAM mRNA CTD PMID:21829687 NCBI chr11:50,780,735...50,985,083
Ensembl chr11:50,781,127...50,985,083
JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 increases expression ISO lead acetate results in increased expression of ALDH1A1 mRNA CTD PMID:22839698 NCBI chr 1:238,222,689...238,264,381
Ensembl chr 1:238,222,521...238,264,330
JBrowse link
G Aldh1l2 aldehyde dehydrogenase 1 family, member L2 increases expression ISO lead acetate results in increased expression of ALDH1L2 mRNA CTD PMID:25270620 NCBI chr 7:26,375,866...26,425,838
Ensembl chr 7:26,375,866...26,425,108
JBrowse link
G Aldh2 aldehyde dehydrogenase 2 family member multiple interactions EXP [lead acetate results in increased abundance of Lead] affects the reaction [Ethanol affects the expression of ALDH2 protein]; [lead acetate results in increased abundance of Lead] which affects the expression of ALDH2 protein; Cyanamide affects the reaction [[lead acetate results in increased abundance of Lead] affects the reaction [Ethanol affects the expression of ALDH2 protein]]; Cyanamide affects the reaction [[lead acetate results in increased abundance of Lead] which affects the expression of ALDH2 protein] CTD PMID:31550440 NCBI chr12:40,466,418...40,498,813
Ensembl chr12:40,466,495...40,498,752
JBrowse link
G Aldh7a1 aldehyde dehydrogenase 7 family, member A1 increases expression ISO lead acetate results in increased expression of ALDH7A1 mRNA CTD PMID:21829687 NCBI chr18:51,619,007...51,651,267
Ensembl chr18:51,619,007...51,651,267
JBrowse link
G Aldoc aldolase, fructose-bisphosphate C decreases expression
increases expression
ISO lead acetate results in decreased expression of ALDOC protein
lead acetate results in increased expression of ALDOA protein
CTD PMID:20797405 NCBI chr10:65,586,504...65,590,093
Ensembl chr10:65,586,504...65,590,126
JBrowse link
G Alms1 ALMS1, centrosome and basal body associated protein multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of ALMS1 mRNA CTD PMID:22839698 NCBI chr 4:117,371,544...117,472,310
Ensembl chr 4:117,371,659...117,472,198
JBrowse link
G Alox15 arachidonate 15-lipoxygenase decreases expression EXP lead acetate results in decreased expression of ALOX15 mRNA CTD PMID:22641619 NCBI chr10:56,953,692...56,962,145
Ensembl chr10:56,953,691...56,962,161
JBrowse link
G Aloxe3 arachidonate lipoxygenase 3 increases expression ISO lead acetate results in increased expression of ALOXE3 mRNA CTD PMID:22613225 NCBI chr10:55,711,996...55,735,915
Ensembl chr10:55,712,043...55,735,911
JBrowse link
G Alpl alkaline phosphatase, biomineralization associated decreases expression EXP lead acetate results in decreased expression of ALPL protein CTD PMID:21712424 NCBI chr 5:156,086,496...156,141,513
Ensembl chr 5:156,086,497...156,141,537
JBrowse link
G Alx3 ALX homeobox 3 decreases methylation EXP lead acetate results in decreased methylation of ALX3 gene CTD PMID:29571894 NCBI chr 2:210,376,510...210,386,928
Ensembl chr 2:210,381,829...210,386,928
JBrowse link
G Amy1a amylase, alpha 1A decreases activity EXP lead acetate results in decreased activity of AMY1 protein CTD PMID:16510233 NCBI chr 2:216,428,709...216,443,518
Ensembl chr 2:216,428,709...216,443,518
JBrowse link
G Angptl1 angiopoietin-like 1 decreases expression ISO lead acetate results in decreased expression of ANGPTL1 mRNA CTD PMID:22609695 NCBI chr13:74,456,487...74,463,031
Ensembl chr13:74,410,010...74,474,681
JBrowse link
G Ankrd24 ankyrin repeat domain 24 decreases expression ISO lead acetate results in decreased expression of ANKRD24 mRNA CTD PMID:21829687 NCBI chr 7:10,917,359...10,937,522
Ensembl chr 7:10,917,367...10,936,415
JBrowse link
G Ankrd33b ankyrin repeat domain 33B increases expression ISO lead acetate results in increased expression of ANKRD33B mRNA CTD PMID:25270620 NCBI chr 2:84,361,061...84,436,912
Ensembl chr 2:84,361,061...84,437,084
JBrowse link
G Ankrd34a ankyrin repeat domain 34A decreases expression ISO lead acetate results in decreased expression of ANKRD34A mRNA CTD PMID:25270620 NCBI chr 2:198,720,277...198,725,155
Ensembl chr 2:198,721,724...198,725,154
JBrowse link
G Antxr2 ANTXR cell adhesion molecule 2 decreases expression ISO lead acetate results in decreased expression of ANTXR2 mRNA CTD PMID:20542052 NCBI chr14:13,191,716...13,331,286
Ensembl chr14:13,192,347...13,274,978
JBrowse link
G Anxa1 annexin A1 decreases expression EXP lead acetate results in decreased expression of ANXA1 mRNA; lead acetate results in decreased expression of ANXA1 protein CTD PMID:11578147 NCBI chr 1:237,893,983...237,910,002
Ensembl chr 1:237,893,966...237,910,012
JBrowse link
G Anxa5 annexin A5 increases expression
multiple interactions
EXP
ISO
lead acetate results in increased expression of ANXA5 mRNA; lead acetate results in increased expression of ANXA5 protein
lead acetate binds to and results in increased activity of ANXA5 protein
CTD PMID:11578147 NCBI chr 2:123,162,477...123,194,730
Ensembl chr 2:123,162,461...123,193,130
JBrowse link
G Ap2a1 adaptor related protein complex 2 subunit alpha 1 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of AP2A1 mRNA CTD PMID:22839698 NCBI chr 1:100,896,582...100,926,443
Ensembl chr 1:100,896,947...100,926,335
JBrowse link
G Ap3d1 adaptor related protein complex 3 subunit delta 1 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of AP3D1 mRNA CTD PMID:22839698 NCBI chr 7:11,838,639...11,873,992
Ensembl chr 7:11,838,639...11,873,984
JBrowse link
G Apaf1 apoptotic peptidase activating factor 1 increases expression ISO lead acetate results in increased expression of APAF1 mRNA CTD PMID:20542052 NCBI chr 7:31,699,309...31,784,192
Ensembl chr 7:31,699,885...31,784,192
JBrowse link
G Apba1 amyloid beta precursor protein binding family A member 1 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of APBA1 mRNA CTD PMID:12634122 NCBI chr 1:241,594,565...241,796,512
Ensembl chr 1:241,594,565...241,796,513
JBrowse link
G Apex1 apurinic/apyrimidinic endodeoxyribonuclease 1 multiple interactions
increases expression
decreases response to substance
ISO [lead acetate results in increased expression of APEX1 protein] which results in increased abundance of Reactive Oxygen Species; APEX1 protein promotes the reaction [lead acetate results in increased expression of CCND1 protein]; APEX1 protein promotes the reaction [lead acetate results in increased phosphorylation of MAPK1 protein]; APEX1 protein promotes the reaction [lead acetate results in increased phosphorylation of MAPK3 protein]; lead acetate promotes the reaction [APEX1 protein results in increased phosphorylation of MAPK1 protein]; lead acetate promotes the reaction [APEX1 protein results in increased phosphorylation of MAPK3 protein]; lead acetate promotes the reaction [MAPK1 protein modified form binds to APEX1 protein]
APEX1 protein results in decreased susceptibility to lead acetate
CTD PMID:23370007 NCBI chr15:27,849,943...27,852,083
Ensembl chr15:27,849,979...27,852,082
JBrowse link
G Aph1b aph-1 homolog B, gamma secretase subunit decreases expression EXP lead acetate results in decreased expression of APH1B mRNA CTD PMID:22641619 NCBI chr 8:72,508,008...72,598,921
Ensembl chr 8:72,476,425...72,629,265
JBrowse link
G Apobec1 apolipoprotein B mRNA editing enzyme catalytic subunit 1 decreases expression EXP lead acetate results in decreased expression of APOBEC1 mRNA CTD PMID:22641619 NCBI chr 4:155,386,367...155,414,034
Ensembl chr 4:155,386,711...155,401,480
JBrowse link
G Apoc2 apolipoprotein C2 increases expression ISO lead acetate results in increased expression of APOC2 mRNA CTD PMID:22609695 NCBI chr 1:80,589,023...80,593,991
Ensembl chr 1:80,589,023...80,594,136
JBrowse link
G Apoe apolipoprotein E increases expression
increases methylation
ISO
EXP
lead acetate results in increased expression of APOE mRNA
lead acetate results in increased methylation of APOE gene
CTD PMID:21829687 PMID:29571894 PMID:29746905 NCBI chr 1:80,612,894...80,616,820
Ensembl chr 1:80,612,895...80,617,057
JBrowse link
G App amyloid beta precursor protein decreases methylation
multiple interactions
increases expression
EXP
ISO
lead acetate results in decreased methylation of APP promoter
[lead acetate results in increased abundance of Lead] which results in increased expression of APP mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of APP protein
lead acetate results in increased expression of APP mRNA; lead acetate results in increased expression of APP protein; lead acetate results in increased expression of APP protein alternative form; lead acetate results in increased expression of APP protein modified form
lead acetate results in increased expression of APP mRNA; lead acetate results in increased expression of APP protein; lead acetate results in increased expression of APP protein modified form
Proanthocyanidins inhibits the reaction [lead acetate results in increased expression of APP protein modified form]
[[lead acetate results in increased abundance of Lead] which co-treated with APP protein modified form] results in decreased expression of SYP protein; [lead acetate co-treated with tolfenamic acid] results in decreased expression of APP mRNA; [lead acetate results in increased abundance of Lead] promotes the reaction [[APP protein co-treated with APP protein modified form] results in decreased expression of GAP43 protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [[APP protein co-treated with APP protein modified form] results in decreased expression of SYP protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein binds to APP protein modified form]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein binds to APP protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein modified form binds to APP protein modified form]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein modified form results in decreased expression of GAP43 protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein modified form results in increased expression of BACE1 protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein results in decreased expression of GAP43 protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein results in decreased expression of SYP protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein results in increased expression of BACE1 protein]; tolfenamic acid inhibits the reaction [lead acetate results in increased expression of APP protein modified form]
CTD PMID:21117136 PMID:22279679 PMID:22764079 PMID:23867794 PMID:24462621 PMID:24806610 PMID:25088297 PMID:29908845 PMID:31730887 PMID:31843630 NCBI chr11:24,425,013...24,641,872
Ensembl chr11:24,425,005...24,641,858
JBrowse link
G Aprt adenine phosphoribosyl transferase decreases activity EXP
ISO
lead acetate results in decreased activity of APRT protein CTD PMID:19428946 NCBI chr19:55,387,288...55,389,256
Ensembl chr19:55,387,288...55,389,256
JBrowse link
G Ar androgen receptor increases expression ISO lead acetate results in increased expression of AR mRNA CTD PMID:21829687 NCBI chr  X:67,656,253...67,828,998
Ensembl chr  X:67,656,253...67,829,026
JBrowse link
G Arc activity-regulated cytoskeleton-associated protein decreases expression EXP lead acetate results in decreased expression of ARC mRNA CTD PMID:22641619 NCBI chr 7:115,907,097...115,911,059
Ensembl chr 7:115,907,097...115,910,541
JBrowse link
G Arfgap2 ADP-ribosylation factor GTPase activating protein 2 decreases expression ISO lead acetate results in decreased expression of ARFGAP2 mRNA CTD PMID:21829687 NCBI chr 3:80,081,541...80,093,659
Ensembl chr 3:80,081,647...80,093,658
JBrowse link
G Arfgef2 ADP ribosylation factor guanine nucleotide exchange factor 2 decreases expression ISO lead acetate results in decreased expression of ARFGEF2 mRNA CTD PMID:21829687 NCBI chr 3:163,570,435...163,656,612
Ensembl chr 3:163,570,532...163,656,626
JBrowse link
G Arglu1 arginine and glutamate rich 1 increases expression ISO lead acetate results in increased expression of ARGLU1 mRNA CTD PMID:21829687 NCBI chr16:86,600,877...86,625,084
Ensembl chr16:86,600,877...86,625,083
JBrowse link
G Arhgap17 Rho GTPase activating protein 17 decreases expression ISO lead acetate results in decreased expression of ARHGAP17 mRNA CTD PMID:21829687 NCBI chr 1:193,239,036...193,328,425
Ensembl chr 1:193,239,040...193,328,371
JBrowse link
G Arhgap24 Rho GTPase activating protein 24 increases expression ISO lead acetate results in increased expression of ARHGAP24 mRNA CTD PMID:20542052 NCBI chr14:8,383,211...8,600,526
Ensembl chr14:8,383,214...8,600,512
JBrowse link
G Arl1 ADP-ribosylation factor like GTPase 1 decreases expression ISO lead acetate results in decreased expression of ARL1 mRNA CTD PMID:21829687 NCBI chr 7:29,282,411...29,293,455
Ensembl chr 7:29,282,305...29,293,399
JBrowse link
G Arl8b ADP-ribosylation factor like GTPase 8B increases expression ISO lead acetate results in increased expression of ARL8B mRNA CTD PMID:20542052 NCBI chr 4:140,837,745...140,881,866
Ensembl chr 4:140,837,745...140,881,865
JBrowse link
G Arpin actin-related protein 2/3 complex inhibitor decreases expression EXP lead acetate results in decreased expression of ARPIN mRNA CTD PMID:22641619 NCBI chr 1:141,664,790...141,672,789
Ensembl chr 1:141,662,850...141,672,810
JBrowse link
G Arpp21 cAMP regulated phosphoprotein 21 decreases expression ISO lead acetate results in decreased expression of ARPP21 mRNA CTD PMID:20542052 NCBI chr 8:120,323,895...120,492,790
Ensembl chr 8:120,323,897...120,446,507
JBrowse link
G Arrdc4 arrestin domain containing 4 decreases expression
increases expression
ISO lead acetate results in decreased expression of ARRDC4 mRNA
lead acetate results in increased expression of ARRDC4 mRNA
CTD PMID:21829687 PMID:22839698 NCBI chr 1:129,766,097...129,780,076
Ensembl chr 1:129,766,100...129,780,356
JBrowse link
G Art3 ADP-ribosyltransferase 3 increases expression ISO lead acetate results in increased expression of ART3 mRNA CTD PMID:22609695 NCBI chr14:17,143,037...17,225,389
Ensembl chr14:17,143,040...17,225,389
JBrowse link
G Arvcf ARVCF, delta catenin family member decreases expression ISO lead acetate results in decreased expression of ARVCF mRNA CTD PMID:22609695 NCBI chr11:86,736,125...86,793,795
Ensembl chr11:86,736,142...86,793,791
JBrowse link
G Asah1 N-acylsphingosine amidohydrolase 1 increases expression ISO lead acetate results in increased expression of ASAH1 mRNA CTD PMID:21829687 NCBI chr16:53,998,604...54,030,006
Ensembl chr16:53,998,560...54,040,836
JBrowse link
G Asb14 ankyrin repeat and SOCS box-containing 14 decreases expression EXP
ISO
lead acetate results in decreased expression of ASB14 mRNA CTD PMID:22609695 PMID:22641619 NCBI chr16:2,537,209...2,556,930
Ensembl chr16:2,537,248...2,556,735
JBrowse link
G Asb6 ankyrin repeat and SOCS box-containing 6 increases expression ISO lead acetate results in increased expression of ASB6 mRNA CTD PMID:22609695 NCBI chr 3:9,659,707...9,664,445
Ensembl chr 3:9,659,710...9,664,318
JBrowse link
G Asb9 ankyrin repeat and SOCS box-containing 9 increases expression ISO lead acetate results in increased expression of ASB9 mRNA CTD PMID:22609695 NCBI chr  X:31,700,637...31,745,790
Ensembl chr  X:31,700,633...31,780,425
JBrowse link
G Asf1a anti-silencing function 1A histone chaperone multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of ASF1A mRNA CTD PMID:22839698 NCBI chr20:34,894,419...34,909,265
Ensembl chr20:34,894,419...34,909,265
JBrowse link
G Asl argininosuccinate lyase increases expression EXP lead acetate results in increased expression of ASL mRNA CTD PMID:11578147 NCBI chr12:30,160,922...30,178,348
Ensembl chr12:30,165,694...30,178,341
JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) increases expression EXP
ISO
lead acetate results in increased expression of ASNS mRNA CTD PMID:11578147 PMID:25270620 NCBI chr 4:33,742,876...33,761,106
Ensembl chr 4:33,743,364...33,761,163
JBrowse link
G Aspdh aspartate dehydrogenase domain containing increases expression EXP lead acetate results in increased expression of ASPDH mRNA CTD PMID:22641619 NCBI chr 1:100,471,066...100,473,327
Ensembl chr 1:100,470,722...100,473,459
JBrowse link
G Asph aspartate-beta-hydroxylase increases expression ISO lead acetate results in increased expression of ASPH mRNA CTD PMID:22839698 NCBI chr 5:22,577,680...22,799,333
Ensembl chr 5:22,577,675...22,799,349
JBrowse link
G Aspn asporin decreases expression EXP lead acetate results in decreased expression of ASPN mRNA CTD PMID:22641619 NCBI chr17:14,655,958...14,681,355
Ensembl chr17:14,656,009...14,679,409
JBrowse link
G Ass1 argininosuccinate synthase 1 decreases expression EXP lead acetate results in decreased expression of ASS1 mRNA CTD PMID:11578147 NCBI chr 3:10,327,411...10,375,847
Ensembl chr 3:10,327,414...10,375,826
JBrowse link
G Atf4 activating transcription factor 4 increases expression
decreases expression
EXP
ISO
lead acetate results in increased expression of ATF4 protein
lead acetate results in decreased expression of ATF4 mRNA
CTD PMID:22811615 PMID:24260418 NCBI chr 7:121,480,723...121,482,781
Ensembl chr 7:121,480,723...121,482,772
JBrowse link
G Atf6 activating transcription factor 6 increases expression EXP
ISO
lead acetate results in increased expression of ATF6 mRNA CTD PMID:11578147 PMID:21829687 NCBI chr13:89,053,457...89,242,531
Ensembl chr13:89,055,983...89,242,443
JBrowse link
G Atf7 activating transcription factor 7 increases expression ISO lead acetate results in increased expression of ATF7 mRNA CTD PMID:22609695 NCBI chr 7:144,131,382...144,223,463
Ensembl chr 7:144,136,325...144,223,429
JBrowse link
G Atm ATM serine/threonine kinase multiple interactions
increases phosphorylation
ISO ATM protein affects the reaction [lead acetate results in decreased expression of COX4 protein]; lead acetate promotes the reaction [PINK1 protein binds to ATM protein]
lead acetate results in increased phosphorylation of ATM protein
CTD PMID:29660402 NCBI chr 8:58,015,938...58,119,973
Ensembl chr 8:58,015,940...58,120,045
JBrowse link
G Atp12a ATPase H+/K+ transporting non-gastric alpha2 subunit increases expression ISO lead acetate results in increased expression of ATP12A mRNA CTD PMID:25270620 NCBI chr15:36,561,306...36,590,171
Ensembl chr15:36,565,495...36,590,171
JBrowse link
G Atp1b2 ATPase Na+/K+ transporting subunit beta 2 increases expression EXP lead acetate results in increased expression of ATP1B2 mRNA CTD PMID:22160880 NCBI chr10:56,205,622...56,211,879
Ensembl chr10:56,205,625...56,211,891
JBrowse link
G Atp6v1a ATPase H+ transporting V1 subunit A affects expression ISO lead acetate affects the expression of ATP6V1A protein CTD PMID:20797405 NCBI chr11:61,531,386...61,584,634
Ensembl chr11:61,531,416...61,584,634
JBrowse link
G Atp6v1b1 ATPase H+ transporting V1 subunit B1 increases expression ISO lead acetate results in increased expression of ATP6V1B1 mRNA CTD PMID:22609695 NCBI chr 4:115,417,100...115,435,754
Ensembl chr 4:115,416,580...115,437,206
JBrowse link
G Atp6v1b2 ATPase H+ transporting V1 subunit B2 increases expression EXP
ISO
lead acetate results in increased expression of ATP6V1B2 mRNA CTD PMID:11578147 PMID:25270620 NCBI chr16:22,326,537...22,350,143
Ensembl chr16:22,326,529...22,350,155
JBrowse link
G Atp6v1e1 ATPase H+ transporting V1 subunit E1 increases expression ISO lead acetate results in increased expression of ATP6V1E1 protein CTD PMID:20797405 NCBI chr 4:153,351,434...153,373,558
Ensembl chr 4:153,351,421...153,373,649
JBrowse link
G Atp6v1h ATPase H+ transporting V1 subunit H increases expression ISO lead acetate results in increased expression of ATP6V1H mRNA CTD PMID:25270620 NCBI chr 5:14,262,352...14,367,898
Ensembl chr 5:14,262,349...14,367,898
JBrowse link
G Atp7a ATPase copper transporting alpha multiple interactions
increases expression
decreases expression
EXP ATP7A protein modified form inhibits the reaction [lead acetate binds to HSPA5 protein]
lead acetate results in increased expression of ATP7A mRNA
lead acetate results in decreased expression of ATP7A mRNA; lead acetate results in decreased expression of ATP7A protein
CTD PMID:10702365 PMID:24316150 PMID:25579025 NCBI chr  X:77,076,085...77,193,644
Ensembl chr  X:77,076,106...77,193,644
JBrowse link
G Atp9b ATPase phospholipid transporting 9B (putative) increases expression ISO lead acetate results in increased expression of ATP9B mRNA CTD PMID:21829687 NCBI chr18:77,343,551...77,535,608
Ensembl chr18:77,343,551...77,535,593
JBrowse link
G Atxn1 ataxin 1 decreases expression EXP lead acetate results in decreased expression of ATXN1 mRNA CTD PMID:11578147 NCBI chr17:19,160,986...19,533,814
Ensembl chr17:19,249,952...19,533,814
JBrowse link
G Aurka aurora kinase A increases expression ISO lead acetate results in increased expression of AURKA mRNA CTD PMID:20542052 NCBI chr 3:170,364,177...170,380,278
Ensembl chr 3:170,364,181...170,378,210
JBrowse link
G Aurkc aurora kinase C increases expression ISO lead acetate results in increased expression of AURKC mRNA CTD PMID:22609695 NCBI chr 1:69,958,452...69,964,546
Ensembl chr 1:69,958,452...69,963,592
JBrowse link
G B3galt2 Beta-1,3-galactosyltransferase 2 decreases expression ISO lead acetate results in decreased expression of B3GALT2 mRNA CTD PMID:27562236 NCBI chr13:60,435,946...60,444,957
Ensembl chr13:60,435,946...60,444,957
JBrowse link
G B3galt6 Beta-1,3-galactosyltransferase 6 decreases methylation EXP lead acetate results in decreased methylation of B3GALT6 gene CTD PMID:29571894 NCBI chr 5:173,423,475...173,425,611
Ensembl chr 5:173,423,475...173,425,611
JBrowse link
G B3gat2 beta-1,3-glucuronyltransferase 2 decreases expression ISO lead acetate results in decreased expression of B3GAT2 mRNA CTD PMID:21829687 NCBI chr 9:29,984,077...30,068,649
Ensembl chr 9:29,984,077...30,068,649
JBrowse link
G B3gnt4 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 increases expression EXP lead acetate results in increased expression of B3GNT4 mRNA CTD PMID:22641619 NCBI chr12:38,503,361...38,506,793
Ensembl chr12:38,503,361...38,504,774
JBrowse link
G B4galnt1 beta-1,4-N-acetyl-galactosaminyl transferase 1 decreases expression ISO lead acetate results in decreased expression of B4GALNT1 mRNA CTD PMID:22609695 NCBI chr 7:70,439,273...70,459,556
Ensembl chr 7:70,452,579...70,459,880
JBrowse link
G B4galnt2 beta-1,4-N-acetyl-galactosaminyl transferase 2 increases expression ISO lead acetate results in increased expression of B4GALNT2 mRNA CTD PMID:22609695 NCBI chr10:83,677,768...83,701,487 JBrowse link
G Baat bile acid CoA:amino acid N-acyltransferase decreases expression ISO lead acetate results in decreased expression of BAAT mRNA CTD PMID:22609695 NCBI chr 5:64,768,397...64,777,368
Ensembl chr 5:64,768,401...64,777,368
JBrowse link
G Bace1 beta-secretase 1 increases expression
multiple interactions
ISO
EXP
lead acetate results in increased expression of BACE1 mRNA; lead acetate results in increased expression of BACE1 protein
[lead acetate results in increased abundance of Lead] which results in increased expression of BACE1 mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of BACE1 protein
[lead acetate results in increased abundance of Lead] promotes the reaction [APP protein modified form results in increased expression of BACE1 protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein results in increased expression of BACE1 protein]; [lead acetate results in increased abundance of Lead] which results in increased expression of BACE1 protein
CTD PMID:23867794 PMID:29908845 PMID:31730887 PMID:31843630 NCBI chr 8:50,140,092...50,162,388
Ensembl chr 8:50,139,997...50,162,361
JBrowse link
G Bad BCL2-associated agonist of cell death affects expression EXP lead acetate affects the expression of BAD protein CTD PMID:18618274 NCBI chr 1:222,198,516...222,207,459
Ensembl chr 1:222,198,534...222,207,453
JBrowse link
G Bag1 BAG cochaperone 1 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of BAG1 mRNA CTD PMID:12634122 NCBI chr 5:57,254,421...57,267,002
Ensembl chr 5:57,254,421...57,267,002
JBrowse link
G Baiap2l1 BAR/IMD domain containing adaptor protein 2 like 1 decreases expression EXP lead acetate results in decreased expression of BAIAP2L1 mRNA CTD PMID:22641619 NCBI chr12:12,226,967...12,321,172
Ensembl chr12:12,227,010...12,321,172
JBrowse link
G Barhl1 BarH-like homeobox 1 decreases expression ISO lead acetate results in decreased expression of BARHL1 mRNA CTD PMID:22609695 NCBI chr 3:7,491,234...7,498,555
Ensembl chr 3:7,491,234...7,498,555
JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions
increases expression
affects expression
decreases expression
EXP
ISO
[Cadmium Chloride co-treated with lead acetate] results in increased expression of BAX protein; [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of BAX protein; Acetylcysteine affects the reaction [lead acetate results in increased expression of BAX protein]; Ascorbic Acid inhibits the reaction [lead acetate results in increased expression of BAX protein]; Genistein affects the reaction [lead acetate results in increased expression of BAX protein]
lead acetate results in increased expression of BAX mRNA; lead acetate results in increased expression of BAX protein
NFE2L2 protein inhibits the reaction [lead acetate results in increased expression of BAX protein]
lead acetate affects the expression of BAX protein
lead acetate results in decreased expression of BAX mRNA; lead acetate results in decreased expression of BAX protein
CTD PMID:17959157 PMID:23086308 PMID:23146751 PMID:24960054 PMID:25031709 PMID:26396915 PMID:26498409 PMID:26542248 PMID:26797587 NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
JBrowse link
G Bbx BBX high mobility group box domain containing decreases methylation EXP lead acetate results in decreased methylation of BBX gene CTD PMID:29571894 NCBI chr11:52,983,286...53,228,557
Ensembl chr11:53,081,025...53,228,716
JBrowse link
G Bcat1 branched chain amino acid transaminase 1 increases expression EXP
ISO
lead acetate results in increased expression of BCAT1 mRNA CTD PMID:11578147 PMID:25270620 NCBI chr 4:179,259,305...179,340,021
Ensembl chr 4:179,259,308...179,339,795
JBrowse link
G Bccip BRCA2 and CDKN1A interacting protein decreases expression EXP lead acetate results in decreased expression of BCCIP mRNA CTD PMID:22641619 NCBI chr 1:205,777,474...205,789,887
Ensembl chr 1:205,777,130...205,790,175
JBrowse link
G Bche butyrylcholinesterase multiple interactions
increases activity
EXP ferulic acid promotes the reaction [lead acetate results in increased activity of BCHE protein] CTD PMID:25322819 NCBI chr 2:171,104,476...171,196,186
Ensembl chr 2:171,100,140...171,196,395
JBrowse link
G Bcl10 BCL10, immune signaling adaptor increases expression ISO lead acetate results in increased expression of BCL10 mRNA CTD PMID:20542052 NCBI chr 2:251,805,392...251,814,957
Ensembl chr 2:251,805,392...251,814,957
JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions
decreases expression
affects expression
increases expression
EXP
ISO
[Cadmium Chloride co-treated with lead acetate] results in decreased expression of BCL2 protein; [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in decreased expression of BCL2 protein; Ascorbic Acid promotes the reaction [lead acetate results in increased expression of BCL2 protein]; Genistein inhibits the reaction [lead acetate results in decreased expression of BCL2 protein]
NFE2L2 protein inhibits the reaction [lead acetate results in decreased expression of BCL2 protein]
lead acetate affects the expression of BCL2 protein
lead acetate results in decreased expression of BCL2 mRNA; lead acetate results in decreased expression of BCL2 protein
lead acetate results in increased expression of BCL2 mRNA
lead acetate affects the expression of BCL2 mRNA
CTD PMID:17959157 PMID:18618274 PMID:19026729 PMID:22609695 PMID:23086308 PMID:23146751 PMID:24960054 PMID:25031709 PMID:26396915 PMID:26498409 PMID:26542248 PMID:26797587 NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
JBrowse link
G Bcl2l1 Bcl2-like 1 affects expression
multiple interactions
ISO lead acetate affects the expression of BCL2L1 protein
HMOX1 protein affects the reaction [lead acetate affects the expression of BCL2L1 protein]
CTD PMID:26542248 NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
JBrowse link
G Bcl2l11 BCL2 like 11 increases expression ISO lead acetate results in increased expression of BCL2L11 mRNA CTD PMID:21829687 NCBI chr 3:120,726,906...120,764,192
Ensembl chr 3:120,726,906...120,764,192
JBrowse link
G Bco2 beta-carotene oxygenase 2 decreases expression ISO lead acetate results in decreased expression of BCO2 mRNA CTD PMID:22609695 NCBI chr 8:54,965,577...54,990,604
Ensembl chr 8:54,965,583...54,998,864
JBrowse link
G Bdh2 3-hydroxybutyrate dehydrogenase 2 increases expression ISO lead acetate results in increased expression of BDH2 mRNA CTD PMID:20542052 NCBI chr 2:240,461,505...240,482,149
Ensembl chr 2:240,461,505...240,482,145
JBrowse link
G Bdnf brain-derived neurotrophic factor multiple interactions
affects expression
decreases expression
decreases secretion
decreases response to substance
EXP
ISO
[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of BDNF protein; BDNF protein inhibits the reaction [lead acetate results in decreased expression of SYP protein]; BDNF protein inhibits the reaction [lead acetate results in decreased expression of VAMP2 protein]
lead acetate affects the expression of BDNF mRNA alternative form
lead acetate results in decreased expression of BDNF mRNA alternative form
lead acetate results in decreased expression of BDNF protein
lead acetate results in decreased secretion of BDNF protein
BDNF protein results in decreased susceptibility to lead acetate
CTD PMID:20375082 PMID:23146751 PMID:23680456 PMID:24260418 PMID:27492863 PMID:27984133 NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
JBrowse link
G Becn1 beclin 1 increases cleavage
increases expression
EXP lead acetate results in increased cleavage of BECN1 protein
lead acetate results in increased expression of BECN1 protein
CTD PMID:22811615 NCBI chr10:89,209,944...89,225,297
Ensembl chr10:89,209,940...89,225,297
JBrowse link
G Best3 bestrophin 3 decreases expression EXP lead acetate results in decreased expression of BEST3 mRNA CTD PMID:22641619 NCBI chr 7:59,971,084...60,057,162
Ensembl chr 7:60,015,998...60,057,152
JBrowse link
G Bex4 brain expressed, X-linked 4 increases expression EXP lead acetate results in increased expression of BEX4 mRNA CTD PMID:22641619
G Bglap bone gamma-carboxyglutamate protein multiple interactions
decreases expression
EXP Ethanol promotes the reaction [lead acetate results in decreased expression of BGLAP protein] CTD PMID:23376407 NCBI chr 2:187,741,770...187,748,445
Ensembl chr 2:187,741,770...187,742,747
JBrowse link
G Bhmt betaine-homocysteine S-methyltransferase decreases expression EXP lead acetate results in decreased expression of BHMT mRNA CTD PMID:22641619 NCBI chr 2:23,236,573...23,256,158
Ensembl chr 2:23,236,575...23,256,158
JBrowse link
G Bid BH3 interacting domain death agonist affects expression EXP lead acetate affects the expression of BID protein CTD PMID:18618274 NCBI chr 4:153,439,812...153,465,247
Ensembl chr 4:153,442,218...153,465,203
JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 decreases expression ISO lead acetate results in decreased expression of BIRC3 mRNA CTD PMID:21829687 NCBI chr 8:6,048,590...6,076,828
Ensembl chr 8:6,048,969...6,076,598
JBrowse link
G Bloc1s2 biogenesis of lysosomal organelles complex-1, subunit 2 increases expression EXP lead acetate results in increased expression of BLOC1S2 mRNA CTD PMID:22641619 NCBI chr 1:263,913,901...263,920,989
Ensembl chr 1:263,913,854...263,920,962
JBrowse link
G Blvrb biliverdin reductase B increases expression ISO lead acetate results in increased expression of BLVRB mRNA CTD PMID:25270620 NCBI chr 1:84,256,063...84,273,726
Ensembl chr 1:84,256,159...84,274,075
JBrowse link
G Bmp10 bone morphogenetic protein 10 increases methylation EXP lead acetate results in increased methylation of BMP10 gene CTD PMID:29571894 NCBI chr 4:119,224,906...119,230,534
Ensembl chr 4:119,225,040...119,230,728
JBrowse link
G Bmp2 bone morphogenetic protein 2 multiple interactions
decreases expression
increases expression
increases activity
ISO
EXP
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of BMP2 mRNA
lead acetate results in decreased expression of BMP2 mRNA
lead acetate results in increased expression of BMP2 mRNA
lead acetate results in increased activity of BMP2 protein
BMP2 promotes the reaction [lead acetate results in increased expression of ACAN mRNA]; BMP2 promotes the reaction [lead acetate results in increased expression of COL2A1 mRNA]; BMP2 promotes the reaction [lead acetate results in increased expression of SOX9 mRNA]; lead acetate inhibits the reaction [BMP2 protein results in increased phosphorylation of SMAD1 protein]; lead acetate inhibits the reaction [BMP2 protein results in increased phosphorylation of SMAD5 protein]; lead acetate inhibits the reaction [BMP2 protein results in increased phosphorylation of SMAD9 protein]; lead acetate promotes the reaction [BMP2 results in increased expression of ACAN mRNA]; lead acetate promotes the reaction [BMP2 results in increased expression of SOX9 mRNA]
CTD PMID:12634122 PMID:17805416 PMID:21829687 PMID:22641619 NCBI chr 3:126,335,963...126,346,771
Ensembl chr 3:126,335,863...126,346,318
JBrowse link
G Bmp3 bone morphogenetic protein 3 decreases expression EXP lead acetate results in decreased expression of BMP3 mRNA CTD PMID:22641619 NCBI chr14:12,362,912...12,387,572
Ensembl chr14:12,359,363...12,387,102
JBrowse link
G Bmp4 bone morphogenetic protein 4 multiple interactions
decreases expression
ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of BMP4 mRNA
lead acetate results in decreased expression of BMP4 mRNA
CTD PMID:12634122 PMID:22613225 NCBI chr15:20,776,060...20,791,013
Ensembl chr15:20,776,054...20,822,740
JBrowse link
G Bpifb3 BPI fold containing family B, member 3 increases expression ISO lead acetate results in increased expression of BPIFB3 mRNA CTD PMID:20542052 NCBI chr 3:149,401,890...149,416,506
Ensembl chr 3:149,401,890...149,416,506
JBrowse link
G Brca1 BRCA1, DNA repair associated decreases expression ISO lead acetate results in decreased expression of BRCA1 mRNA CTD PMID:22613225 NCBI chr10:89,394,821...89,455,093
Ensembl chr10:89,394,803...89,454,681
JBrowse link
G Bri3 brain protein I3 decreases expression ISO lead acetate results in decreased expression of BRI3 mRNA CTD PMID:21829687 NCBI chr12:12,322,247...12,330,929
Ensembl chr12:12,322,243...12,330,939
JBrowse link
G Bsg basigin (Ok blood group) multiple interactions
affects expression
ISO lead acetate results in decreased expression of and affects the localization of BSG protein
lead acetate affects the expression of BSG mRNA
CTD PMID:30615929 NCBI chr 7:12,875,536...12,882,753
Ensembl chr 7:12,875,537...12,882,753
JBrowse link
G Bsx brain specific homeobox decreases expression EXP lead acetate results in decreased expression of BSX mRNA CTD PMID:22641619 NCBI chr 8:45,061,670...45,065,430
Ensembl chr 8:45,061,670...45,065,430
JBrowse link
G Btbd1 BTB domain containing 1 increases expression ISO lead acetate results in increased expression of BTBD1 mRNA CTD PMID:22609695 NCBI chr 1:143,609,729...143,647,124
Ensembl chr 1:143,609,731...143,647,124
JBrowse link
G Btbd7 BTB domain containing 7 decreases expression ISO lead acetate results in decreased expression of BTBD7 mRNA CTD PMID:21829687 NCBI chr 6:126,658,398...126,748,497
Ensembl chr 6:126,661,634...126,710,858
JBrowse link
G Btbd9 BTB domain containing 9 increases expression ISO lead acetate results in increased expression of BTBD9 mRNA CTD PMID:20542052 NCBI chr20:8,899,286...9,253,936
Ensembl chr20:8,901,931...9,249,820
JBrowse link
G Btg2 BTG anti-proliferation factor 2 decreases expression EXP lead acetate results in decreased expression of BTG2 mRNA CTD PMID:22641619 NCBI chr13:50,913,185...50,916,944
Ensembl chr13:50,913,180...50,916,982
JBrowse link
G Btla B and T lymphocyte associated increases expression ISO lead acetate results in increased expression of BTLA mRNA CTD PMID:20542052 NCBI chr11:60,523,692...60,547,234
Ensembl chr11:60,524,917...60,547,201
JBrowse link
G Btnl7 butyrophilin-like 7 increases expression EXP lead acetate results in increased expression of BTNL7 mRNA CTD PMID:22641619 NCBI chr20:2,757,008...2,769,215
Ensembl chr20:2,757,004...2,768,426
JBrowse link
G Bub1 BUB1 mitotic checkpoint serine/threonine kinase decreases expression ISO lead acetate results in decreased expression of BUB1 mRNA CTD PMID:22613225 NCBI chr 3:120,373,604...120,404,910
Ensembl chr 3:120,373,604...120,404,910
JBrowse link
G C2 complement C2 increases expression ISO lead acetate results in increased expression of C2 mRNA CTD PMID:22609695 NCBI chr20:4,542,340...4,561,152
Ensembl chr20:4,542,340...4,561,152
JBrowse link
G C9 complement C9 decreases expression ISO lead acetate results in decreased expression of C9 mRNA CTD PMID:22609695 NCBI chr 2:55,775,562...55,823,807
Ensembl chr 2:55,775,274...55,823,826
JBrowse link
G Ca11 carbonic anhydrase 11 increases expression ISO lead acetate results in increased expression of CAR11 mRNA CTD PMID:20542052 NCBI chr 1:101,682,009...101,687,358
Ensembl chr 1:101,682,172...101,687,293
JBrowse link
G Ca13 carbonic anhydrase 13 affects expression EXP lead acetate affects the expression of CAR13 mRNA CTD PMID:22641619 NCBI chr 2:88,282,961...88,314,254
Ensembl chr 2:88,282,961...88,314,254
JBrowse link
G Ca14 carbonic anhydrase 14 affects expression EXP lead acetate affects the expression of CAR14 mRNA CTD PMID:21864555 NCBI chr 2:198,010,142...198,017,635
Ensembl chr 2:198,010,349...198,016,898
JBrowse link
G Ca8 carbonic anhydrase 8 decreases expression ISO lead acetate results in decreased expression of CAR8 mRNA CTD PMID:22613225 NCBI chr 5:21,249,018...21,345,810
Ensembl chr 5:21,249,020...21,345,810
JBrowse link
G Cables1 Cdk5 and Abl enzyme substrate 1 increases expression EXP lead acetate results in increased expression of CABLES1 mRNA CTD PMID:22641619 NCBI chr18:3,317,724...3,421,721
Ensembl chr18:3,317,724...3,421,721
JBrowse link
G Cacna1f calcium voltage-gated channel subunit alpha1 F decreases expression EXP lead acetate results in decreased expression of CACNA1F mRNA CTD PMID:22641619 NCBI chr  X:15,712,709...15,741,135
Ensembl chr  X:15,712,713...15,741,103
JBrowse link
G Cacna2d4 calcium voltage-gated channel auxiliary subunit alpha2delta 4 decreases expression EXP lead acetate results in decreased expression of CACNA2D4 mRNA CTD PMID:22641619 NCBI chr 4:151,298,548...151,409,263
Ensembl chr 4:151,298,548...151,409,263
JBrowse link
G Calb2 calbindin 2 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased expression of CALB2 protein; Ascorbic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of CALB2 protein] CTD PMID:31708536 NCBI chr19:41,482,743...41,509,617
Ensembl chr19:41,482,728...41,509,658
JBrowse link
G Calca calcitonin-related polypeptide alpha decreases expression
multiple interactions
EXP lead acetate results in decreased expression of CALCA mRNA; lead acetate results in decreased expression of CALCA protein
[Ethanol co-treated with lead acetate] results in increased expression of CALCA protein
CTD PMID:22641619 PMID:23376407 NCBI chr 1:184,184,018...184,188,922
Ensembl chr 1:184,184,020...184,188,911
JBrowse link
G Cald1 caldesmon 1 decreases expression EXP lead acetate results in decreased expression of CALD1 mRNA CTD PMID:11578147 NCBI chr 4:62,103,948...62,291,375
Ensembl chr 4:62,220,736...62,291,489
JBrowse link
G Calml3 calmodulin-like 3 increases expression EXP lead acetate results in increased expression of CALML3 mRNA CTD PMID:11578147 NCBI chr17:70,070,458...70,073,697
Ensembl chr17:70,072,156...70,073,530
JBrowse link
G Calr calreticulin decreases expression ISO lead acetate results in decreased expression of CALR mRNA CTD PMID:21829687 NCBI chr19:25,956,771...25,961,666
Ensembl chr19:25,956,771...25,961,666
JBrowse link
G Calu calumenin increases expression ISO lead acetate results in increased expression of CALU mRNA CTD PMID:20542052 NCBI chr 4:56,625,611...56,653,112
Ensembl chr 4:56,625,561...56,653,111
JBrowse link
G Camk2a calcium/calmodulin-dependent protein kinase II alpha decreases expression
multiple interactions
decreases phosphorylation
EXP
ISO
lead acetate results in decreased expression of CAMK2A mRNA
[lead acetate results in increased abundance of Lead] which results in increased expression of and results in decreased phosphorylation of CAMK2A protein
Quercetin inhibits the reaction [lead acetate results in decreased phosphorylation of CAMK2A protein]
CTD PMID:22160880 PMID:23855546 PMID:30905827 NCBI chr18:56,193,978...56,295,869
Ensembl chr18:56,193,978...56,295,869
JBrowse link
G Camk2d calcium/calmodulin-dependent protein kinase II delta decreases expression EXP lead acetate results in decreased expression of CAMK2D mRNA CTD PMID:22641619 NCBI chr 2:230,900,907...231,132,207
Ensembl chr 2:230,901,126...231,132,039
JBrowse link
G Camk2n2 calcium/calmodulin-dependent protein kinase II inhibitor 2 decreases expression ISO lead acetate results in decreased expression of CAMK2N2 mRNA CTD PMID:20542052 NCBI chr11:83,975,430...83,976,557
Ensembl chr11:83,975,367...83,976,588
JBrowse link
G Cand1 cullin-associated and neddylation-dissociated 1 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of CAND1 mRNA CTD PMID:22839698 NCBI chr 7:62,124,362...62,162,451
Ensembl chr 7:62,124,362...62,162,453
JBrowse link
G Capsl calcyphosine-like increases expression EXP lead acetate results in increased expression of CAPSL mRNA CTD PMID:22641619 NCBI chr 2:58,724,855...58,755,220
Ensembl chr 2:58,724,855...58,747,843
JBrowse link
G Card14 caspase recruitment domain family, member 14 decreases expression ISO lead acetate results in decreased expression of CARD14 mRNA CTD PMID:22609695 NCBI chr10:108,440,480...108,469,012
Ensembl chr10:108,440,950...108,468,310
JBrowse link
G Cars cysteinyl-tRNA synthetase increases expression EXP lead acetate results in increased expression of CARS mRNA CTD PMID:11578147 NCBI chr 1:216,759,367...216,801,652
Ensembl chr 1:216,759,366...216,801,656
JBrowse link
G Casp1 caspase 1 increases expression ISO lead acetate results in increased expression of CASP1 mRNA CTD PMID:22609695 NCBI chr 8:2,605,743...2,614,637
Ensembl chr 8:2,604,962...2,614,631
JBrowse link
G Casp3 caspase 3 increases expression
increases activity
increases cleavage
multiple interactions
affects expression
decreases expression
EXP
ISO
lead acetate results in increased expression of CASP3 mRNA; lead acetate results in increased expression of CASP3 protein
lead acetate results in increased activity of CASP3 protein
lead acetate results in increased cleavage of CASP3 protein
HMOX1 protein affects the reaction [lead acetate affects the expression of CASP3 protein]; NFE2L2 protein inhibits the reaction [lead acetate results in increased activity of CASP3 protein]
[Cadmium Chloride co-treated with lead acetate] results in increased expression of CASP3 protein; [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased expression of CASP3 protein modified form; Biological Factors inhibits the reaction [lead acetate results in increased expression of CASP3 mRNA]; Biological Factors inhibits the reaction [lead acetate results in increased expression of CASP3 protein]; Genistein inhibits the reaction [lead acetate results in increased cleavage of CASP3 protein]; lead acetate promotes the reaction [sodium arsenite results in increased expression of CASP3 mRNA]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [lead acetate promotes the reaction [sodium arsenite results in increased expression of CASP3 mRNA]]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [lead acetate results in increased expression of CASP3 mRNA]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite promotes the reaction [lead acetate results in increased expression of CASP3 mRNA]]; Plant Oils inhibits the reaction [lead acetate results in increased expression of CASP3 protein]; Plant Preparations inhibits the reaction [lead acetate results in increased expression of CASP3 mRNA]; Plant Preparations inhibits the reaction [lead acetate results in increased expression of CASP3 protein]; sodium arsenite promotes the reaction [lead acetate results in increased expression of CASP3 mRNA]; sodium bisulfide inhibits the reaction [lead acetate results in increased expression of CASP3 protein]; sodium boranocarbonate inhibits the reaction [lead acetate results in increased expression of CASP3 protein]
lead acetate results in increased expression of CASP3 protein; lead acetate results in increased expression of CASP3 protein modified form
[S-allylcysteine co-treated with Clotrimazole] inhibits the reaction [lead acetate results in increased activity of CASP3 protein]; Clotrimazole inhibits the reaction [lead acetate results in increased activity of CASP3 protein]; MIR671 mRNA inhibits the reaction [lead acetate results in increased expression of CASP3 protein]; PPARGC1A protein inhibits the reaction [lead acetate results in increased activity of CASP3 protein]; S-allylcysteine inhibits the reaction [lead acetate results in increased activity of CASP3 protein]
lead acetate results in decreased expression of CASP3 mRNA
CTD PMID:19026729 PMID:21640820 PMID:22033380 PMID:23146751 PMID:23318731 PMID:23680456 PMID:23906897 PMID:25031709 PMID:26498409 PMID:26542248 PMID:26797587 PMID:27236077 PMID:27604105 PMID:30251767 PMID:30703413 PMID:30980911 NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
JBrowse link
G Casp8 caspase 8 multiple interactions
increases activity
ISO 1,3-dimethylthiourea inhibits the reaction [lead acetate results in increased activity of CASP8 protein]; [S-allylcysteine co-treated with Clotrimazole] inhibits the reaction [lead acetate results in increased activity of CASP8 protein]; Clotrimazole inhibits the reaction [lead acetate results in increased activity of CASP8 protein]; Imipramine inhibits the reaction [lead acetate results in increased activity of CASP8 protein]; S-allylcysteine inhibits the reaction [lead acetate results in increased activity of CASP8 protein] CTD PMID:22033380 NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
JBrowse link
G Casp9 caspase 9 increases expression
multiple interactions
increases activity
EXP
ISO
lead acetate results in increased expression of CASP9 mRNA
lead acetate results in increased expression of CASP9 protein
MIR671 mRNA inhibits the reaction [lead acetate results in increased expression of CASP9 protein]; PPARGC1A protein inhibits the reaction [lead acetate results in increased activity of CASP9 protein]
[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased cleavage of CASP9 protein; IL1RN protein inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased cleavage of CASP9 protein]; lead acetate promotes the reaction [sodium arsenite results in increased expression of CASP9 mRNA]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [lead acetate promotes the reaction [sodium arsenite results in increased expression of CASP9 mRNA]]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [lead acetate results in increased expression of CASP9 mRNA]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite promotes the reaction [lead acetate results in increased expression of CASP9 mRNA]]; SB 203580 inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased cleavage of CASP9 protein]; sodium arsenite promotes the reaction [lead acetate results in increased expression of CASP9 mRNA]
CTD PMID:23906897 PMID:26396915 PMID:27236077 PMID:27604105 NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
JBrowse link
G Cat catalase multiple interactions
increases expression
affects activity
decreases expression
decreases activity
increases activity
ISO
EXP
[lead acetate results in increased abundance of Lead] which results in decreased activity of CAT protein; [lead acetate results in increased abundance of Lead] which results in decreased expression of CAT mRNA; [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of CAT mRNA; Ascorbic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased activity of CAT protein]; Ascorbic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of CAT mRNA]; rosmarinic acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased activity of CAT protein]; rosmarinic acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of CAT mRNA]
lead acetate results in increased expression of CAT mRNA
lead acetate results in increased expression of CAT mRNA; lead acetate results in increased expression of CAT protein
lead acetate affects the activity of CAT protein
lead acetate results in decreased expression of CAT protein
lead acetate results in decreased activity of CAT protein
[S-allylcysteine co-treated with Clotrimazole] inhibits the reaction [lead acetate results in decreased activity of CAT protein]; Clotrimazole inhibits the reaction [lead acetate results in decreased activity of CAT protein]; S-allylcysteine inhibits the reaction [lead acetate results in decreased activity of CAT protein]
lead acetate results in increased activity of CAT protein
3-nitropropionic acid affects the reaction [[lead acetate results in increased abundance of Lead] affects the reaction [Ethanol affects the expression of CAT protein]]; 3-nitropropionic acid affects the reaction [[lead acetate results in increased abundance of Lead] which affects the expression of CAT protein]; [cadmium acetate co-treated with lead acetate] results in increased activity of CAT protein; [lead acetate co-treated with Cadmium Chloride] results in decreased activity of CAT protein; [lead acetate results in increased abundance of Lead] affects the reaction [Ethanol affects the expression of CAT protein]; [lead acetate results in increased abundance of Lead] which affects the expression of CAT protein; [Zinc co-treated with Iron co-treated with Calcium] inhibits the reaction [lead acetate results in decreased expression of CAT protein]; Amitrole affects the reaction [[lead acetate results in increased abundance of Lead] affects the reaction [Ethanol affects the expression of CAT protein]]; Amitrole affects the reaction [[lead acetate results in increased abundance of Lead] which affects the expression of CAT protein]; Biological Factors inhibits the reaction [lead acetate results in decreased activity of CAT protein]; epigallocatechin gallate inhibits the reaction [lead acetate results in decreased activity of CAT protein]; Genistein inhibits the reaction [lead acetate results in decreased expression of CAT protein]; lead acetate promotes the reaction [sodium arsenite results in decreased activity of CAT protein]; lead acetate results in decreased expression of and results in decreased activity of CAT protein; lead acetate results in increased expression of and results in decreased activity of CAT protein; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [lead acetate promotes the reaction [sodium arsenite results in decreased activity of CAT protein]]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [lead acetate results in decreased activity of CAT protein]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite promotes the reaction [lead acetate results in decreased activity of CAT protein]]; Plant Oils inhibits the reaction [lead acetate affects the activity of CAT protein]; Plant Preparations inhibits the reaction [lead acetate results in decreased activity of CAT protein]; sodium arsenite promotes the reaction [lead acetate results in decreased activity of CAT protein]
CTD PMID:12634122 PMID:15569323 PMID:16897041 PMID:19347332 PMID:22033380 PMID:22197700 PMID:22534743 PMID:23906897 PMID:24184865 PMID:24222729 PMID:24970117 PMID:25800560 PMID:26797587 PMID:30251767 PMID:30510688 PMID:30623991 PMID:30703413 PMID:31054310 PMID:31550440 PMID:31610155 NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
JBrowse link
G Cav1 caveolin 1 decreases expression
increases expression
EXP lead acetate results in decreased expression of CAV1 mRNA
lead acetate results in increased expression of CAV1 mRNA
CTD PMID:11578147 PMID:22641619 NCBI chr 4:44,597,123...44,630,206
Ensembl chr 4:44,597,123...44,630,200
JBrowse link
G Cbl Cbl proto-oncogene multiple interactions
increases phosphorylation
EXP CBL protein affects the reaction [lead acetate results in decreased expression of PDGFRA protein]
lead acetate results in increased phosphorylation of CBL protein
CTD PMID:17298174 NCBI chr 8:48,481,256...48,564,775
Ensembl chr 8:48,489,036...48,564,722
JBrowse link
G Cblb Cbl proto-oncogene B decreases expression ISO lead acetate results in decreased expression of CBLB mRNA CTD PMID:21829687 NCBI chr11:51,037,383...51,202,761
Ensembl chr11:51,037,393...51,202,820
JBrowse link
G Cbx1 chromobox 1 decreases expression ISO lead acetate results in decreased expression of CBX1 mRNA CTD PMID:21829687 NCBI chr10:84,656,698...84,677,112
Ensembl chr10:84,669,914...84,675,741
JBrowse link
G Cbx7 chromobox 7 increases expression ISO lead acetate results in increased expression of CBX7 mRNA CTD PMID:22613225 NCBI chr 7:121,136,067...121,153,503
Ensembl chr 7:121,136,058...121,153,383
JBrowse link
G Ccdc117 coiled-coil domain containing 117 decreases expression ISO lead acetate results in decreased expression of CCDC117 mRNA CTD PMID:21829687 NCBI chr14:85,763,396...85,772,762
Ensembl chr14:85,763,397...85,772,762
JBrowse link
G Ccdc18 coiled-coil domain containing 18 increases expression ISO lead acetate results in increased expression of CCDC18 mRNA CTD PMID:22613225 NCBI chr14:1,664,620...1,701,269
NCBI chr14:2,510,184...2,612,070
Ensembl chr14:2,509,363...2,610,929
JBrowse link
G Ccdc6 coiled-coil domain containing 6 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of CCDC6 mRNA CTD PMID:22839698 NCBI chr20:19,729,005...19,825,219
Ensembl chr20:19,732,894...19,825,150
JBrowse link
G Ccdc80 coiled-coil domain containing 80 decreases expression ISO lead acetate results in decreased expression of CCDC80 mRNA CTD PMID:20542052 NCBI chr11:60,645,660...60,679,249
Ensembl chr11:60,645,086...60,679,555
JBrowse link
G Cckar cholecystokinin A receptor decreases expression ISO lead acetate results in decreased expression of CCKAR mRNA CTD PMID:22613225 NCBI chr14:59,610,939...59,619,786
Ensembl chr14:59,611,434...59,619,783
JBrowse link
G Ccl1 C-C motif chemokine ligand 1 increases expression ISO lead acetate results in increased expression of CCL1 mRNA CTD PMID:20542052 NCBI chr10:69,534,976...69,537,836
Ensembl chr10:69,534,933...69,537,882
JBrowse link
G Ccl12 chemokine (C-C motif) ligand 12 increases expression ISO lead acetate results in increased expression of CCL12 mRNA CTD PMID:20542052 NCBI chr10:69,476,866...69,478,416
Ensembl chr10:69,476,775...69,478,462
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions
increases secretion
decreases expression
ISO 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in increased secretion of CCL2 protein]; [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with U 0126] inhibits the reaction [lead acetate results in increased secretion of CCL2 protein]; Celecoxib inhibits the reaction [lead acetate results in increased secretion of CCL2 protein]; Minocycline inhibits the reaction [lead acetate results in increased secretion of CCL2 protein]; U 0126 inhibits the reaction [lead acetate results in increased secretion of CCL2 protein]
lead acetate results in decreased expression of CCL2 mRNA
CTD PMID:21829687 PMID:24530660 NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
JBrowse link
G Ccl28 C-C motif chemokine ligand 28 increases expression ISO lead acetate results in increased expression of CCL28 mRNA CTD PMID:22609695 NCBI chr 2:52,379,341...52,403,979
Ensembl chr 2:52,379,341...52,404,246
JBrowse link
G Ccl3 C-C motif chemokine ligand 3 multiple interactions ISO lead acetate promotes the reaction [Hemagglutinins results in increased secretion of CCL3 protein] CTD PMID:22839698 NCBI chr10:70,869,516...70,871,066
Ensembl chr10:70,869,513...70,871,066
JBrowse link
G Ccl5 C-C motif chemokine ligand 5 increases expression ISO lead acetate results in increased expression of CCL5 mRNA CTD PMID:29746905 NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
JBrowse link
G Ccn1 cellular communication network factor 1 affects expression EXP lead acetate affects the expression of CCN1 mRNA CTD PMID:22641619 NCBI chr 2:251,529,354...251,532,312
Ensembl chr 2:251,529,354...251,532,312
JBrowse link
G Ccn2 cellular communication network factor 2 decreases expression ISO lead acetate results in decreased expression of CCN2 mRNA CTD PMID:25270620 NCBI chr 1:21,851,657...21,854,773
Ensembl chr 1:21,851,660...21,854,773
JBrowse link
G Ccnd1 cyclin D1 multiple interactions
decreases expression
increases expression
ISO APEX1 protein promotes the reaction [lead acetate results in increased expression of CCND1 protein]; E 3330 inhibits the reaction [lead acetate results in increased expression of CCND1 protein]
lead acetate results in decreased expression of CCND1 mRNA
CTD PMID:23370007 PMID:25270620 NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
JBrowse link
G Ccne1 cyclin E1 decreases expression ISO lead acetate results in decreased expression of CCNE1 mRNA CTD PMID:25270620 NCBI chr 1:94,485,830...94,495,112
Ensembl chr 1:94,485,832...94,494,980
JBrowse link
G Ccr2 C-C motif chemokine receptor 2 increases expression EXP
ISO
lead acetate results in increased expression of CCR2 mRNA CTD PMID:22609695 PMID:22641619
G Ccr4 C-C motif chemokine receptor 4 increases expression ISO lead acetate results in increased expression of CCR4 mRNA CTD PMID:20542052 NCBI chr 8:122,530,152...122,535,959
Ensembl chr 8:122,530,624...122,532,070
JBrowse link
G Ccr7 C-C motif chemokine receptor 7 decreases expression ISO lead acetate results in decreased expression of CCR7 mRNA CTD PMID:20542052 NCBI chr10:87,057,335...87,067,444
Ensembl chr10:87,057,136...87,067,456
JBrowse link
G Ccr8 C-C motif chemokine receptor 8 increases expression ISO lead acetate results in increased expression of CCR8 mRNA CTD PMID:22609695 NCBI chr 8:128,779,552...128,782,531
Ensembl chr 8:128,781,395...128,782,456
JBrowse link
G Ccs copper chaperone for superoxide dismutase increases expression ISO lead acetate results in increased expression of CCS mRNA CTD PMID:29746905 NCBI chr 1:220,075,251...220,096,319
Ensembl chr 1:220,075,247...220,096,404
JBrowse link
G Cd163 CD163 molecule increases expression EXP lead acetate results in increased expression of CD163 mRNA CTD PMID:22641619 NCBI chr 4:156,752,063...156,785,467
Ensembl chr 4:156,752,082...156,785,467
JBrowse link
G Cd247 Cd247 molecule increases expression ISO lead acetate results in increased expression of CD247 mRNA CTD PMID:20542052 NCBI chr13:83,996,045...84,071,408
Ensembl chr13:83,996,080...84,071,400
JBrowse link
G Cd27 CD27 molecule increases expression
decreases expression
ISO lead acetate results in increased expression of CD27 mRNA
lead acetate results in decreased expression of CD27 mRNA
CTD PMID:20542052 PMID:21829687 NCBI chr 4:157,744,881...157,751,609
Ensembl chr 4:157,744,882...157,750,088
JBrowse link
G Cd300c2 CD300C molecule 2 increases expression ISO lead acetate results in increased expression of CD300C2 mRNA CTD PMID:22609695 NCBI chr10:104,997,205...104,999,942
Ensembl chr10:104,975,877...105,051,965
JBrowse link
G Cd36 CD36 molecule increases expression ISO lead acetate results in increased expression of CD36 mRNA CTD PMID:30623991 NCBI chr 4:14,150,309...14,191,498
Ensembl chr 4:14,001,761...14,249,749
JBrowse link
G Cd3e CD3e molecule increases expression
increases methylation
EXP lead acetate results in increased expression of CD3E mRNA
lead acetate results in increased methylation of CD3E gene
CTD PMID:22641619 PMID:29571894 NCBI chr 8:49,297,604...49,309,370
Ensembl chr 8:49,297,608...49,308,806
JBrowse link
G Cd40 CD40 molecule multiple interactions ISO [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of CD40 protein CTD PMID:17512567 NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
JBrowse link
G Cd47 Cd47 molecule decreases expression ISO lead acetate results in decreased expression of CD47 mRNA CTD PMID:20542052 NCBI chr11:53,511,485...53,575,754
Ensembl chr11:53,514,595...53,575,175
JBrowse link
G Cd48 Cd48 molecule increases expression EXP lead acetate results in increased expression of CD48 mRNA CTD PMID:22641619 NCBI chr13:90,116,601...90,140,371
Ensembl chr13:90,116,843...90,140,371
JBrowse link
G Cd59 CD59 molecule increases mutagenesis ISO lead acetate results in increased mutagenesis of CD59 protein CTD PMID:17045307 NCBI chr 3:94,010,481...94,028,660
Ensembl chr 3:94,010,475...94,028,621
JBrowse link
G Cd68 Cd68 molecule increases expression ISO lead acetate results in increased expression of CD68 mRNA CTD PMID:21829687 NCBI chr10:56,268,726...56,270,605
Ensembl chr10:56,268,720...56,270,640
JBrowse link
G Cd79a CD79a molecule decreases expression ISO lead acetate results in decreased expression of CD79A mRNA CTD PMID:22609695 NCBI chr 1:81,763,609...81,768,039
Ensembl chr 1:81,763,614...81,767,980
JBrowse link
G Cd80 Cd80 molecule multiple interactions ISO [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of CD80 protein CTD PMID:17512567 NCBI chr11:64,815,201...64,855,293
Ensembl chr11:64,827,635...64,855,353
JBrowse link
G Cd86 CD86 molecule multiple interactions ISO [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of CD86 protein CTD PMID:17512567 NCBI chr11:67,060,305...67,117,990
Ensembl chr11:67,082,193...67,118,795
JBrowse link
G Cd93 CD93 molecule decreases expression EXP
ISO
lead acetate results in decreased expression of CD93 mRNA CTD PMID:22613225 PMID:22641619 NCBI chr 3:142,778,798...142,783,774
Ensembl chr 3:142,778,770...142,783,774
JBrowse link
G Cd99 CD99 molecule (Xg blood group) decreases expression ISO lead acetate results in decreased expression of CD99 mRNA CTD PMID:21829687 NCBI chr20:56,192,426...56,196,961
Ensembl chr20:56,192,390...56,197,025
JBrowse link
G Cdc42ep5 CDC42 effector protein 5 decreases expression EXP lead acetate results in decreased expression of CDC42EP5 mRNA CTD PMID:22641619 NCBI chr 1:73,717,207...73,719,600
Ensembl chr 1:73,719,005...73,719,529
JBrowse link
G Cdc45 cell division cycle 45 increases expression ISO lead acetate results in increased expression of CDC45 mRNA CTD PMID:21829687 NCBI chr11:86,328,785...86,354,099
Ensembl chr11:86,329,012...86,358,453
JBrowse link
G Cdc6 cell division cycle 6 decreases expression ISO lead acetate results in decreased expression of CDC6 mRNA CTD PMID:20542052 NCBI chr10:86,819,477...86,833,301
Ensembl chr10:86,819,472...86,833,402
JBrowse link
G Cdca8 cell division cycle associated 8 increases expression ISO lead acetate results in increased expression of CDCA8 mRNA CTD PMID:21829687 NCBI chr 5:142,911,310...142,933,536
Ensembl chr 5:142,911,305...142,933,526
JBrowse link
G Cdh11 cadherin 11 decreases expression EXP lead acetate results in decreased expression of CDH11 mRNA CTD PMID:11578147 NCBI chr19:2,391,181...2,551,245
Ensembl chr19:2,393,059...2,551,245
JBrowse link
G Cdh17 cadherin 17 increases expression ISO lead acetate results in increased expression of CDH17 mRNA CTD PMID:22609695 NCBI chr 5:25,354,187...25,443,675
Ensembl chr 5:25,391,115...25,443,718
JBrowse link
G Cdh19 cadherin 19 decreases expression EXP lead acetate results in decreased expression of CDH19 mRNA CTD PMID:22641619 NCBI chr13:32,344,954...32,469,887
Ensembl chr13:32,344,966...32,427,177
JBrowse link
G Cdh3 cadherin 3 affects expression EXP lead acetate affects the expression of CDH3 mRNA CTD PMID:22641619 NCBI chr19:38,668,957...38,719,801
Ensembl chr19:38,669,230...38,719,677
JBrowse link
G Cdh7 cadherin 7 decreases expression EXP lead acetate results in decreased expression of CDH7 mRNA CTD PMID:22641619 NCBI chr13:31,081,064...31,228,884
Ensembl chr13:31,081,804...31,231,213
JBrowse link
G Cdk1 cyclin-dependent kinase 1 increases methylation EXP lead acetate results in increased methylation of CDK1 gene CTD PMID:29571894 NCBI chr20:20,576,341...20,591,510
Ensembl chr20:20,576,377...20,591,549
JBrowse link
G Cdk13 cyclin-dependent kinase 13 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of CDK13 mRNA CTD PMID:22839698 NCBI chr17:49,833,194...49,922,932
Ensembl chr17:49,833,400...49,921,550
JBrowse link
G Cdk5 cyclin-dependent kinase 5 multiple interactions
increases expression
increases cleavage
EXP
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of CDK5 protein]; [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] promotes the reaction [CDK5 protein results in increased phosphorylation of PPARG protein]; [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of CDK5 protein; pyrazolanthrone inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of CDK5 protein]
lead acetate results in increased expression of CDK5 mRNA; lead acetate results in increased expression of CDK5 protein
lead acetate results in increased cleavage of CDK5 protein
CTD PMID:24481447 PMID:24954411 PMID:27012722 PMID:27293183 NCBI chr 4:7,282,945...7,287,427
Ensembl chr 4:7,282,948...7,288,383
JBrowse link
G Cdk5r1 cyclin-dependent kinase 5 regulatory subunit 1 multiple interactions ISO lead acetate affects the reaction [MAPT protein affects the abundance of CDK5R1 protein modified form]; lead acetate results in decreased expression of and results in increased cleavage of CDK5R1 protein CTD PMID:24954411 PMID:29203278 NCBI chr10:67,862,054...67,863,255
Ensembl chr10:67,862,054...67,863,255
JBrowse link
G Cdkal1 CDK5 regulatory subunit associated protein 1-like 1 increases expression ISO lead acetate results in increased expression of CDKAL1 mRNA CTD PMID:21829687 NCBI chr17:36,451,031...37,157,882
Ensembl chr17:36,451,058...37,295,069
JBrowse link
G Cdkl4 cyclin-dependent kinase-like 4 increases expression EXP lead acetate results in increased expression of CDKL4 mRNA CTD PMID:22641619 NCBI chr 6:3,232,278...3,272,454
Ensembl chr 6:3,234,090...3,254,779
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A multiple interactions
increases expression
ISO
EXP
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of CDKN1A mRNA
lead acetate results in increased expression of CDKN1A mRNA
CTD PMID:12634122 PMID:22641619 NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of CDKN2A mRNA CTD PMID:12634122 NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 increases expression EXP lead acetate results in increased expression of CDKN3 mRNA CTD PMID:22641619 NCBI chr15:23,553,171...23,564,538
Ensembl chr15:23,553,128...23,564,535
JBrowse link
G Cdon cell adhesion associated, oncogene regulated increases expression ISO lead acetate results in increased expression of CDON mRNA CTD PMID:22609695 NCBI chr 8:36,625,757...36,712,091
Ensembl chr 8:36,625,733...36,710,949
JBrowse link
G Cdr2 cerebellar degeneration-related protein 2 affects expression EXP lead acetate affects the expression of CDR2 mRNA CTD PMID:21864555 NCBI chr 1:190,889,698...190,914,606
Ensembl chr 1:190,889,701...190,914,610
JBrowse link
G Cds2 CDP-diacylglycerol synthase 2 increases expression ISO lead acetate results in increased expression of CDS2 mRNA CTD PMID:21829687 NCBI chr 3:124,896,657...124,935,221
Ensembl chr 3:124,896,618...124,935,226
JBrowse link
G Ceacam1 CEA cell adhesion molecule 1 decreases expression
affects methylation
increases methylation
increases expression
EXP
ISO
lead acetate results in decreased expression of CEACAM1 mRNA
lead acetate affects the methylation of CEACAM3 gene
lead acetate results in increased methylation of CEACAM1 gene
lead acetate results in increased expression of CEACAM1 mRNA
CTD PMID:22609695 PMID:22641619 PMID:29571894 NCBI chr 1:82,327,955...82,344,345
Ensembl chr 1:82,327,955...82,344,345
JBrowse link
G Ceacam12 CEA cell adhesion molecule 12 increases expression ISO lead acetate results in increased expression of CEACAM11 mRNA CTD PMID:22609695 NCBI chr 1:79,474,809...79,481,865
Ensembl chr 1:79,474,809...79,481,865
JBrowse link
G Ceacam4 CEA cell adhesion molecule 4 increases expression EXP lead acetate results in increased expression of CEACAM10 mRNA CTD PMID:22641619 NCBI chr 1:81,643,809...81,650,085
Ensembl chr 1:81,643,816...81,650,094
JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha increases expression
increases methylation
decreases expression
ISO
EXP
lead acetate results in increased expression of CEBPA mRNA
lead acetate results in increased methylation of CEBPA gene
lead acetate results in decreased expression of CEBPA mRNA
CTD PMID:20542052 PMID:21829687 PMID:29571894 NCBI chr 1:91,363,492...91,366,164
Ensembl chr 1:91,363,492...91,366,164
JBrowse link
G Cebpb CCAAT/enhancer binding protein beta affects expression
increases expression
ISO lead acetate affects the expression of CEBPB mRNA
lead acetate results in increased expression of CEBPB mRNA
CTD PMID:21829687 PMID:25270620 NCBI chr 3:164,424,502...164,425,933
Ensembl chr 3:164,424,515...164,425,910
JBrowse link
G Cebpe CCAAT/enhancer binding protein epsilon increases methylation EXP lead acetate results in increased methylation of CEBPE gene CTD PMID:29571894 NCBI chr15:33,356,119...33,357,517
Ensembl chr15:33,355,947...33,358,138
JBrowse link
G Cel carboxyl ester lipase increases expression ISO lead acetate results in increased expression of CEL mRNA CTD PMID:20542052 NCBI chr 3:7,134,021...7,141,522
Ensembl chr 3:7,134,021...7,141,522
JBrowse link
G Cela3b chymotrypsin like elastase 3B increases expression ISO lead acetate results in increased expression of CELA3B mRNA CTD PMID:20542052 NCBI chr 5:155,763,877...155,772,048
Ensembl chr 5:155,763,877...155,772,040
JBrowse link
G Cemip2 cell migration inducing hyaluronidase 2 decreases expression ISO lead acetate results in decreased expression of CEMIP2 mRNA CTD PMID:22613225 NCBI chr 1:239,397,322...239,474,931
Ensembl chr 1:239,398,043...239,474,931
JBrowse link
G Cend1 cell cycle exit and neuronal differentiation 1 increases expression ISO lead acetate results in increased expression of CEND1 mRNA CTD PMID:20542052 NCBI chr 1:214,407,072...214,410,069
Ensembl chr 1:214,408,100...214,408,549
JBrowse link
G Cenpe centromere protein E increases expression EXP lead acetate results in increased expression of CENPE mRNA CTD PMID:11578147 NCBI chr 2:240,395,974...240,454,785
Ensembl chr 2:240,396,152...240,454,747
JBrowse link
G Cenpk centromere protein K increases expression EXP lead acetate results in increased expression of CENPK mRNA CTD PMID:22641619 NCBI chr 2:34,312,766...34,373,945
Ensembl chr 2:34,312,766...34,335,776
JBrowse link
G Cenpo centromere protein O decreases expression ISO lead acetate results in decreased expression of CENPO mRNA CTD PMID:22609695 NCBI chr 6:28,648,804...28,663,527
Ensembl chr 6:28,649,638...28,663,233
JBrowse link
G Cenpv centromere protein V decreases expression ISO lead acetate results in decreased expression of CENPV mRNA CTD PMID:20542052 NCBI chr10:48,846,513...48,861,893
Ensembl chr10:48,846,728...48,860,902
JBrowse link
G Cep162 centrosomal protein 162 increases expression EXP lead acetate results in increased expression of CEP162 mRNA CTD PMID:22641619 NCBI chr 8:94,863,282...94,921,917
Ensembl chr 8:94,863,282...94,922,017
JBrowse link
G Cept1 choline/ethanolamine phosphotransferase 1 decreases expression ISO lead acetate results in decreased expression of CEPT1 mRNA CTD PMID:21829687 NCBI chr 2:209,118,140...209,162,071
Ensembl chr 2:209,118,922...209,160,653
JBrowse link
G Cers4 ceramide synthase 4 decreases expression ISO lead acetate results in decreased expression of CERS4 mRNA CTD PMID:25270620 NCBI chr12:4,439,750...4,474,759
Ensembl chr12:4,439,750...4,474,729
JBrowse link
G Cfap126 cilia and flagella associated protein 126 affects expression EXP lead acetate affects the expression of CFAP126 mRNA CTD PMID:21864555 NCBI chr13:89,480,058...89,495,949
Ensembl chr13:89,480,058...89,495,949
JBrowse link
G Cfap70 cilia and flagella associated protein 70 increases expression EXP lead acetate results in increased expression of CFAP70 mRNA CTD PMID:22641619 NCBI chr15:4,285,049...4,350,707
Ensembl chr15:4,285,052...4,350,714
JBrowse link
G Cfap77 cilia and flagella associated protein 77 decreases expression EXP lead acetate results in decreased expression of CFAP77 mRNA CTD PMID:22641619 NCBI chr 3:7,508,500...7,632,311
Ensembl chr 3:7,508,496...7,632,345
JBrowse link
G Cfhr1 complement factor H-related 1 decreases expression ISO lead acetate results in decreased expression of CFHR1 mRNA CTD PMID:22609695 NCBI chr13:56,862,666...56,877,650
Ensembl chr13:56,836,994...56,877,650
JBrowse link
G Cfp complement factor properdin increases expression ISO lead acetate results in increased expression of CFP mRNA CTD PMID:20542052 NCBI chr  X:1,311,121...1,316,683
Ensembl chr  X:1,311,121...1,316,682
JBrowse link
G Cga glycoprotein hormones, alpha polypeptide decreases activity
multiple interactions
ISO lead acetate results in decreased activity of CGA protein
lead acetate inhibits the reaction [CGA protein results in increased abundance of Progesterone]
CTD PMID:11213355 PMID:12647776 NCBI chr 5:50,362,491...50,393,368
Ensembl chr 5:50,381,244...50,393,367
JBrowse link
G Cgref1 cell growth regulator with EF hand domain 1 decreases expression
affects methylation
EXP lead acetate results in decreased expression of CGREF1 mRNA
lead acetate affects the methylation of CGREF1 gene
CTD PMID:29571894 NCBI chr 6:26,797,126...26,809,132
Ensembl chr 6:26,797,126...26,809,129
JBrowse link
G Chchd5 coiled-coil-helix-coiled-coil-helix domain containing 5 increases expression EXP lead acetate results in increased expression of CHCHD5 mRNA CTD PMID:22641619 NCBI chr 3:121,659,962...121,664,286
Ensembl chr 3:121,660,110...121,664,496
JBrowse link
G Chd3 chromodomain helicase DNA binding protein 3 decreases expression ISO lead acetate results in decreased expression of CHD3 mRNA CTD PMID:21829687 NCBI chr10:55,943,467...55,970,417
Ensembl chr10:55,943,446...55,965,216
JBrowse link
G Chd7 chromodomain helicase DNA binding protein 7 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of CHD7 mRNA CTD PMID:22839698 NCBI chr 5:21,769,087...21,952,036
Ensembl chr 5:21,830,882...21,950,696
JBrowse link
G Chdh choline dehydrogenase increases expression ISO lead acetate results in increased expression of CHDH mRNA CTD PMID:22613225 NCBI chr16:6,078,083...6,109,386
Ensembl chr16:6,078,122...6,109,382
JBrowse link
G Chek1 checkpoint kinase 1 increases expression ISO lead acetate results in increased expression of CHEK1 mRNA CTD PMID:22609695 NCBI chr 8:39,181,162...39,201,588
Ensembl chr 8:39,181,163...39,243,882
JBrowse link
G Chid1 chitinase domain containing 1 increases expression ISO lead acetate results in increased expression of CHID1 mRNA CTD PMID:21829687 NCBI chr 1:214,476,418...214,511,569
Ensembl chr 1:214,476,387...214,511,529
JBrowse link
G Chrnb4 cholinergic receptor nicotinic beta 4 subunit decreases expression EXP lead acetate results in decreased expression of CHRNB4 mRNA CTD PMID:22641619 NCBI chr 8:59,610,489...59,629,073
Ensembl chr 8:59,609,693...59,629,133
JBrowse link
G Chuk component of inhibitor of nuclear factor kappa B kinase complex decreases expression EXP lead acetate results in decreased expression of CHUK protein CTD PMID:16547843 NCBI chr 1:263,848,829...263,884,354
Ensembl chr 1:263,848,884...263,885,169
JBrowse link
G Ciapin1 cytokine induced apoptosis inhibitor 1 increases expression ISO lead acetate results in increased expression of CIAPIN1 mRNA CTD PMID:20542052 NCBI chr19:10,596,923...10,612,414
Ensembl chr19:10,596,960...10,610,049
JBrowse link
G Ckb creatine kinase B multiple interactions
increases expression
ISO
EXP
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of CKB mRNA
Curcumin inhibits the reaction [lead acetate results in increased secretion of [CKM protein binds to CKB protein]]; lead acetate results in increased secretion of [CKM protein binds to CKB protein]
lead acetate results in increased expression of CKB protein
CTD PMID:12634122 PMID:20797405 PMID:21378372 NCBI chr 6:136,142,956...136,145,838
Ensembl chr 6:136,142,956...136,145,837
JBrowse link
G Cklf chemokine-like factor affects expression ISO lead acetate affects the expression of CKLF mRNA CTD PMID:21829687 NCBI chr19:903,609...914,880
Ensembl chr19:906,411...914,880
JBrowse link
G Ckm creatine kinase, M-type multiple interactions
increases expression
ISO
EXP
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of CKM mRNA
Curcumin inhibits the reaction [lead acetate results in increased secretion of [CKM protein binds to CKB protein]]; lead acetate results in increased secretion of [CKM protein binds to CKB protein]
lead acetate results in increased expression of CKM mRNA
CTD PMID:11578147 PMID:12634122 PMID:21378372 NCBI chr 1:80,321,507...80,331,841
Ensembl chr 1:80,321,585...80,331,841
JBrowse link
G Clcn3 chloride voltage-gated channel 3 increases expression EXP lead acetate results in increased expression of CLCN3 mRNA CTD PMID:11578147 NCBI chr16:32,448,821...32,520,649
Ensembl chr16:32,449,116...32,519,148
JBrowse link
G Clcn7 chloride voltage-gated channel 7 increases expression EXP lead acetate results in increased expression of CLCN7 mRNA CTD PMID:11578147 NCBI chr10:14,492,844...14,518,167
Ensembl chr10:14,492,844...14,516,894
JBrowse link
G Cldn1 claudin 1 affects expression EXP lead acetate affects the expression of CLDN1 mRNA CTD PMID:21864555 NCBI chr11:77,815,216...77,830,373
Ensembl chr11:77,815,181...77,830,416
JBrowse link
G Cldn19 claudin 19 affects expression EXP lead acetate affects the expression of CLDN19 mRNA CTD PMID:21864555 NCBI chr 5:138,300,692...138,307,982
Ensembl chr 5:138,300,107...138,305,683
JBrowse link
G Cldn23 claudin 23 increases expression ISO lead acetate results in increased expression of CLDN23 mRNA CTD PMID:22609695 NCBI chr16:59,988,603...59,990,327
Ensembl chr16:59,988,603...59,990,326
JBrowse link
G Cldn5 claudin 5 multiple interactions
decreases expression
ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of CLDN5 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of CLDN5 protein]
[lead acetate results in increased abundance of Lead] which results in decreased expression of CLDN5 protein
CTD PMID:24200059 PMID:31730887 NCBI chr11:86,356,292...86,357,718
Ensembl chr11:86,356,294...86,357,718
JBrowse link
G Clec3a C-type lectin domain family 3, member A increases expression EXP lead acetate results in increased expression of CLEC3A mRNA CTD PMID:22641619 NCBI chr19:46,733,668...46,741,245
Ensembl chr19:46,733,633...46,743,013
JBrowse link
G Clec4a C-type lectin domain family 4, member A increases expression ISO lead acetate results in increased expression of CLEC4N mRNA CTD PMID:20542052 NCBI chr 4:156,049,800...156,069,260
Ensembl chr 4:156,050,054...156,069,313
JBrowse link
G Clgn calmegin decreases expression ISO lead acetate results in decreased expression of CLGN mRNA CTD PMID:22609695 NCBI chr19:24,545,257...24,578,527
Ensembl chr19:24,545,318...24,576,798
JBrowse link
G Clic6 chloride intracellular channel 6 affects expression EXP lead acetate affects the expression of CLIC6 mRNA CTD PMID:21864555 NCBI chr11:32,655,653...32,698,004
Ensembl chr11:32,655,616...32,699,382
JBrowse link
G Cltrn collectrin, amino acid transport regulator affects expression EXP lead acetate affects the expression of CLTRN mRNA CTD PMID:22641619 NCBI chr  X:32,118,082...32,153,687
Ensembl chr  X:32,118,054...32,153,794
JBrowse link
G Cmbl carboxymethylenebutenolidase homolog multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of CMBL mRNA CTD PMID:22839698 NCBI chr 2:84,645,084...84,666,836
Ensembl chr 2:84,645,084...84,666,835
JBrowse link
G Cmc1 C-x(9)-C motif containing 1 decreases expression ISO lead acetate results in decreased expression of CMC1 mRNA CTD PMID:21829687 NCBI chr 8:126,437,345...126,495,347
Ensembl chr 8:126,437,345...126,495,347
JBrowse link
G Cndp2 carnosine dipeptidase 2 increases expression ISO lead acetate results in increased expression of CNDP2 mRNA CTD PMID:21829687 NCBI chr18:81,521,966...81,539,065
Ensembl chr18:81,521,968...81,539,065
JBrowse link
G Cngb3 cyclic nucleotide gated channel subunit beta 3 decreases expression EXP lead acetate results in decreased expression of CNGB3 mRNA CTD PMID:22641619 NCBI chr 5:33,097,353...33,507,467
Ensembl chr 5:33,097,654...33,507,467
JBrowse link
G Cnmd chondromodulin affects expression EXP lead acetate affects the expression of CNMD mRNA CTD PMID:22641619 NCBI chr15:61,923,291...61,947,840
Ensembl chr15:61,923,299...61,947,764
JBrowse link
G Cnnm3 cyclin and CBS domain divalent metal cation transport mediator 3 decreases expression ISO lead acetate results in decreased expression of CNNM3 mRNA CTD PMID:21829687 NCBI chr 9:43,093,120...43,108,486
Ensembl chr 9:43,093,138...43,108,486
JBrowse link
G Cnp 2',3'-cyclic nucleotide 3' phosphodiesterase decreases expression
multiple interactions
ISO
EXP
lead acetate results in decreased expression of CNP protein
[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of CNP protein
CTD PMID:20797405 PMID:23680456 NCBI chr10:88,490,798...88,497,357
Ensembl chr10:88,490,798...88,497,356
JBrowse link
G Cntnap2 contactin associated protein 2 decreases expression ISO lead acetate results in decreased expression of CNTNAP2 mRNA CTD PMID:20542052 NCBI chr 4:74,700,539...77,025,463 JBrowse link
G Cog8 component of oligomeric golgi complex 8 decreases expression ISO lead acetate results in decreased expression of COG8 mRNA CTD PMID:21829687 NCBI chr19:39,246,656...39,257,406
Ensembl chr19:39,246,625...39,257,451
JBrowse link
G Col11a1 collagen type XI alpha 1 chain decreases expression EXP lead acetate results in decreased expression of COL11A1 mRNA CTD PMID:11578147 NCBI chr 2:216,863,423...217,056,523
Ensembl chr 2:216,863,428...217,056,523
JBrowse link
G Col13a1 collagen type XIII alpha 1 chain decreases expression EXP lead acetate results in decreased expression of COL13A1 mRNA CTD PMID:11578147 NCBI chr20:31,456,502...31,598,360
Ensembl chr20:31,456,852...31,598,118
JBrowse link
G Col15a1 collagen type XV alpha 1 chain decreases expression EXP
ISO
lead acetate results in decreased expression of COL15A1 mRNA CTD PMID:11578147 PMID:22613225 NCBI chr 5:62,840,360...62,950,240 JBrowse link
G Col16a1 collagen type XVI alpha 1 chain decreases expression EXP lead acetate results in decreased expression of COL16A1 mRNA CTD PMID:11578147 NCBI chr 5:148,257,030...148,311,645
Ensembl chr 5:148,257,642...148,311,645
JBrowse link
G Col18a1 collagen type XVIII alpha 1 chain decreases expression EXP lead acetate results in decreased expression of COL18A1 mRNA CTD PMID:11578147 NCBI chr20:12,225,202...12,332,858
Ensembl chr20:12,225,202...12,332,858
JBrowse link
G Col19a1 collagen type XIX alpha 1 chain decreases expression
increases expression
EXP
ISO
lead acetate results in decreased expression of COL19A1 mRNA
lead acetate results in increased expression of COL19A1 mRNA
CTD PMID:11578147 PMID:20542052 NCBI chr 9:30,508,003...30,864,836
Ensembl chr 9:30,515,089...30,844,199
JBrowse link
G Col1a1 collagen type I alpha 1 chain decreases expression
increases expression
EXP lead acetate results in decreased expression of COL1A1 mRNA
lead acetate results in increased expression of COL1A1 mRNA
CTD PMID:11578147 PMID:22641619 NCBI chr10:82,745,801...82,762,790
Ensembl chr10:82,745,801...82,762,789
JBrowse link
G Col22a1 collagen type XXII alpha 1 chain decreases expression ISO lead acetate results in decreased expression of COL22A1 mRNA CTD PMID:22609695 NCBI chr 7:113,014,896...113,251,165
Ensembl chr 7:113,015,747...113,228,439
JBrowse link
G Col2a1 collagen type II alpha 1 chain multiple interactions
increases expression
decreases expression
ISO
EXP
BMP2 promotes the reaction [lead acetate results in increased expression of COL2A1 mRNA]
lead acetate results in decreased expression of COL2A1 mRNA
CTD PMID:11578147 PMID:17805416 NCBI chr 7:139,454,945...139,484,403
Ensembl chr 7:139,455,242...139,483,997
JBrowse link
G Col4a1 collagen type IV alpha 1 chain decreases expression EXP lead acetate results in decreased expression of COL4A1 mRNA CTD PMID:11578147 NCBI chr16:83,522,162...83,632,153
Ensembl chr16:83,522,162...83,632,153
JBrowse link
G Col4a3 collagen type IV alpha 3 chain increases expression EXP lead acetate results in increased expression of COL4A3 mRNA CTD PMID:11578147 NCBI chr 9:88,357,528...88,484,735
Ensembl chr 9:88,357,556...88,485,830
JBrowse link
G Col4a4 collagen type IV alpha 4 chain decreases expression EXP lead acetate results in decreased expression of COL4A4 mRNA CTD PMID:11578147 NCBI chr 9:88,314,763...88,357,183
Ensembl chr 9:88,232,455...88,357,182
JBrowse link
G Col4a5 collagen type IV alpha 5 chain decreases expression EXP lead acetate results in decreased expression of COL4A5 mRNA CTD PMID:11578147 NCBI chr  X:112,769,595...112,983,720
Ensembl chr  X:112,769,645...112,983,685
JBrowse link
G Col4a6 collagen type IV alpha 6 chain decreases expression EXP lead acetate results in decreased expression of COL4A6 mRNA CTD PMID:11578147 NCBI chr  X:112,405,647...112,768,337
Ensembl chr  X:112,405,647...112,473,822
JBrowse link
G Col5a2 collagen type V alpha 2 chain decreases expression EXP lead acetate results in decreased expression of COL5A2 mRNA CTD PMID:11578147 NCBI chr 9:52,091,088...52,238,735
Ensembl chr 9:52,092,511...52,238,564
JBrowse link
G Col6a1 collagen type VI alpha 1 chain increases expression EXP lead acetate results in increased expression of COL6A1 mRNA CTD PMID:11578147 NCBI chr20:12,657,913...12,676,370
Ensembl chr20:12,658,065...12,675,561
JBrowse link
G Col6a2 collagen type VI alpha 2 chain multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of COL6A2 mRNA CTD PMID:12634122 NCBI chr20:12,773,472...12,801,179
Ensembl chr20:12,773,427...12,801,180
JBrowse link
G Col7a1 collagen type VII alpha 1 chain increases expression EXP lead acetate results in increased expression of COL7A1 mRNA CTD PMID:11578147 NCBI chr 8:117,694,441...117,726,844
Ensembl chr 8:117,694,605...117,726,844
JBrowse link
G Col8a1 collagen type VIII alpha 1 chain decreases expression EXP lead acetate results in decreased expression of COL8A1 mRNA CTD PMID:11578147 PMID:22641619 NCBI chr11:44,877,690...45,006,203
Ensembl chr11:44,877,859...45,007,891
JBrowse link
G Col9a1 collagen type IX alpha 1 chain decreases expression EXP lead acetate results in decreased expression of COL9A1 mRNA CTD PMID:11578147 NCBI chr 9:30,419,001...30,502,307
Ensembl chr 9:30,419,001...30,502,298
JBrowse link
G Col9a3 collagen type IX alpha 3 chain decreases expression EXP lead acetate results in decreased expression of COL9A3 mRNA CTD PMID:11578147 NCBI chr 3:176,102,287...176,124,839
Ensembl chr 3:176,102,351...176,124,306
JBrowse link
G Colgalt1 collagen beta(1-O)galactosyltransferase 1 increases expression ISO lead acetate results in increased expression of COLGALT1 mRNA CTD PMID:21829687 NCBI chr16:20,039,969...20,052,277
Ensembl chr16:20,039,969...20,052,276
JBrowse link
G Commd6 COMM domain containing 6 increases expression EXP lead acetate results in increased expression of COMMD6 mRNA CTD PMID:22641619 NCBI chr15:86,136,096...86,142,672
Ensembl chr15:86,136,096...86,142,672
JBrowse link
G Coprs coordinator of PRMT5 and differentiation stimulator increases expression ISO lead acetate results in increased expression of COPRS mRNA CTD PMID:22609695 NCBI chr16:80,826,681...80,831,791
Ensembl chr16:80,826,681...80,831,791
JBrowse link
G Cp ceruloplasmin multiple interactions
decreases expression
EXP [Zinc co-treated with Iron co-treated with Calcium] inhibits the reaction [lead acetate results in decreased expression of CP protein] CTD PMID:22534743 NCBI chr 2:104,744,249...104,803,034
Ensembl chr 2:104,744,461...104,799,853
JBrowse link
G Cpa1 carboxypeptidase A1 increases expression ISO lead acetate results in increased expression of CPA1 mRNA CTD PMID:20542052 NCBI chr 4:57,952,982...57,959,109
Ensembl chr 4:57,952,982...57,959,109
JBrowse link
G Cpa2 carboxypeptidase A2 increases expression ISO lead acetate results in increased expression of CPA2 mRNA CTD PMID:20542052 PMID:22609695 NCBI chr 4:57,855,416...57,879,239
Ensembl chr 4:57,855,416...57,879,239
JBrowse link
G Cpa5 carboxypeptidase A5 increases expression ISO lead acetate results in increased expression of CPA5 mRNA CTD PMID:22609695 NCBI chr 4:57,925,334...57,945,069
Ensembl chr 4:57,925,323...57,945,069
JBrowse link
G Cpb1 carboxypeptidase B1 increases expression ISO lead acetate results in increased expression of CPB1 mRNA CTD PMID:20542052 NCBI chr 2:105,059,293...105,089,682
Ensembl chr 2:105,059,426...105,089,659
JBrowse link
G Cpb2 carboxypeptidase B2 increases expression ISO lead acetate results in increased expression of CPB2 mRNA CTD PMID:22609695 NCBI chr15:57,290,849...57,339,762
Ensembl chr15:57,290,849...57,339,760
JBrowse link
G Cplx4 complexin 4 decreases expression EXP lead acetate results in decreased expression of CPLX4 mRNA CTD PMID:22641619 NCBI chr18:61,657,216...61,672,641
Ensembl chr18:61,656,758...61,672,663
JBrowse link
G Cpne1 copine 1 increases expression ISO lead acetate results in increased expression of CPNE1 mRNA CTD PMID:21829687 NCBI chr 3:151,617,733...151,625,448
NCBI chr 3:152,150,143...152,192,936
Ensembl chr 3:151,616,037...151,625,644
Ensembl chr 3:151,616,037...151,625,644
JBrowse link
G Cpsf3 cleavage and polyadenylation specific factor 3 decreases expression ISO lead acetate results in decreased expression of CPSF3 mRNA CTD PMID:20542052 NCBI chr 6:43,363,792...43,391,712
Ensembl chr 6:43,363,792...43,391,712
JBrowse link
G Crabp1 cellular retinoic acid binding protein 1 decreases expression
decreases methylation
increases expression
EXP lead acetate results in decreased expression of CRABP1 mRNA
lead acetate results in decreased methylation of CRABP1 gene
lead acetate results in increased expression of CRABP1 mRNA
CTD PMID:22641619 PMID:29571894 NCBI chr 8:59,344,097...59,352,135
Ensembl chr 8:59,344,083...59,352,132
JBrowse link
G Crb3 crumbs cell polarity complex component 3 decreases expression
increases expression
EXP
ISO
lead acetate results in decreased expression of CRB3 mRNA
lead acetate results in increased expression of CRB3 mRNA
CTD PMID:22609695 PMID:22641619 NCBI chr 9:9,982,529...9,986,896
Ensembl chr 9:9,980,720...9,985,630
JBrowse link
G Creb1 cAMP responsive element binding protein 1 multiple interactions
decreases phosphorylation
decreases expression
EXP
ISO
[lead acetate promotes the reaction [GRIN1 protein binds to GRIN2B protein]] which results in decreased phosphorylation of CREB1 protein; [lead acetate results in increased abundance of Lead] which results in decreased phosphorylation of CREB1 protein
Quercetin inhibits the reaction [lead acetate results in decreased phosphorylation of CREB1 protein]
lead acetate results in decreased expression of CREB1 mRNA
CTD PMID:12480136 PMID:23855546 PMID:24260418 PMID:30905827 NCBI chr 9:71,229,753...71,298,994
Ensembl chr 9:71,230,108...71,293,435
JBrowse link
G Creb3l3 cAMP responsive element binding protein 3-like 3 decreases expression ISO lead acetate results in decreased expression of CREB3L3 mRNA CTD PMID:25270620 NCBI chr 7:11,490,852...11,499,287
Ensembl chr 7:11,490,852...11,499,282
JBrowse link
G Creb5 cAMP responsive element binding protein 5 increases expression ISO lead acetate results in increased expression of CREB5 mRNA CTD PMID:24260418 NCBI chr 4:83,390,782...83,840,356
Ensembl chr 4:83,391,283...83,836,351
JBrowse link
G Crhr2 corticotropin releasing hormone receptor 2 increases expression ISO lead acetate results in increased expression of CRHR2 mRNA CTD PMID:22613225 NCBI chr 4:85,286,371...85,329,374
Ensembl chr 4:85,286,372...85,329,362
JBrowse link
G Crispld1 cysteine-rich secretory protein LCCL domain containing 1 increases expression EXP lead acetate results in increased expression of CRISPLD1 mRNA CTD PMID:22641619 NCBI chr 5:663,750...711,033
Ensembl chr 5:670,754...711,033
JBrowse link
G Crispld2 cysteine-rich secretory protein LCCL domain containing 2 affects expression ISO lead acetate affects the expression of CRISPLD2 mRNA CTD PMID:21829687 NCBI chr19:52,647,038...52,705,118
Ensembl chr19:52,647,070...52,705,131
JBrowse link
G Crkl CRK like proto-oncogene, adaptor protein decreases expression ISO lead acetate results in decreased expression of CRKL mRNA CTD PMID:22609695 NCBI chr11:87,338,606...87,356,644
Ensembl chr11:87,778,312...87,815,043
JBrowse link
G Crnkl1 crooked neck pre-mRNA splicing factor 1 decreases expression ISO lead acetate results in decreased expression of CRNKL1 mRNA CTD PMID:21829687 NCBI chr 6:18,349,226...18,351,540
Ensembl chr 6:18,349,167...18,351,536
JBrowse link
G Crp C-reactive protein multiple interactions
increases secretion
EXP Curcumin inhibits the reaction [lead acetate results in increased secretion of CRP protein] CTD PMID:21378372 NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
JBrowse link
G Crx cone-rod homeobox decreases expression EXP lead acetate results in decreased expression of CRX mRNA CTD PMID:22641619 NCBI chr 1:77,744,593...77,758,913
Ensembl chr 1:77,745,288...77,750,960
JBrowse link
G Cryab crystallin, alpha B increases expression ISO lead acetate results in increased expression of CRYAB mRNA CTD PMID:22609695 NCBI chr 8:55,178,543...55,182,546
Ensembl chr 8:55,178,289...55,182,545
JBrowse link
G Cryba1 crystallin, beta A1 increases expression ISO lead acetate results in increased expression of CRYBA1 mRNA CTD PMID:22609695 NCBI chr10:65,160,777...65,167,504
Ensembl chr10:65,161,152...65,167,494
JBrowse link
G Cryl1 crystallin, lambda 1 decreases expression ISO lead acetate results in decreased expression of CRYL1 mRNA CTD PMID:21829687 NCBI chr15:37,543,727...37,663,586
Ensembl chr15:37,543,727...37,663,584
JBrowse link
G Cryzl1 crystallin zeta like 1 increases expression ISO lead acetate results in increased expression of CRYZL1 mRNA CTD PMID:25270620 NCBI chr11:31,847,741...31,893,042
Ensembl chr11:31,847,745...31,892,531
JBrowse link
G Csf1r colony stimulating factor 1 receptor affects expression ISO lead acetate affects the expression of CSF1R mRNA CTD PMID:21829687 NCBI chr18:56,414,493...56,458,300
Ensembl chr18:56,414,488...56,458,300
JBrowse link
G Csf2 colony stimulating factor 2 multiple interactions ISO [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of CD40 protein; [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of CD80 protein; [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of CD86 protein; [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of H2 protein; [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of ICAM1 protein; [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of IL10 protein; [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of IL6 protein; [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of TNF protein CTD PMID:17512567 NCBI chr10:39,602,089...39,604,070
Ensembl chr10:39,602,089...39,604,070
JBrowse link
G Csf2ra colony stimulating factor 2 receptor subunit alpha increases expression ISO lead acetate results in increased expression of CSF2RA mRNA CTD PMID:21829687 NCBI chr14:1,462,292...1,467,264
Ensembl chr14:1,462,358...1,467,264
JBrowse link
G Csnk2a2 casein kinase 2 alpha 2 increases expression ISO lead acetate results in increased expression of CSNK2A2 mRNA CTD PMID:22609695 NCBI chr19:9,972,537...10,012,043
Ensembl chr19:9,972,537...10,012,043
JBrowse link
G Cth cystathionine gamma-lyase multiple interactions
decreases expression
EXP sodium bisulfide inhibits the reaction [lead acetate results in decreased expression of CTH protein]; sodium boranocarbonate inhibits the reaction [lead acetate results in decreased expression of CTH protein] CTD PMID:30980911 NCBI chr 2:264,266,959...264,293,040
Ensembl chr 2:264,266,984...264,293,046
JBrowse link
G Ctnna3 catenin alpha 3 increases expression EXP lead acetate results in increased expression of CTNNA3 mRNA CTD PMID:22641619 NCBI chr20:25,063,124...26,640,428
Ensembl chr20:26,516,836...26,589,209
JBrowse link
G Ctnnb1 catenin beta 1 increases phosphorylation
multiple interactions
EXP
ISO
lead acetate results in increased phosphorylation of CTNNB1 protein
WNT7A protein inhibits the reaction [lead acetate results in increased phosphorylation of CTNNB1 protein]
CTD PMID:24999626 NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
JBrowse link
G Ctps1 CTP synthase 1 decreases expression ISO lead acetate results in decreased expression of CTPS mRNA CTD PMID:22613225 NCBI chr 5:139,475,934...139,505,065
Ensembl chr 5:139,475,934...139,505,065
JBrowse link
G Ctr9 CTR9 homolog, Paf1/RNA polymerase II complex component increases expression ISO lead acetate results in increased expression of CTR9 mRNA CTD PMID:21829687 NCBI chr 1:175,839,140...175,869,167
Ensembl chr 1:175,839,108...175,869,165
JBrowse link
G Ctrb1 chymotrypsinogen B1 increases expression ISO lead acetate results in increased expression of CTRB1 mRNA CTD PMID:22609695 NCBI chr19:43,906,344...43,911,020
Ensembl chr19:43,906,292...43,911,057
JBrowse link
G Ctrc chymotrypsin C increases expression ISO lead acetate results in increased expression of CTRC mRNA CTD PMID:20542052 PMID:22609695 NCBI chr 5:160,394,677...160,403,373
Ensembl chr 5:160,394,580...160,405,050
JBrowse link
G Ctrl chymotrypsin-like increases expression ISO lead acetate results in increased expression of CTRL mRNA CTD PMID:20542052 NCBI chr19:37,905,864...37,907,714
Ensembl chr19:37,905,864...37,907,714
JBrowse link
G Ctsa cathepsin A increases expression EXP
ISO
lead acetate results in increased expression of CTSA mRNA CTD PMID:11578147 PMID:21829687 NCBI chr 3:161,298,750...161,304,627
Ensembl chr 3:161,298,962...161,304,625
JBrowse link
G Ctsc cathepsin C decreases expression EXP lead acetate results in decreased expression of CTSC mRNA CTD PMID:22641619 NCBI chr 1:151,918,514...151,949,979
Ensembl chr 1:151,918,571...151,949,983
JBrowse link
G Ctsh cathepsin H increases expression ISO lead acetate results in increased expression of CTSH mRNA CTD PMID:21829687 NCBI chr 8:97,439,155...97,458,293
Ensembl chr 8:97,439,161...97,458,287
JBrowse link
G Ctso cathepsin O increases expression ISO lead acetate results in increased expression of CTSO mRNA CTD PMID:21829687 NCBI chr 2:180,857,178...180,881,677 JBrowse link
G Ctsz cathepsin Z increases expression ISO lead acetate results in increased expression of CTSZ mRNA CTD PMID:22613225 NCBI chr 3:172,527,107...172,537,877
Ensembl chr 3:172,527,107...172,537,877
JBrowse link
G Cttn cortactin decreases expression ISO lead acetate results in decreased expression of CTTN mRNA CTD PMID:21829687 NCBI chr 1:217,602,698...217,638,196
NCBI chr 1:215,255,385...215,290,882
Ensembl chr 1:217,602,698...217,638,152
Ensembl chr 1:217,602,698...217,638,152
JBrowse link
G Cuzd1 CUB and zona pellucida-like domains 1 increases expression ISO lead acetate results in increased expression of CUZD1 mRNA CTD PMID:20542052 NCBI chr 1:201,881,846...201,894,970
Ensembl chr 1:201,881,836...201,894,775
JBrowse link
G Cx3cl1 C-X3-C motif chemokine ligand 1 increases secretion EXP lead acetate results in increased secretion of CX3CL1 protein CTD PMID:17047031 NCBI chr19:10,644,267...10,654,861
Ensembl chr19:10,644,244...10,653,800
JBrowse link
G Cx3cr1 C-X3-C motif chemokine receptor 1 increases expression ISO lead acetate results in increased expression of CX3CR1 mRNA CTD PMID:21829687 NCBI chr 8:128,740,756...128,754,514
Ensembl chr 8:128,740,756...128,754,514
JBrowse link
G Cxcl17 C-X-C motif chemokine ligand 17 decreases expression EXP lead acetate results in decreased expression of CXCL17 mRNA CTD PMID:22641619 NCBI chr 1:82,267,381...82,279,145
Ensembl chr 1:82,267,381...82,279,145
JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 multiple interactions
affects expression
ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of CXCR4 mRNA
lead acetate affects the expression of CXCR4 mRNA
CTD PMID:12634122 PMID:21829687 NCBI chr13:45,314,952...45,318,856
Ensembl chr13:45,314,933...45,318,878
JBrowse link
G Cyb5b cytochrome b5 type B increases expression ISO lead acetate results in increased expression of CYB5B mRNA CTD PMID:21829687 NCBI chr19:39,357,814...39,391,680
Ensembl chr19:39,357,791...39,393,189
JBrowse link
G Cybb cytochrome b-245 beta chain affects expression
increases expression
ISO
EXP
lead acetate affects the expression of CYBB mRNA
lead acetate results in increased expression of CYBB mRNA
lead acetate results in increased expression of CYBB protein
CTD PMID:15569323 PMID:21829687 PMID:22641619 NCBI chr  X:14,578,330...14,610,049
Ensembl chr  X:14,578,264...14,612,547
JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 multiple interactions
decreases expression
decreases activity
EXP
ISO
[cadmium acetate co-treated with lead acetate] results in decreased expression of CYP11A1 mRNA
lead acetate results in decreased expression of CYP11A1 protein
lead acetate results in decreased expression of CYP11A1 mRNA; lead acetate results in decreased expression of CYP11A1 protein
lead acetate results in decreased activity of CYP11A1 protein
CTD PMID:12647776 PMID:21182167 PMID:22806249 PMID:25270620 PMID:25981801 NCBI chr 8:62,798,317...62,809,848
Ensembl chr 8:62,779,875...62,809,893
JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 increases expression
decreases expression
ISO lead acetate results in increased expression of CYP17A1 mRNA
lead acetate results in decreased expression of CYP17A1 mRNA; lead acetate results in decreased expression of CYP17A1 protein
CTD PMID:21335049 PMID:22806249 NCBI chr 1:266,422,127...266,429,947
Ensembl chr 1:266,422,132...266,428,239
JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 decreases expression
multiple interactions
EXP lead acetate results in decreased expression of CYP19A1 mRNA
epigallocatechin gallate inhibits the reaction [lead acetate results in decreased expression of CYP19A1 mRNA]
CTD PMID:31054310 NCBI chr 8:58,744,849...58,772,408
Ensembl chr 8:58,744,849...58,772,408
JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 increases expression EXP lead acetate results in increased expression of CYP1B1 mRNA CTD PMID:22641619 NCBI chr 6:2,308,179...2,316,739
Ensembl chr 6:2,307,808...2,316,722
JBrowse link
G Cyp27a1 cytochrome P450, family 27, subfamily a, polypeptide 1 decreases expression ISO lead acetate results in decreased expression of CYP27A1 mRNA CTD PMID:21829687 NCBI chr 9:81,968,285...81,998,213
Ensembl chr 9:81,968,332...81,998,169
JBrowse link
G Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 decreases expression ISO lead acetate results in decreased expression of CYP27B1 mRNA CTD PMID:22609695 NCBI chr 7:70,333,150...70,340,006
Ensembl chr 7:70,335,061...70,340,005
JBrowse link
G Cyp2a3 cytochrome P450, family 2, subfamily a, polypeptide 3 increases expression ISO lead acetate results in increased expression of CYP2A5 mRNA CTD PMID:30623991 NCBI chr 1:83,653,248...83,662,118
Ensembl chr 1:83,653,234...83,766,484
JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 decreases expression ISO lead acetate results in decreased expression of CYP2B10 mRNA CTD PMID:21829687 NCBI chr 7:99,142,431...99,183,540
Ensembl chr 7:99,142,450...99,181,783
JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 increases expression ISO lead acetate results in increased expression of CYP2B9 mRNA CTD PMID:21335049 NCBI chr 1:83,163,103...83,236,615
Ensembl chr 1:83,163,079...83,236,615
JBrowse link
G Cyp2r1 cytochrome P450, family 2, subfamily r, polypeptide 1 increases expression EXP lead acetate results in increased expression of CYP2R1 mRNA CTD PMID:22641619 NCBI chr 1:184,060,521...184,106,604
Ensembl chr 1:184,093,920...184,106,200
JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 increases expression EXP lead acetate results in increased expression of CYP3A9 mRNA CTD PMID:22641619 NCBI chr12:19,074,288...19,114,491
Ensembl chr12:19,074,583...19,114,399
JBrowse link
G Cyp4f6 cytochrome P450, family 4, subfamily f, polypeptide 6 decreases expression ISO lead acetate results in decreased expression of CYP4F16 mRNA CTD PMID:21829687 NCBI chr 7:15,198,950...15,225,547
Ensembl chr 7:15,198,940...15,225,410
JBrowse link
G Dao D-amino-acid oxidase increases expression EXP
ISO
lead acetate results in increased expression of DAO mRNA
lead acetate results in increased expression of DAO mRNA; lead acetate results in increased expression of DAO protein
CTD PMID:11578147 PMID:25242007 NCBI chr12:48,353,691...48,373,647
Ensembl chr12:48,354,196...48,365,784
JBrowse link
G Dapk1 death associated protein kinase 1 increases expression ISO lead acetate results in increased expression of DAPK1 mRNA CTD PMID:21829687 NCBI chr17:4,297,038...4,454,941
Ensembl chr17:4,297,224...4,454,778
JBrowse link
G Dapl1 death associated protein-like 1 decreases expression ISO lead acetate results in decreased expression of DAPL1 mRNA CTD PMID:21829687 NCBI chr 3:45,538,408...45,559,281
Ensembl chr 3:45,538,797...45,559,331
JBrowse link
G Dars1 aspartyl-tRNA synthetase 1 increases expression EXP lead acetate results in increased expression of DARS mRNA CTD PMID:11578147 NCBI chr13:45,074,067...45,127,815
Ensembl chr13:45,074,072...45,127,815
JBrowse link
G Dbf4 DBF4 zinc finger decreases expression ISO lead acetate results in decreased expression of DBF4 mRNA CTD PMID:21829687 NCBI chr 4:22,898,527...22,914,091
Ensembl chr 4:22,898,527...22,914,177
JBrowse link
G Dbn1 drebrin 1 increases expression EXP lead acetate results in increased expression of DBN1 mRNA CTD PMID:11578147 NCBI chr17:9,679,511...9,693,878
Ensembl chr17:9,679,628...9,693,820
JBrowse link
G Dcstamp dendrocyte expressed seven transmembrane protein increases expression ISO lead acetate results in increased expression of DCSTAMP mRNA CTD PMID:20542052 NCBI chr 7:78,642,016...78,651,763
Ensembl chr 7:78,649,875...78,650,906
JBrowse link
G Dctn3 dynactin subunit 3 increases expression ISO lead acetate results in increased expression of DCTN3 mRNA CTD PMID:21829687 NCBI chr 5:58,098,706...58,106,706
Ensembl chr 5:58,098,706...58,106,706
JBrowse link
G Dcun1d1 defective in cullin neddylation 1 domain containing 1 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of DCUN1D1 mRNA CTD PMID:22839698 NCBI chr 2:122,476,173...122,527,153
Ensembl chr 2:122,476,173...122,646,445
JBrowse link
G Dcxr dicarbonyl and L-xylulose reductase increases expression ISO lead acetate results in increased expression of DCXR mRNA CTD PMID:21829687 NCBI chr10:109,906,119...109,909,696
Ensembl chr10:109,906,815...109,909,715
JBrowse link
G Ddah1 dimethylarginine dimethylaminohydrolase 1 increases expression ISO
EXP
lead acetate results in increased expression of DDAH1 mRNA CTD PMID:11578147 PMID:20680508 NCBI chr 2:251,634,368...251,766,009
Ensembl chr 2:251,634,431...251,766,014
JBrowse link
G Ddc dopa decarboxylase decreases expression EXP lead acetate results in decreased expression of DDC mRNA CTD PMID:22641619 NCBI chr14:91,905,919...91,996,816
Ensembl chr14:91,905,919...91,996,774
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression ISO
EXP
lead acetate results in increased expression of DDIT3 mRNA
lead acetate results in increased expression of DDIT3 protein
CTD PMID:22811615 PMID:25270620 NCBI chr 7:70,578,564...70,585,074
Ensembl chr 7:70,580,198...70,585,084
JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 increases expression ISO lead acetate results in increased expression of DDIT4 mRNA CTD PMID:21829687 NCBI chr20:29,509,283...29,511,382
Ensembl chr20:29,509,289...29,511,382
JBrowse link
G Ddr2 discoidin domain receptor tyrosine kinase 2 increases expression EXP lead acetate results in increased expression of DDR2 mRNA CTD PMID:22641619 NCBI chr13:88,311,639...88,436,561
Ensembl chr13:88,317,145...88,436,789
JBrowse link
G Ddx23 DEAD-box helicase 23 increases expression ISO lead acetate results in increased expression of DDX23 mRNA CTD PMID:22613225 NCBI chr 7:140,325,453...140,342,730
Ensembl chr 7:140,325,431...140,342,727
JBrowse link
G Ddx39a DExD-box helicase 39A affects expression ISO lead acetate affects the expression of DDX39A mRNA CTD PMID:21829687 NCBI chr19:24,846,530...24,854,886
Ensembl chr19:24,846,938...24,854,953
JBrowse link
G Ddx39b DExD-box helicase 39B decreases expression ISO lead acetate results in decreased expression of DDX39B mRNA CTD PMID:21829687 NCBI chr20:4,806,103...4,818,600
Ensembl chr20:4,806,108...4,818,568
JBrowse link
G Ddx3y DEAD-box helicase 3, Y-linked increases expression
decreases expression
ISO lead acetate results in increased expression of DDX3Y mRNA
lead acetate results in decreased expression of DDX3Y mRNA; lead acetate results in decreased expression of DDX3Y protein
CTD PMID:22609695 PMID:24140753 NCBI chr13:105,408,179...105,411,348
Ensembl chr13:105,408,179...105,411,348
JBrowse link
G Dedd2 death effector domain containing 2 increases expression ISO lead acetate results in increased expression of DEDD2 mRNA CTD PMID:21829687 NCBI chr 1:82,073,024...82,089,028
Ensembl chr 1:82,072,544...82,088,275
JBrowse link
G Denr density regulated reinitiation and release factor increases expression ISO lead acetate results in increased expression of DENR mRNA CTD PMID:20542052 NCBI chr12:38,095,717...38,117,758
Ensembl chr12:38,096,034...38,116,919
JBrowse link
G Dgcr6 DiGeorge syndrome critical region gene 6 increases expression ISO lead acetate results in increased expression of DGCR6 mRNA CTD PMID:22613225 NCBI chr11:87,076,205...87,081,306
Ensembl chr11:87,076,381...87,081,950
JBrowse link
G Dgcr8 DGCR8 microprocessor complex subunit decreases expression EXP lead acetate results in decreased expression of DGCR8 mRNA CTD PMID:11578147 NCBI chr11:86,852,682...86,885,233
Ensembl chr11:86,852,711...86,885,224
JBrowse link
G Dgka diacylglycerol kinase, alpha increases expression EXP lead acetate results in increased expression of DGKA mRNA CTD PMID:11578147 NCBI chr 7:3,143,826...3,170,764
Ensembl chr 7:3,143,827...3,170,146
JBrowse link
G Dhrs3 dehydrogenase/reductase 3 decreases expression EXP lead acetate results in decreased expression of DHRS3 mRNA CTD PMID:22641619 NCBI chr 5:162,809,090...162,843,385
Ensembl chr 5:162,808,646...162,843,383
JBrowse link
G Dhx29 DExH-box helicase 29 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of DHX29 mRNA CTD PMID:22839698 NCBI chr 2:44,787,066...44,837,834
Ensembl chr 2:44,787,002...44,837,831
JBrowse link
G Dhx58 DEXH-box helicase 58 increases expression ISO lead acetate results in increased expression of DHX58 mRNA CTD PMID:22609695 NCBI chr10:88,599,722...88,611,562
Ensembl chr10:88,599,680...88,611,105
JBrowse link
G Diaph2 diaphanous-related formin 2 increases expression ISO lead acetate results in increased expression of DIAPH2 mRNA CTD PMID:21829687 NCBI chr  X:99,722,910...100,363,228 JBrowse link
G Dio1 iodothyronine deiodinase 1 decreases expression ISO lead acetate results in decreased expression of DIO1 mRNA CTD PMID:22609695 NCBI chr 5:126,894,837...126,911,532
Ensembl chr 5:126,895,286...126,911,520
JBrowse link
G Dio2 iodothyronine deiodinase 2 increases expression EXP lead acetate results in increased expression of DIO2 mRNA CTD PMID:22641619 NCBI chr 6:114,475,156...114,489,443
Ensembl chr 6:114,476,142...114,476,723
JBrowse link
G Dio3os DIO3 opposite strand upstream RNA decreases expression ISO lead acetate results in decreased expression of DIO3OS mRNA CTD PMID:27562236 NCBI chr 6:134,623,450...134,626,974 JBrowse link
G Disc1 DISC1 scaffold protein increases expression EXP lead acetate results in increased expression of DISC1 mRNA CTD PMID:11578147 NCBI chr19:57,818,838...58,069,992
Ensembl chr19:57,820,260...58,066,152
JBrowse link
G Disp3 dispatched RND transporter family member 3 increases expression ISO lead acetate results in increased expression of DISP3 mRNA CTD PMID:20542052 NCBI chr 5:165,051,522...165,099,826
Ensembl chr 5:165,052,871...165,083,487
JBrowse link
G Dld dihydrolipoamide dehydrogenase decreases expression EXP lead acetate results in decreased expression of DLD protein CTD PMID:25981801 NCBI chr 6:50,597,677...50,618,694
Ensembl chr 6:50,597,677...50,618,694
JBrowse link
G Dleu7 deleted in lymphocytic leukemia, 7 increases expression ISO lead acetate results in increased expression of DLEU7 mRNA CTD PMID:20542052 NCBI chr15:45,360,505...45,378,840
Ensembl chr15:45,360,503...45,376,476
JBrowse link
G Dlg4 discs large MAGUK scaffold protein 4 increases expression
affects expression
decreases expression
EXP lead acetate results in increased expression of DLG4 mRNA
lead acetate affects the expression of DLG4 protein
lead acetate results in decreased expression of DLG4 protein
CTD PMID:27492863 PMID:27984133 NCBI chr10:56,625,845...56,655,543
Ensembl chr10:56,627,411...56,653,599
JBrowse link
G Dlg5 discs large MAGUK scaffold protein 5 decreases expression ISO lead acetate results in decreased expression of DLG5 mRNA CTD PMID:21829687 NCBI chr15:120,213...230,312
Ensembl chr15:120,372...228,977
JBrowse link
G Dlx2 distal-less homeobox 2 increases expression ISO lead acetate results in increased expression of DLX2 mRNA CTD PMID:22609695 NCBI chr 3:58,180,088...58,181,971
Ensembl chr 3:58,180,088...58,181,971
JBrowse link
G Dmbt1 deleted in malignant brain tumors 1 increases expression
decreases expression
ISO lead acetate results in increased expression of DMBT1 mRNA
lead acetate results in decreased expression of DMBT1 mRNA
CTD PMID:20542052 PMID:22609695 NCBI chr 1:201,620,642...201,689,905
NCBI chr 1:203,149,414...203,228,705
JBrowse link
G Dmrt2 doublesex and mab-3 related transcription factor 2 decreases expression ISO lead acetate results in decreased expression of DMRT2 mRNA CTD PMID:21829687 NCBI chr 1:243,662,819...243,669,312
Ensembl chr 1:243,662,823...243,669,312
JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 increases expression ISO lead acetate results in increased expression of DNAJB1 mRNA CTD PMID:21829687 NCBI chr19:24,747,178...24,750,919
Ensembl chr19:24,747,178...24,750,919
JBrowse link
G Dnajb6 DnaJ heat shock protein family (Hsp40) member B6 decreases expression ISO lead acetate results in decreased expression of DNAJB6 mRNA CTD PMID:22609695 NCBI chr 4:2,711,329...2,774,969
Ensembl chr 4:2,711,385...2,774,890
JBrowse link
G Dnajc21 DnaJ heat shock protein family (Hsp40) member C21 decreases expression ISO lead acetate results in decreased expression of DNAJC21 mRNA CTD PMID:21829687 NCBI chr 2:60,419,446...60,446,656
Ensembl chr 2:60,419,525...60,446,510
JBrowse link
G Dnmt1 DNA methyltransferase 1 decreases expression
multiple interactions
increases expression
EXP
ISO
lead acetate results in decreased expression of DNMT1 mRNA; lead acetate results in decreased expression of DNMT1 protein
[lead acetate results in increased abundance of Lead] which affects the expression of DNMT1 protein
lead acetate results in increased expression of DNMT1 mRNA; lead acetate results in increased expression of DNMT1 protein
CTD PMID:21117136 PMID:22160880 PMID:22764079 PMID:23246732 PMID:29481626 NCBI chr 8:21,922,515...21,968,495
Ensembl chr 8:21,922,515...21,968,495
JBrowse link
G Dnmt3a DNA methyltransferase 3 alpha increases expression
multiple interactions
decreases expression
EXP
ISO
lead acetate results in increased expression of DNMT3A protein
[lead acetate results in increased abundance of Lead] which affects the expression of DNMT3A protein
lead acetate results in decreased expression of DNMT3A protein
CTD PMID:23246732 PMID:29481626 NCBI chr 6:28,205,375...28,346,052
Ensembl chr 6:28,235,695...28,340,577
JBrowse link
G Dnmt3l DNA methyltransferase 3 like increases methylation EXP lead acetate results in increased methylation of DNMT3L gene CTD PMID:29571894 NCBI chr20:11,344,513...11,359,090
Ensembl chr20:11,344,514...11,359,090
JBrowse link
G Dnpep aspartyl aminopeptidase increases expression
decreases expression
ISO lead acetate results in increased expression of DNPEP mRNA
lead acetate results in decreased expression of DNPEP mRNA
CTD PMID:21829687 PMID:22609695 PMID:25270620 NCBI chr 9:82,505,529...82,514,399
Ensembl chr 9:82,505,530...82,514,399
JBrowse link
G Dntt DNA nucleotidylexotransferase decreases expression ISO lead acetate results in decreased expression of DNTT mRNA CTD PMID:22609695 NCBI chr 1:260,289,626...260,321,174
Ensembl chr 1:260,289,589...260,321,320
JBrowse link
G Dock1 dedicator of cyto-kinesis 1 increases expression ISO lead acetate results in increased expression of DOCK1 mRNA CTD PMID:20542052 NCBI chr 1:206,900,617...207,414,852
Ensembl chr 1:206,900,617...207,414,843
JBrowse link
G Dok2 docking protein 2 affects expression ISO lead acetate affects the expression of DOK2 mRNA CTD PMID:21829687 NCBI chr15:52,449,884...52,455,414
Ensembl chr15:52,451,161...52,456,409
JBrowse link
G Dok3 docking protein 3 increases expression ISO lead acetate results in increased expression of DOK3 mRNA CTD PMID:21829687 NCBI chr17:9,639,064...9,644,090
Ensembl chr17:9,639,330...9,644,090
JBrowse link
G Dpp4 dipeptidylpeptidase 4 decreases expression ISO lead acetate results in decreased expression of DPP4 mRNA CTD PMID:22609695 NCBI chr 3:48,291,055...48,372,672
Ensembl chr 3:48,291,055...48,372,672
JBrowse link
G Dpt dermatopontin decreases expression EXP lead acetate results in decreased expression of DPT mRNA CTD PMID:22641619 NCBI chr13:83,073,307...83,102,404
Ensembl chr13:83,073,544...83,102,401
JBrowse link
G Dpysl2 dihydropyrimidinase-like 2 increases expression ISO lead acetate results in increased expression of DPYSL2 protein CTD PMID:20797405 NCBI chr15:43,475,640...43,581,725
Ensembl chr15:43,477,629...43,542,939
JBrowse link
G Drd2 dopamine receptor D2 multiple interactions
increases expression
EXP [lead acetate co-treated with Morphine] results in increased expression of DRD2 mRNA; [lead acetate co-treated with Morphine] results in increased expression of DRD2 protein
lead acetate results in increased expression of DRD2 mRNA; lead acetate results in increased expression of DRD2 protein
CTD PMID:23702354 NCBI chr 8:53,678,777...53,743,643
Ensembl chr 8:53,678,777...53,743,642
JBrowse link
G Dsc1 desmocollin 1 decreases expression ISO lead acetate results in decreased expression of DSC1 mRNA CTD PMID:22609695 NCBI chr18:11,877,918...11,906,828
Ensembl chr18:11,877,561...11,906,827
JBrowse link
G Dsc2 desmocollin 2 decreases expression ISO lead acetate results in decreased expression of DSC2 mRNA CTD PMID:22609695 NCBI chr18:11,826,705...11,858,801
Ensembl chr18:11,826,706...11,858,754
JBrowse link
G Dsp desmoplakin decreases expression EXP lead acetate results in decreased expression of DSP mRNA CTD PMID:22641619 NCBI chr17:27,286,811...27,334,453
Ensembl chr17:27,286,796...27,334,379
JBrowse link
G Dusp1 dual specificity phosphatase 1 increases expression
decreases expression
ISO
EXP
lead acetate results in increased expression of DUSP1 mRNA
lead acetate results in decreased expression of DUSP1 mRNA
CTD PMID:21829687 PMID:22641619 NCBI chr10:16,970,642...16,973,425
Ensembl chr10:16,970,626...16,973,418
JBrowse link
G Dusp12 dual specificity phosphatase 12 decreases expression EXP lead acetate results in decreased expression of DUSP12 mRNA CTD PMID:22641619 NCBI chr13:89,258,309...89,267,402
Ensembl chr13:89,258,310...89,267,402
JBrowse link
G Dusp16 dual specificity phosphatase 16 decreases expression ISO lead acetate results in decreased expression of DUSP16 mRNA CTD PMID:21829687 NCBI chr 4:168,470,141...168,551,346
Ensembl chr 4:168,472,412...168,517,177
JBrowse link
G Dusp23 dual specificity phosphatase 23 increases expression ISO lead acetate results in increased expression of DUSP23 mRNA CTD PMID:21829687 NCBI chr13:91,018,670...91,019,862
Ensembl chr13:91,018,510...91,020,112
JBrowse link
G Dync1li1 dynein cytoplasmic 1 light intermediate chain 1 increases methylation
decreases expression
EXP lead acetate results in increased methylation of DYNC1LI1 gene
lead acetate results in decreased expression of DYNC1LI1 mRNA
CTD PMID:29571894 NCBI chr 8:122,743,274...122,776,801
Ensembl chr 8:122,743,189...122,776,806
JBrowse link
G Ears2 glutamyl-tRNA synthetase 2, mitochondrial increases expression ISO lead acetate results in increased expression of EARS2 mRNA CTD PMID:22609695 NCBI chr 1:191,997,512...192,025,350
Ensembl chr 1:191,997,512...192,025,350
JBrowse link
G Ebpl EBP like decreases expression EXP lead acetate results in decreased expression of EBPL mRNA CTD PMID:22641619 NCBI chr15:41,668,119...41,691,518
Ensembl chr15:41,668,119...41,691,518
JBrowse link
G Ednrb endothelin receptor type B increases expression ISO lead acetate results in increased expression of EDNRB mRNA CTD PMID:22839698 NCBI chr15:88,004,775...88,036,354
Ensembl chr15:88,006,977...88,036,354
JBrowse link
G Eea1 early endosome antigen 1 decreases methylation EXP lead acetate results in decreased methylation of EEA1 gene CTD PMID:29571894 NCBI chr 7:37,101,415...37,186,534
Ensembl chr 7:37,018,459...37,186,732
JBrowse link
G Efcab1 EF hand calcium binding domain 1 affects expression
decreases expression
EXP lead acetate affects the expression of EFCAB1 mRNA
lead acetate results in decreased expression of EFCAB1 mRNA
CTD PMID:21864555 PMID:22641619 NCBI chr11:90,214,563...90,234,319
Ensembl chr11:90,221,056...90,234,286
JBrowse link
G Efcab2 EF-hand calcium binding domain 2 increases expression EXP lead acetate results in increased expression of EFCAB2 mRNA CTD PMID:22641619 NCBI chr13:96,303,578...96,414,404
Ensembl chr13:96,303,703...96,414,404
JBrowse link
G Egf epidermal growth factor increases expression ISO lead acetate results in increased expression of EGF mRNA CTD PMID:27562236 NCBI chr 2:68,820,616...68,895,537 JBrowse link
G Egfr epidermal growth factor receptor decreases expression
increases phosphorylation
multiple interactions
EXP
ISO
lead acetate results in decreased expression of EGFR protein
lead acetate results in increased phosphorylation of EGFR protein
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead acetate results in increased phosphorylation of EGFR protein]; EGFR mutant form inhibits the reaction [lead acetate results in increased activity of PRKCA protein]; EGFR mutant form inhibits the reaction [lead acetate results in increased phosphorylation of SRC protein]; RTKI cpd inhibits the reaction [lead acetate results in increased phosphorylation of EGFR protein]
CTD PMID:17298174 PMID:19133285 NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
JBrowse link
G Egln3 egl-9 family hypoxia-inducible factor 3 decreases expression ISO lead acetate results in decreased expression of EGLN3 mRNA CTD PMID:22609695 NCBI chr 6:75,050,329...75,075,795
Ensembl chr 6:75,050,329...75,075,795
JBrowse link
G Egr1 early growth response 1 decreases expression EXP lead acetate results in decreased expression of EGR1 mRNA CTD PMID:22641619 NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
JBrowse link
G Egr2 early growth response 2 decreases expression
increases methylation
EXP lead acetate results in decreased expression of EGR2 mRNA
lead acetate results in increased methylation of EGR2 gene
CTD PMID:22641619 PMID:29571894 NCBI chr20:22,452,170...22,461,018
Ensembl chr20:22,454,463...22,459,025
JBrowse link
G Ehd2 EH-domain containing 2 increases expression ISO lead acetate results in increased expression of EHD2 mRNA CTD PMID:29746905 NCBI chr 1:77,847,599...77,865,870
Ensembl chr 1:77,847,600...77,865,870
JBrowse link
G Eif1ax eukaryotic translation initiation factor 1A, X-linked decreases expression ISO lead acetate results in decreased expression of EIF1AX mRNA CTD PMID:21829687 NCBI chr  X:37,579,959...37,595,300
Ensembl chr  X:37,579,957...37,595,486
JBrowse link
G Eif2ak2 eukaryotic translation initiation factor 2-alpha kinase 2 increases expression ISO lead acetate results in increased expression of EIF2AK2 mRNA CTD PMID:20542052 NCBI chr 6:1,428,845...1,466,193
Ensembl chr 6:1,428,834...1,466,201
JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 increases phosphorylation
multiple interactions
EXP lead acetate results in increased phosphorylation of EIF2AK3 protein
Proanthocyanidins inhibits the reaction [lead acetate results in increased phosphorylation of EIF2AK3 protein]
CTD PMID:25088297 NCBI chr 4:98,648,513...98,709,695
Ensembl chr 4:98,648,545...98,709,694
JBrowse link
G Eif2ak4 eukaryotic translation initiation factor 2 alpha kinase 4 decreases expression ISO lead acetate results in decreased expression of EIF2AK4 mRNA CTD PMID:22613225 NCBI chr 3:110,159,624...110,245,382
Ensembl chr 3:110,159,708...110,249,217
JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2 subunit alpha increases phosphorylation
multiple interactions
EXP lead acetate results in increased phosphorylation of EIF2S1 protein
Proanthocyanidins inhibits the reaction [lead acetate results in increased phosphorylation of EIF2S1 protein]
CTD PMID:25088297 NCBI chr 6:102,048,372...102,073,041
Ensembl chr 6:102,048,372...102,073,041
JBrowse link
G Eif3c eukaryotic translation initiation factor 3, subunit C increases expression EXP lead acetate results in increased expression of EIF3CL mRNA CTD PMID:11578147 NCBI chr 1:197,964,406...197,982,917
Ensembl chr 1:197,964,407...197,982,601
JBrowse link
G Eif4a1 eukaryotic translation initiation factor 4A1 decreases expression ISO lead acetate results in decreased expression of EIF4A1 mRNA CTD PMID:21829687 NCBI chr10:56,271,257...56,276,764
Ensembl chr10:56,271,257...56,276,764
JBrowse link
G Eif4e3 eukaryotic translation initiation factor 4E family member 3 increases expression ISO lead acetate results in increased expression of EIF4E3 mRNA CTD PMID:22613225 NCBI chr 4:132,068,581...132,111,092
Ensembl chr 4:132,068,598...132,111,079
JBrowse link
G Eif4g2 eukaryotic translation initiation factor 4, gamma 2 increases expression ISO lead acetate results in increased expression of EIF4G2 mRNA CTD PMID:20542052 NCBI chr 1:175,883,362...175,895,510
Ensembl chr 1:175,883,363...175,895,510
JBrowse link
G Elavl4 ELAV like RNA binding protein 4 increases expression ISO lead acetate results in increased expression of ELAVL4 mRNA CTD PMID:24260418 NCBI chr 5:130,001,387...130,144,557
Ensembl chr 5:130,001,372...130,085,838
JBrowse link
G Elf2 E74 like ETS transcription factor 2 increases expression ISO lead acetate results in increased expression of ELF2 mRNA CTD PMID:22609695 NCBI chr 2:140,310,374...140,399,312
Ensembl chr 2:140,310,375...140,387,505
JBrowse link
G Elf5 E74 like ETS transcription factor 5 decreases expression ISO lead acetate results in decreased expression of ELF5 mRNA CTD PMID:22609695 NCBI chr 3:93,333,514...93,374,454
Ensembl chr 3:93,351,619...93,371,656
JBrowse link
G Elovl1 ELOVL fatty acid elongase 1 increases expression EXP lead acetate results in increased expression of ELOVL1 mRNA CTD PMID:22641619 NCBI chr 5:137,255,868...137,260,486
Ensembl chr 5:137,255,908...137,260,483
JBrowse link
G Emcn endomucin decreases expression EXP lead acetate results in decreased expression of EMCN mRNA CTD PMID:22641619 NCBI chr 2:242,634,319...242,715,489
Ensembl chr 2:242,634,399...242,714,182
JBrowse link
G Emg1 EMG1 N1-specific pseudouridine methyltransferase decreases expression ISO lead acetate results in decreased expression of EMG1 mRNA CTD PMID:21829687 NCBI chr 4:157,222,366...157,230,647
Ensembl chr 4:157,222,385...157,230,647
JBrowse link
G Eml4 EMAP like 4 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of EML4 mRNA CTD PMID:22839698 NCBI chr 6:6,618,370...6,674,550
Ensembl chr 6:6,619,076...6,674,554
JBrowse link
G Eno1 enolase 1 increases expression ISO lead acetate results in increased expression of ENO1 protein CTD PMID:20797405 NCBI chr 5:167,288,223...167,299,610
Ensembl chr 5:167,288,223...167,299,609
JBrowse link
G Eno3 enolase 3 increases expression ISO lead acetate results in increased expression of ENO3 mRNA CTD PMID:21829687 NCBI chr10:57,278,271...57,283,661
Ensembl chr10:57,278,307...57,283,653
JBrowse link
G Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 decreases expression EXP lead acetate results in decreased expression of ENPP2 mRNA CTD PMID:21864555 NCBI chr 7:94,479,931...94,563,086
Ensembl chr 7:94,480,396...94,563,001
JBrowse link
G Enpp6 ectonucleotide pyrophosphatase/phosphodiesterase 6 increases expression EXP lead acetate results in increased expression of ENPP6 mRNA CTD PMID:22641619 NCBI chr16:48,315,500...48,437,258
Ensembl chr16:48,315,914...48,437,242
JBrowse link
G Entpd5 ectonucleoside triphosphate diphosphohydrolase 5 increases expression ISO lead acetate results in increased expression of ENTPD5 mRNA CTD PMID:21829687 NCBI chr 6:108,087,677...108,123,811
Ensembl chr 6:108,087,418...108,120,579
JBrowse link
G Entpd8 ectonucleoside triphosphate diphosphohydrolase 8 increases expression ISO lead acetate results in increased expression of ENTPD8 mRNA CTD PMID:20542052 NCBI chr 3:2,286,363...2,299,720
Ensembl chr 3:2,288,667...2,302,782
JBrowse link
G Epb41l3 erythrocyte membrane protein band 4.1-like 3 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of EPB41L3 mRNA CTD PMID:12634122 NCBI chr 9:117,314,935...117,666,408
Ensembl chr 9:117,538,009...117,666,410
JBrowse link
G Epha2 Eph receptor A2 increases expression EXP lead acetate results in increased expression of EPHA2 mRNA CTD PMID:11578147 NCBI chr 5:159,845,773...159,874,203
Ensembl chr 5:159,845,774...159,874,206
JBrowse link
G Epha5 EPH receptor A5 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of EPHA5 mRNA CTD PMID:12634122 NCBI chr14:25,589,312...25,958,258
Ensembl chr14:25,589,762...25,958,227
JBrowse link
G Epha8 Eph receptor A8 increases expression EXP lead acetate results in increased expression of EPHA8 mRNA CTD PMID:22641619 NCBI chr 5:155,293,731...155,321,016
Ensembl chr 5:155,295,314...155,316,495
JBrowse link
G Ephb1 Eph receptor B1 increases expression ISO lead acetate results in increased expression of EPHB1 mRNA CTD PMID:20542052 NCBI chr 8:110,376,954...110,813,193
Ensembl chr 8:110,376,954...110,813,000
JBrowse link
G Ephb3 Eph receptor B3 decreases expression EXP lead acetate results in decreased expression of EPHB3 mRNA CTD PMID:11578147 NCBI chr11:83,527,960...83,546,742
Ensembl chr11:83,527,962...83,546,674
JBrowse link
G Ephx2 epoxide hydrolase 2 affects expression EXP lead acetate affects the expression of EPHX2 mRNA CTD PMID:21864555 PMID:22641619 NCBI chr15:42,757,241...42,794,211
Ensembl chr15:42,757,235...42,794,279
JBrowse link
G Eprs glutamyl-prolyl-tRNA synthetase increases expression EXP lead acetate results in increased expression of EPRS mRNA CTD PMID:11578147 NCBI chr13:103,300,911...103,371,651
Ensembl chr13:103,300,932...103,371,577
JBrowse link
G Epx eosinophil peroxidase decreases expression ISO lead acetate results in decreased expression of EPX mRNA CTD PMID:22609695 NCBI chr10:75,160,690...75,171,774
Ensembl chr10:75,160,690...75,171,774
JBrowse link
G Eras ES cell expressed Ras decreases expression
increases expression
ISO lead acetate results in decreased expression of ERAS mRNA
lead acetate results in increased expression of ERAS mRNA
CTD PMID:22609695 PMID:25270620 NCBI chr  X:15,318,215...15,322,601
Ensembl chr  X:15,419,028...15,423,414
Ensembl chr  X:15,419,028...15,423,414
JBrowse link
G Erbb3 erb-b2 receptor tyrosine kinase 3 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of ERBB3 mRNA CTD PMID:12634122 NCBI chr 7:2,989,202...3,010,610
Ensembl chr 7:2,989,340...3,010,350
JBrowse link
G Ercc2 ERCC excision repair 2, TFIIH core complex helicase subunit multiple interactions
increases expression
ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of ERCC2 mRNA
lead acetate results in increased expression of ERCC2 mRNA
CTD PMID:12634122 PMID:29746905 NCBI chr 1:80,293,574...80,307,334
Ensembl chr 1:80,293,566...80,307,344
JBrowse link
G Ercc5 ERCC excision repair 5, endonuclease multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of ERCC5 mRNA CTD PMID:12634122 NCBI chr 9:50,928,847...50,970,962
Ensembl chr 9:50,925,619...50,970,955
JBrowse link
G Eri2 ERI1 exoribonuclease family member 2 increases expression EXP lead acetate results in increased expression of ERI2 mRNA CTD PMID:22641619 NCBI chr 1:189,540,145...189,549,891
Ensembl chr 1:189,540,145...189,549,891
JBrowse link
G Ern1 endoplasmic reticulum to nucleus signaling 1 increases expression
increases phosphorylation
multiple interactions
ISO
EXP
lead acetate results in increased expression of ERN1 mRNA
lead acetate results in increased phosphorylation of ERN1 protein
Proanthocyanidins inhibits the reaction [lead acetate results in increased phosphorylation of ERN1 protein]
CTD PMID:21829687 PMID:25088297 NCBI chr10:94,588,555...94,682,072
Ensembl chr10:94,588,555...94,681,914
JBrowse link
G Esm1 endothelial cell-specific molecule 1 decreases expression EXP lead acetate results in decreased expression of ESM1 mRNA CTD PMID:22641619 NCBI chr 2:45,104,392...45,113,130
Ensembl chr 2:45,104,305...45,113,131
JBrowse link
G Esrp2 epithelial splicing regulatory protein 2 increases expression ISO lead acetate results in increased expression of ESRP2 mRNA CTD PMID:22609695 NCBI chr19:38,113,412...38,120,578
Ensembl chr19:38,113,412...38,120,578
JBrowse link
G Etf1 eukaryotic translation termination factor 1 increases expression ISO lead acetate results in increased expression of ETF1 mRNA CTD PMID:22609695 NCBI chr18:27,698,693...27,725,694
Ensembl chr18:27,698,695...27,725,694
JBrowse link
G Etfb electron transfer flavoprotein subunit beta increases expression
decreases expression
ISO
EXP
lead acetate results in increased expression of ETFB mRNA
lead acetate results in decreased expression of ETFB mRNA
CTD PMID:20542052 PMID:22641619 NCBI chr 1:98,472,776...98,486,940
Ensembl chr 1:98,472,745...98,486,976
JBrowse link
G Etfbkmt electron transfer flavoprotein subunit beta lysine methyltransferase increases expression EXP lead acetate results in increased expression of ETFBKMT mRNA CTD PMID:22641619 NCBI chr 4:183,655,968...183,665,757
Ensembl chr 4:183,656,013...183,665,754
JBrowse link
G Evl Enah/Vasp-like increases expression EXP lead acetate results in increased expression of EVL mRNA CTD PMID:11578147 NCBI chr 6:132,470,283...132,590,242
Ensembl chr 6:132,510,757...132,590,241
JBrowse link
G Eya4 EYA transcriptional coactivator and phosphatase 4 increases expression EXP lead acetate results in increased expression of EYA4 mRNA CTD PMID:22641619 NCBI chr 1:23,237,617...23,611,580
Ensembl chr 1:23,409,408...23,610,164
JBrowse link
G F13a1 coagulation factor XIII A1 chain increases expression ISO lead acetate results in increased expression of F13A1 mRNA CTD PMID:27562236 NCBI chr17:28,504,650...28,680,015
Ensembl chr17:28,504,623...28,680,362
JBrowse link
G F2r coagulation factor II (thrombin) receptor decreases expression ISO lead acetate results in decreased expression of F2R mRNA CTD PMID:22613225 NCBI chr 2:26,118,760...26,135,340
Ensembl chr 2:26,118,760...26,135,340
JBrowse link
G F2rl2 coagulation factor II (thrombin) receptor-like 2 increases expression ISO lead acetate results in increased expression of F2RL2 mRNA CTD PMID:27562236 NCBI chr 2:26,240,385...26,245,533
Ensembl chr 2:26,240,385...26,245,533
JBrowse link
G F5 coagulation factor V affects expression EXP lead acetate affects the expression of F5 mRNA CTD PMID:22641619 NCBI chr13:82,479,997...82,535,540
Ensembl chr13:82,479,998...82,535,534
JBrowse link
G Fa2h fatty acid 2-hydroxylase increases expression ISO lead acetate results in increased expression of FA2H mRNA CTD PMID:20542052 NCBI chr19:43,545,380...43,596,788
Ensembl chr19:43,545,378...43,596,801
JBrowse link
G Fabp4 fatty acid binding protein 4 decreases expression
affects methylation
increases expression
ISO
EXP
lead acetate results in decreased expression of FABP4 mRNA
lead acetate affects the methylation of FABP4 gene
lead acetate results in increased expression of FABP4 mRNA
CTD PMID:22609695 PMID:29571894 NCBI chr 2:93,792,666...93,797,267
Ensembl chr 2:93,792,601...93,797,305
JBrowse link
G Fabp9 fatty acid binding protein 9 increases expression
multiple interactions
ISO lead acetate results in increased expression of FABP9 mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of FABP9 protein
CTD PMID:22609695 PMID:32142724 NCBI chr 2:93,803,503...93,807,069
Ensembl chr 2:93,803,449...93,807,069
JBrowse link
G Fah fumarylacetoacetate hydrolase increases expression EXP lead acetate results in increased expression of FAH mRNA CTD PMID:22641619 NCBI chr 1:146,713,663...146,736,339
Ensembl chr 1:146,713,676...146,736,261
JBrowse link
G Fam114a1l1 family with sequence similarity 114, member A1-like 1 increases expression EXP lead acetate results in increased expression of FAM114A1L1 mRNA CTD PMID:22641619 NCBI chr 9:120,099,302...120,101,072
Ensembl chr 9:120,099,333...120,101,098
JBrowse link
G Fam160a1 family with sequence similarity 160, member A1 decreases expression EXP lead acetate results in decreased expression of FAM160A1 mRNA CTD PMID:22641619 NCBI chr 2:184,684,851...184,993,350
Ensembl chr 2:184,941,700...185,168,773
JBrowse link
G Fam81b family with sequence similarity 81, member B decreases expression EXP lead acetate results in decreased expression of FAM81B mRNA CTD PMID:22641619 NCBI chr 2:3,004,688...3,134,667
Ensembl chr 2:3,025,217...3,124,543
JBrowse link
G Fam83d family with sequence similarity 83, member D increases expression EXP lead acetate results in increased expression of FAM83D mRNA CTD PMID:22641619 NCBI chr 3:155,269,344...155,288,612
Ensembl chr 3:155,269,347...155,288,533
JBrowse link
G Fan1 FANCD2 and FANCI associated nuclease 1 increases expression ISO lead acetate results in increased expression of FAN1 mRNA CTD PMID:20542052 NCBI chr 1:125,182,117...125,209,772
Ensembl chr 1:125,181,838...125,209,727
JBrowse link
G Fanca FA complementation group A decreases expression ISO lead acetate results in decreased expression of FANCA mRNA CTD PMID:22609695 NCBI chr19:56,067,548...56,126,075
Ensembl chr19:56,067,548...56,126,063
JBrowse link
G Farsa phenylalanyl-tRNA synthetase subunit alpha decreases expression EXP lead acetate results in decreased expression of FARSA mRNA CTD PMID:11578147 NCBI chr19:25,969,255...25,978,777
Ensembl chr19:25,969,255...25,978,776
JBrowse link
G Fas Fas cell surface death receptor multiple interactions ISO [S-allylcysteine co-treated with Clotrimazole] inhibits the reaction [lead acetate affects the localization of and results in increased activity of FAS protein]; lead acetate affects the localization of and results in increased activity of FAS protein; S-allylcysteine inhibits the reaction [lead acetate affects the localization of and results in increased activity of FAS protein] CTD PMID:22033380 NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
JBrowse link
G Fasn fatty acid synthase increases expression ISO lead acetate results in increased expression of FASN mRNA CTD PMID:30623991 NCBI chr10:109,987,735...110,005,901
Ensembl chr10:109,987,735...110,005,901
JBrowse link
G Fat1 FAT atypical cadherin 1 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of FAT1 mRNA CTD PMID:12634122 NCBI chr16:50,372,150...50,501,716
Ensembl chr16:50,372,128...50,501,921
JBrowse link
G Fbl fibrillarin affects localization ISO lead acetate affects the localization of FBL protein CTD PMID:10942594 NCBI chr 1:85,103,519...85,112,619
Ensembl chr 1:85,103,519...85,112,619
JBrowse link
G Fbln2 fibulin 2 decreases expression EXP lead acetate results in decreased expression of FBLN2 mRNA CTD PMID:22641619 NCBI chr 4:122,835,237...122,895,127
Ensembl chr 4:122,835,436...122,895,121
JBrowse link
G Fbn1 fibrillin 1 increases expression ISO lead acetate results in increased expression of FBN1 mRNA CTD PMID:20542052 NCBI chr 3:117,569,708...117,766,160
Ensembl chr 3:117,569,697...117,766,120
JBrowse link
G Fbxl3 F-box and leucine-rich repeat protein 3 decreases expression ISO lead acetate results in decreased expression of FBXL3 mRNA CTD PMID:22609695 NCBI chr15:93,647,307...93,667,395
Ensembl chr15:93,647,310...93,667,395
JBrowse link
G Fbxl6 F-box and leucine-rich repeat protein 6 decreases expression ISO lead acetate results in decreased expression of FBXL6 mRNA CTD PMID:21829687 NCBI chr 7:117,602,056...117,604,954
Ensembl chr 7:117,602,041...117,605,141
JBrowse link
G Fbxo32 F-box protein 32 increases expression ISO lead acetate results in increased expression of FBXO32 mRNA CTD PMID:20542052 NCBI chr 7:98,065,664...98,098,071
Ensembl chr 7:98,063,735...98,098,268
JBrowse link
G Fbxo33 F-box protein 33 increases expression ISO lead acetate results in increased expression of FBXO33 mRNA CTD PMID:21829687 NCBI chr 6:80,302,291...80,334,536
Ensembl chr 6:80,302,303...80,334,522
JBrowse link
G Fbxw12 F-box and WD repeat domain containing 12 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of FBXW12 mRNA CTD PMID:22839698 NCBI chr 8:117,871,409...117,890,944
Ensembl chr 8:117,871,442...117,890,930
JBrowse link
G Fcer2 Fc fragment of IgE receptor II increases expression ISO lead acetate results in increased expression of FCER2A mRNA CTD PMID:21829687 NCBI chr12:2,233,772...2,245,324
Ensembl chr12:2,233,778...2,245,324
JBrowse link
G Fcgr2a Fc fragment of IgG receptor IIa affects binding ISO lead acetate binds to FCGR3 protein CTD PMID:10666595 NCBI chr13:91,146,878...91,163,691
Ensembl chr13:91,168,973...91,198,036
Ensembl chr13:91,168,973...91,198,036
JBrowse link
G Fcgr3a Fc fragment of IgG receptor IIIa decreases expression ISO lead acetate results in decreased expression of FCGR4 mRNA CTD PMID:21829687 NCBI chr13:89,385,775...89,396,047
Ensembl chr13:89,385,859...89,396,051
JBrowse link
G Fcgrt Fc fragment of IgG receptor and transporter decreases expression ISO lead acetate results in decreased expression of FCGRT mRNA CTD PMID:21829687 NCBI chr 1:101,086,872...101,096,159
Ensembl chr 1:101,086,877...101,095,594
JBrowse link
G Fcrl2 Fc receptor-like 2 decreases expression EXP lead acetate results in decreased expression of FCRLS mRNA CTD PMID:22641619 NCBI chr 2:186,594,442...186,605,115
Ensembl chr 2:186,595,051...186,606,172
JBrowse link
G Fermt1 fermitin family member 1 decreases expression EXP lead acetate results in decreased expression of FERMT1 mRNA CTD PMID:22641619 NCBI chr 3:125,566,744...125,607,864
Ensembl chr 3:125,566,643...125,607,735
JBrowse link
G Fga fibrinogen alpha chain decreases expression ISO lead acetate results in decreased expression of FGA mRNA CTD PMID:25270620 NCBI chr 2:181,997,562...182,013,726
Ensembl chr 2:182,006,242...182,013,763
JBrowse link
G Fgb fibrinogen beta chain decreases expression ISO lead acetate results in decreased expression of FGB mRNA CTD PMID:25270620 NCBI chr 2:182,028,044...182,035,026
Ensembl chr 2:182,027,115...182,038,178
JBrowse link
G Fgf1 fibroblast growth factor 1 affects expression EXP lead acetate affects the expression of FGF1 mRNA CTD PMID:21864555 NCBI chr18:32,273,830...32,359,831
Ensembl chr18:32,273,770...32,359,824
JBrowse link
G Fgf18 fibroblast growth factor 18 decreases expression ISO lead acetate results in decreased expression of FGF18 mRNA CTD PMID:22609695 NCBI chr10:18,047,109...18,082,290
Ensembl chr10:18,047,109...18,063,391
JBrowse link
G Fgf2 fibroblast growth factor 2 decreases expression EXP lead acetate results in decreased expression of FGF2 mRNA CTD PMID:22160880 NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681
JBrowse link
G Fgf21 fibroblast growth factor 21 increases expression ISO lead acetate results in increased expression of FGF21 mRNA CTD PMID:22609695 NCBI chr 1:101,595,579...101,596,822
Ensembl chr 1:101,595,579...101,596,822
JBrowse link
G Fgfr1 Fibroblast growth factor receptor 1 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of FGFR1 mRNA CTD PMID:22839698 NCBI chr16:71,265,390...71,319,046
Ensembl chr16:71,266,248...71,319,449
JBrowse link
G Fgfr4 fibroblast growth factor receptor 4 decreases expression ISO lead acetate results in decreased expression of FGFR4 mRNA CTD PMID:22609695 NCBI chr17:9,990,072...10,004,339
Ensembl chr17:9,990,078...10,004,321
JBrowse link
G Fgg fibrinogen gamma chain decreases expression ISO lead acetate results in decreased expression of FGG mRNA CTD PMID:25270620 NCBI chr 2:181,987,080...181,994,523
Ensembl chr 2:181,987,217...181,994,514
JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 increases expression
increases methylation
EXP lead acetate results in increased expression of FKBP5 mRNA
lead acetate results in increased methylation of FKBP5 gene
CTD PMID:22641619 PMID:29571894 NCBI chr20:7,976,704...8,097,290
Ensembl chr20:7,976,713...8,019,020
JBrowse link
G Flg2 filaggrin family member 2 decreases expression EXP lead acetate results in decreased expression of FLG2 mRNA CTD PMID:22641619 NCBI chr 2:193,480,880...193,485,463
Ensembl chr 2:193,483,793...193,485,313
JBrowse link
G Flt4 Fms related receptor tyrosine kinase 4 increases expression EXP lead acetate results in increased expression of FLT4 mRNA CTD PMID:11578147 NCBI chr10:35,078,782...35,120,296
Ensembl chr10:35,078,726...35,121,599
JBrowse link
G Fmnl3 formin-like 3 decreases expression ISO lead acetate results in decreased expression of FMNL3 mRNA CTD PMID:22609695 NCBI chr 7:140,981,801...141,033,318
Ensembl chr 7:140,983,342...141,001,993
JBrowse link
G Fmo2 flavin containing dimethylaniline monoxygenase 2 decreases expression ISO lead acetate results in decreased expression of FMO2 mRNA CTD PMID:29746905 NCBI chr13:80,752,526...80,775,264
Ensembl chr13:80,755,058...80,775,264
JBrowse link
G Fmo5 flavin containing dimethylaniline monoxygenase 5 decreases expression ISO lead acetate results in decreased expression of FMO5 mRNA CTD PMID:25270620 NCBI chr 2:199,796,870...199,823,927
Ensembl chr 2:199,796,881...199,823,927
JBrowse link
G Fmr1 FMRP translational regulator 1 increases methylation EXP lead acetate results in increased methylation of FMR1 gene CTD PMID:29571894 NCBI chr  X:154,684,924...154,722,369
Ensembl chr  X:154,684,935...154,722,314
JBrowse link
G Fn1 fibronectin 1 increases expression EXP lead acetate results in increased expression of FN1 mRNA CTD PMID:22641619 NCBI chr 9:78,900,111...78,969,018
Ensembl chr 9:78,900,103...78,969,078
JBrowse link
G Fndc3a fibronectin type III domain containing 3a increases expression ISO lead acetate results in increased expression of FNDC3A mRNA CTD PMID:22609695 NCBI chr15:54,378,865...54,582,954
Ensembl chr15:54,381,044...54,528,480
JBrowse link
G Folh1 folate hydrolase 1 increases methylation EXP lead acetate results in increased methylation of FOLH1 gene CTD PMID:29571894 NCBI chr 1:150,323,768...150,395,415
Ensembl chr 1:150,323,768...150,395,415
JBrowse link
G Folr1 folate receptor alpha affects expression EXP lead acetate affects the expression of FOLR1 mRNA CTD PMID:21864555 PMID:22641619 NCBI chr 1:166,934,457...166,945,864
Ensembl chr 1:166,934,460...166,943,592
JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions
decreases expression
increases expression
EXP
ISO
lead acetate affects the reaction [Amphetamine results in increased expression of FOS protein]; lead acetate inhibits the reaction [HSPA5 protein binds to FOS enhancer]
lead acetate results in decreased expression of FOS mRNA
lead acetate results in increased expression of FOS protein
CTD PMID:15111246 PMID:15111640 PMID:21829687 PMID:22641619 NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of FOSL1 mRNA CTD PMID:12634122 NCBI chr 1:220,826,560...220,835,066
Ensembl chr 1:220,826,560...220,835,066
JBrowse link
G Foxd4 forkhead box D4 increases expression ISO lead acetate results in increased expression of FOXD4 mRNA CTD PMID:22609695 NCBI chr 1:242,808,886...242,810,186
Ensembl chr 1:242,808,965...242,810,186
JBrowse link
G Foxp2 forkhead box P2 decreases expression ISO lead acetate results in decreased expression of FOXP2 mRNA CTD PMID:22613225 NCBI chr 4:41,364,441...41,944,685
Ensembl chr 4:41,364,441...41,942,023
JBrowse link
G Foxp3 forkhead box P3 increases expression ISO
EXP
lead acetate results in increased expression of FOXP3 mRNA
lead acetate results in increased expression of FOXP3 protein
CTD PMID:20542052 PMID:23058909 NCBI chr  X:15,753,175...15,768,648
Ensembl chr  X:15,753,175...15,768,522
JBrowse link
G Frem2 FRAS1 related extracellular matrix 2 increases expression ISO lead acetate results in increased expression of FREM2 mRNA CTD PMID:20542052 NCBI chr 2:142,747,501...142,885,604
Ensembl chr 2:142,747,501...142,885,604
JBrowse link
G Frk fyn-related Src family tyrosine kinase increases expression EXP lead acetate results in increased expression of FRK mRNA CTD PMID:11578147 NCBI chr20:41,266,408...41,383,731
Ensembl chr20:41,266,566...41,383,424
JBrowse link
G Frmd3 FERM domain containing 3 decreases expression ISO lead acetate results in decreased expression of FRMD3 mRNA CTD PMID:22613225 NCBI chr 5:90,040,495...90,282,327
Ensembl chr 5:90,040,495...90,282,327
JBrowse link
G Frmd4b FERM domain containing 4B decreases expression ISO lead acetate results in decreased expression of FRMD4B mRNA CTD PMID:22609695 NCBI chr 4:129,658,137...129,984,735
Ensembl chr 4:129,658,840...129,846,642
JBrowse link
G Fry FRY microtubule binding protein increases expression ISO lead acetate results in increased expression of FRY mRNA CTD PMID:21829687 NCBI chr12:5,573,729...5,822,874
Ensembl chr12:5,573,729...5,822,874
JBrowse link
G Fth1 ferritin heavy chain 1 increases expression ISO lead acetate results in increased expression of FTH1 mRNA CTD PMID:20542052 NCBI chr 1:226,030,940...226,033,228
Ensembl chr 1:226,030,938...226,033,228
JBrowse link
G Ftl1 ferritin light chain 1 increases expression EXP
ISO
lead acetate results in increased expression of FTL mRNA CTD PMID:11578147 PMID:27562236 NCBI chr 1:101,448,190...101,450,034
Ensembl chr 1:101,448,346...101,449,829
JBrowse link
G Fut4 fucosyltransferase 4 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of FUT4 mRNA CTD PMID:22839698 NCBI chr 8:13,258,768...13,262,729
Ensembl chr 8:13,258,768...13,262,729
JBrowse link
G Fyb2 FYN binding protein 2 decreases expression EXP lead acetate results in decreased expression of FYB2 mRNA CTD PMID:22641619 NCBI chr 5:124,442,386...124,561,766 JBrowse link
G Fyn FYN proto-oncogene, Src family tyrosine kinase multiple interactions
increases activity
EXP FYN protein affects the reaction [lead acetate results in decreased expression of PDGFRA protein]
lead acetate results in increased activity of FYN protein
CTD PMID:17298174 NCBI chr20:44,436,354...44,630,316
Ensembl chr20:44,436,403...44,630,317
JBrowse link
G G6pd glucose-6-phosphate dehydrogenase decreases activity
multiple interactions
EXP lead acetate results in decreased activity of G6PD protein
[naringenin co-treated with lead acetate] results in decreased activity of G6PD protein
CTD PMID:25228019 PMID:30980912 NCBI chr  X:156,274,800...156,293,935
Ensembl chr  X:156,274,800...156,293,926
JBrowse link
G Gaa alpha glucosidase increases expression EXP lead acetate results in increased expression of GAA mRNA CTD PMID:11578147 NCBI chr10:108,395,873...108,412,999
Ensembl chr10:108,395,860...108,413,059
JBrowse link
G Gab2 GRB2-associated binding protein 2 increases expression ISO lead acetate results in increased expression of GAB2 mRNA CTD PMID:20542052 NCBI chr 1:162,082,876...162,283,379
Ensembl chr 1:162,083,030...162,279,727
JBrowse link
G Gabrq gamma-aminobutyric acid type A receptor subunit theta decreases expression EXP lead acetate results in decreased expression of GABRQ mRNA CTD PMID:22641619 NCBI chr  X:152,852,230...152,869,012
Ensembl chr  X:152,852,506...152,864,975
JBrowse link
G Gabrr1 gamma-aminobutyric acid type A receptor subunit rho 1 decreases expression EXP lead acetate results in decreased expression of GABRR1 mRNA CTD PMID:22641619 NCBI chr 5:48,374,048...48,411,170
Ensembl chr 5:48,374,096...48,411,170
JBrowse link
G Gad2 glutamate decarboxylase 2 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased expression of GAD2 protein CTD PMID:31785328 NCBI chr17:89,171,576...89,234,770
Ensembl chr17:89,171,250...89,238,040
JBrowse link
G Gadd45g growth arrest and DNA-damage-inducible, gamma increases methylation EXP lead acetate results in increased methylation of GADD45G gene CTD PMID:29571894 NCBI chr17:13,391,474...13,393,219
Ensembl chr17:13,391,467...13,393,243
JBrowse link
G Galns galactosamine (N-acetyl)-6-sulfatase decreases expression ISO lead acetate results in decreased expression of GALNS mRNA CTD PMID:21829687 NCBI chr19:55,391,004...55,423,328
Ensembl chr19:55,389,462...55,423,150
JBrowse link
G Galnt9 polypeptide N-acetylgalactosaminyltransferase 9 increases methylation EXP lead acetate results in increased methylation of GALNT9 gene CTD PMID:29571894 NCBI chr12:52,106,506...52,187,205
Ensembl chr12:52,106,506...52,187,164
JBrowse link
G Galr1 galanin receptor 1 decreases expression EXP
ISO
lead acetate results in decreased expression of GALR1 mRNA CTD PMID:22609695 PMID:22641619 NCBI chr18:79,243,009...79,258,570
Ensembl chr18:79,243,009...79,258,570
JBrowse link
G Galr2 galanin receptor 2 increases expression ISO lead acetate results in increased expression of GALR2 mRNA CTD PMID:22609695 NCBI chr10:105,156,793...105,159,221
Ensembl chr10:105,156,632...105,237,611
JBrowse link
G Gap43 growth associated protein 43 multiple interactions ISO [lead acetate results in increased abundance of Lead] promotes the reaction [[APP protein co-treated with APP protein modified form] results in decreased expression of GAP43 protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein modified form results in decreased expression of GAP43 protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein results in decreased expression of GAP43 protein]; [lead acetate results in increased abundance of Lead] which results in decreased expression of GAP43 protein CTD PMID:31843630 NCBI chr11:58,624,198...58,717,916
Ensembl chr11:58,624,198...58,717,914
JBrowse link
G Gapdh glyceraldehyde-3-phosphate dehydrogenase increases expression ISO lead acetate results in increased expression of GAPDH protein CTD PMID:20797405 NCBI chr 4:157,676,336...157,680,322
Ensembl chr 4:157,676,595...157,679,962
JBrowse link
G Gast gastrin increases expression
multiple interactions
ISO lead acetate results in increased expression of GAST mRNA; lead acetate results in increased expression of GAST protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in increased expression of GAST mRNA]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead acetate results in increased expression of GAST mRNA]; RTKI cpd inhibits the reaction [lead acetate results in increased expression of GAST mRNA]
CTD PMID:23765435 NCBI chr10:88,245,532...88,248,485
Ensembl chr10:88,245,532...88,248,484
JBrowse link
G Gata2 GATA binding protein 2 decreases expression ISO lead acetate results in decreased expression of GATA2 mRNA CTD PMID:21829687 NCBI chr 4:120,129,028...120,142,490
Ensembl chr 4:120,133,713...120,142,488
JBrowse link
G Gata3 GATA binding protein 3 decreases expression ISO lead acetate results in decreased expression of GATA3 mRNA CTD PMID:22613225 NCBI chr17:72,419,752...72,452,043
Ensembl chr17:72,429,618...72,450,681
JBrowse link
G Gata6 GATA binding protein 6 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of GATA6 mRNA CTD PMID:12634122 NCBI chr18:2,415,821...2,447,087
Ensembl chr18:2,416,552...2,446,338
JBrowse link
G Gatm glycine amidinotransferase decreases expression ISO lead acetate results in decreased expression of GATM mRNA CTD PMID:20542052 NCBI chr 3:114,711,570...114,728,155
Ensembl chr 3:114,711,562...114,728,410
JBrowse link
G Gbx2 gastrulation brain homeobox 2 decreases expression ISO lead acetate results in decreased expression of GBX2 mRNA CTD PMID:22613225 PMID:25270620 NCBI chr 9:97,063,265...97,065,855
Ensembl chr 9:97,063,728...97,065,817
JBrowse link
G Gc GC, vitamin D binding protein increases expression EXP lead acetate results in increased expression of GC mRNA CTD PMID:22641619 NCBI chr14:20,267,023...20,302,577
Ensembl chr14:20,266,891...20,302,581
JBrowse link
G Gch1 GTP cyclohydrolase 1 decreases expression
increases expression
EXP
ISO
lead acetate results in decreased expression of GCH1 mRNA
lead acetate results in increased expression of GCH1 mRNA
CTD PMID:22641619 PMID:25270620 NCBI chr15:23,935,011...23,968,971
Ensembl chr15:23,934,585...23,969,011
JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit multiple interactions
increases expression
ISO NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of GCLC mRNA] CTD PMID:26498409 NCBI chr 8:85,059,051...85,097,471
Ensembl chr 8:85,059,051...85,097,468
JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit increases expression
multiple interactions
ISO lead acetate results in increased expression of GCLM mRNA
NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of GCLM mRNA]
CTD PMID:25270620 PMID:26498409 NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874
JBrowse link
G Gcnt3 glucosaminyl (N-acetyl) transferase 3, mucin type increases expression ISO lead acetate results in increased expression of GCNT3 mRNA CTD PMID:21829687 NCBI chr 8:76,449,078...76,459,431
Ensembl chr 8:76,449,081...76,452,554
JBrowse link
G Gcnt4 glucosaminyl (N-acetyl) transferase 4 increases expression EXP lead acetate results in increased expression of GCNT4 mRNA CTD PMID:22641619 Ensembl chr 2:27,713,880...27,780,119 JBrowse link
G Gdap2 ganglioside-induced differentiation-associated-protein 2 decreases expression ISO lead acetate results in decreased expression of GDAP2 mRNA CTD PMID:21829687 NCBI chr 2:202,470,485...202,526,849
Ensembl chr 2:202,470,487...202,526,849
JBrowse link
G Gdf15 growth differentiation factor 15 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of GDF15 mRNA CTD PMID:12634122 NCBI chr16:20,555,395...20,557,978
Ensembl chr16:20,555,395...20,557,978
JBrowse link
G Gdf2 growth differentiation factor 2 increases expression ISO lead acetate results in increased expression of GDF2 mRNA CTD PMID:22609695 NCBI chr16:10,267,510...10,293,545
Ensembl chr16:10,267,482...10,273,239
JBrowse link
G Gdf5 growth differentiation factor 5 increases expression ISO lead acetate results in increased expression of GDF5 mRNA CTD PMID:22609695 NCBI chr 3:151,482,672...151,487,129
Ensembl chr 3:151,483,249...151,486,693
JBrowse link
G Gfap glial fibrillary acidic protein multiple interactions
increases expression
decreases expression
EXP
ISO
[[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein; [Cadmium Chloride co-treated with sodium arsenite co-treated with lead acetate] results in decreased expression of GFAP protein; [lead acetate co-treated with Morphine] results in increased expression of GFAP mRNA; [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of GFAP protein; [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] promotes the reaction [PPARG protein binds to GFAP promoter]; [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of GFAP mRNA; [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of GFAP protein; CR8 compound inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of GFAP protein]
lead acetate results in increased expression of GFAP protein
lead acetate results in increased expression of GFAP mRNA
lead acetate results in decreased expression of GFAP protein
CTD PMID:17047031 PMID:20829427 PMID:21322097 PMID:24481447 PMID:26396915 PMID:26478469 NCBI chr10:90,990,762...90,999,435
Ensembl chr10:90,990,762...90,999,506
JBrowse link
G Ggct gamma-glutamyl cyclotransferase increases expression ISO lead acetate results in increased expression of GGCT mRNA CTD PMID:22609695 NCBI chr 4:85,186,644...85,192,857
Ensembl chr 4:85,186,644...85,192,834
JBrowse link
G Ghitm growth hormone inducible transmembrane protein increases expression ISO lead acetate results in increased expression of GHITM mRNA CTD PMID:25270620 NCBI chr16:14,370,269...14,382,647
Ensembl chr16:14,371,531...14,382,641
JBrowse link
G Gimap7 GTPase, IMAP family member 7 increases expression ISO lead acetate results in increased expression of GIMAP7 mRNA CTD PMID:21829687 NCBI chr 4:78,354,335...78,358,505
Ensembl chr 4:78,354,335...78,358,503
JBrowse link
G Gja1 gap junction protein, alpha 1 increases expression
increases uptake
multiple interactions
decreases expression
EXP lead acetate results in increased expression of GJA1 protein
GJA1 protein results in increased uptake of lead acetate
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of GJA1 protein]; Dasatinib promotes the reaction [lead acetate results in decreased expression of GJA1 protein]; GJA1 protein inhibits the reaction [Carbenoxolone results in decreased uptake of lead acetate]
CTD PMID:20932874 PMID:26926986 PMID:28916327 PMID:29457680 NCBI chr20:37,876,650...37,889,097
Ensembl chr20:37,876,650...37,889,089
JBrowse link
G Gja8 gap junction protein, alpha 8 increases expression ISO lead acetate results in increased expression of GJA8 mRNA CTD PMID:22609695 NCBI chr 2:199,050,854...199,052,470
Ensembl chr 2:199,050,854...199,052,470
JBrowse link
G Gjb6 gap junction protein, beta 6 increases expression EXP lead acetate results in increased expression of GJB6 mRNA CTD PMID:22641619 NCBI chr15:37,400,888...37,411,656
Ensembl chr15:37,400,889...37,410,848
JBrowse link
G Gjc2 gap junction protein, gamma 2 increases expression EXP
ISO
lead acetate results in increased expression of GJC2 mRNA CTD PMID:22609695 PMID:22641619 NCBI chr10:45,526,740...45,535,520
Ensembl chr10:45,526,745...45,534,570
JBrowse link
G Gjc3 gap junction protein, gamma 3 increases expression EXP lead acetate results in increased expression of GJC3 mRNA CTD PMID:22641619 NCBI chr12:19,166,074...19,177,701
Ensembl chr12:19,166,239...19,167,015
JBrowse link
G Gk glycerol kinase increases expression EXP lead acetate results in increased expression of GK mRNA CTD PMID:11578147 NCBI chr  X:54,227,291...54,303,897
Ensembl chr  X:54,227,397...54,303,864
JBrowse link
G Gldn gliomedin increases expression EXP lead acetate results in increased expression of GLDN mRNA CTD PMID:22641619 NCBI chr 8:58,870,516...58,914,605
Ensembl chr 8:58,870,516...58,914,603
JBrowse link
G Gli1 GLI family zinc finger 1 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of GLI1 mRNA CTD PMID:12634122 NCBI chr 7:70,620,794...70,633,171
Ensembl chr 7:70,620,766...70,630,338
JBrowse link
G Glipr2 GLI pathogenesis-related 2 increases expression ISO lead acetate results in increased expression of GLIPR2 mRNA CTD PMID:25270620 NCBI chr 5:59,415,415...59,446,732
Ensembl chr 5:59,416,076...59,446,647
JBrowse link
G Glod4 glyoxalase domain containing 4 increases expression ISO lead acetate results in increased expression of GLOD4 mRNA CTD PMID:21829687 NCBI chr10:64,379,922...64,398,263
Ensembl chr10:64,379,921...64,398,294
JBrowse link
G Glra2 glycine receptor, alpha 2 decreases expression EXP
ISO
lead acetate results in decreased expression of GLRA2 mRNA CTD PMID:22613225 PMID:22641619 NCBI chr  X:30,612,894...30,832,078
Ensembl chr  X:30,612,903...30,831,483
JBrowse link
G Glra3 glycine receptor, alpha 3 decreases expression EXP lead acetate results in decreased expression of GLRA3 mRNA CTD PMID:22641619 NCBI chr16:37,676,959...37,908,221
Ensembl chr16:37,676,962...38,063,821
JBrowse link
G Glul glutamate-ammonia ligase increases expression
multiple interactions
decreases expression
ISO
EXP
lead acetate results in increased expression of GLUL mRNA
[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of GLUL protein
lead acetate results in decreased expression of GLUL mRNA
CTD PMID:20542052 PMID:23680456 PMID:25270620 NCBI chr13:71,331,052...71,340,207
Ensembl chr13:71,331,052...71,340,229
JBrowse link
G Gmnn geminin, DNA replication inhibitor decreases expression ISO lead acetate results in decreased expression of GMNN mRNA CTD PMID:25270620 NCBI chr17:42,302,523...42,310,783
Ensembl chr17:42,302,540...42,310,783
JBrowse link
G Gna13 G protein subunit alpha 13 increases expression ISO lead acetate results in increased expression of GNA13 mRNA CTD PMID:21829687 NCBI chr10:97,647,196...97,680,030
Ensembl chr10:97,647,111...97,684,730
JBrowse link
G Gnao1 G protein subunit alpha o1 increases expression ISO lead acetate results in increased expression of GNAO1 protein CTD PMID:20797405 NCBI chr19:11,513,201...11,669,578
Ensembl chr19:11,513,201...11,669,578
JBrowse link
G Gnb4 G protein subunit beta 4 increases expression ISO lead acetate results in increased expression of GNB4 mRNA CTD PMID:21829687 NCBI chr 2:118,978,965...119,007,877
Ensembl chr 2:118,978,973...119,007,835
JBrowse link
G Gng12 G protein subunit gamma 12 decreases expression ISO lead acetate results in decreased expression of GNG12 mRNA CTD PMID:22613225 NCBI chr 4:97,634,925...97,763,478
Ensembl chr 4:97,657,671...97,760,102
JBrowse link
G Gngt2 G protein subunit gamma transducin 2 decreases expression EXP lead acetate results in decreased expression of GNGT2 mRNA CTD PMID:22641619 NCBI chr10:83,654,321...83,658,601
Ensembl chr10:83,655,460...83,658,589
JBrowse link
G Golph3 golgi phosphoprotein 3 increases methylation
decreases expression
EXP lead acetate results in increased methylation of GOLPH3 gene
lead acetate results in decreased expression of GOLPH3 mRNA
CTD PMID:29571894 NCBI chr 2:62,360,754...62,388,773
Ensembl chr 2:62,360,754...62,388,771
JBrowse link
G Gosr2 golgi SNAP receptor complex member 2 increases expression EXP lead acetate results in increased expression of GOSR2 mRNA CTD PMID:11578147 NCBI chr10:91,735,772...91,756,123
Ensembl chr10:91,736,780...91,756,081
JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1 multiple interactions
increases expression
ISO [S-allylcysteine co-treated with Clotrimazole] inhibits the reaction [lead acetate results in increased expression of GOT1 protein] CTD PMID:22033380 NCBI chr 1:263,246,248...263,269,762
Ensembl chr 1:263,246,248...263,269,762
JBrowse link
G Got2 glutamic-oxaloacetic transaminase 2 increases expression EXP lead acetate results in increased expression of GOT2 mRNA CTD PMID:11578147 NCBI chr19:9,587,637...9,613,323
Ensembl chr19:9,587,653...9,613,340
JBrowse link
G Gpat4 glycerol-3-phosphate acyltransferase 4 increases expression ISO lead acetate results in increased expression of GPAT4 mRNA CTD PMID:20542052 NCBI chr16:73,615,949...73,649,769
Ensembl chr16:73,615,949...73,649,767
JBrowse link
G Gpatch4 G patch domain containing 4 increases expression EXP lead acetate results in increased expression of GPATCH4 mRNA CTD PMID:22641619 NCBI chr 2:187,404,731...187,424,047
Ensembl chr 2:187,415,262...187,424,045
JBrowse link
G Gpd1 glycerol-3-phosphate dehydrogenase 1 increases expression EXP lead acetate results in increased expression of GPD1 mRNA CTD PMID:22641619 NCBI chr 7:141,368,928...141,377,931
Ensembl chr 7:141,370,491...141,377,928
JBrowse link
G Gpr132 G protein-coupled receptor 132 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of GPR132 mRNA CTD PMID:22839698 NCBI chr 6:137,652,213...137,671,658
Ensembl chr 6:137,652,213...137,664,133
JBrowse link
G Gpr139 G protein-coupled receptor 139 decreases expression EXP lead acetate results in decreased expression of GPR139 mRNA CTD PMID:22641619 NCBI chr 1:188,854,371...188,895,223
Ensembl chr 1:188,854,371...188,895,223
JBrowse link
G Gpr155 G protein-coupled receptor 155 increases expression ISO lead acetate results in increased expression of GPR155 mRNA CTD PMID:21829687 NCBI chr 3:60,051,545...60,105,567
Ensembl chr 3:60,051,535...60,105,242
JBrowse link
G Gpr183 G protein-coupled receptor 183 increases expression EXP lead acetate results in increased expression of GPR183 mRNA CTD PMID:22641619 NCBI chr15:108,364,701...108,376,221
Ensembl chr15:108,364,701...108,376,221
JBrowse link
G Gprasp1 G protein-coupled receptor associated sorting protein 1 increases expression ISO lead acetate results in increased expression of GPRASP1 mRNA CTD PMID:21829687 NCBI chr  X:106,306,795...106,313,904
Ensembl chr  X:106,306,795...106,313,853
JBrowse link
G Gpt glutamic--pyruvic transaminase increases expression
multiple interactions
ISO lead acetate results in increased expression of GPT protein
[S-allylcysteine co-treated with Clotrimazole] inhibits the reaction [lead acetate results in increased expression of GPT protein]
CTD PMID:22033380 NCBI chr 7:117,759,083...117,761,932
Ensembl chr 7:117,759,083...117,761,931
JBrowse link
G Gpx1 glutathione peroxidase 1 decreases expression
multiple interactions
increases expression
EXP
ISO
lead acetate results in decreased expression of GPX1 mRNA; lead acetate results in decreased expression of GPX1 protein
[lead acetate results in increased abundance of Lead] which results in decreased expression of GPX1 mRNA; Ascorbic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of GPX1 mRNA]; rosmarinic acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of GPX1 mRNA]
lead acetate results in increased expression of GPX1 mRNA
CTD PMID:15014207 PMID:22197700 PMID:29746905 PMID:30623991 PMID:31610155 NCBI chr 8:117,117,430...117,118,528
Ensembl chr 8:117,117,430...117,118,522
JBrowse link
G Gpx4 glutathione peroxidase 4 affects expression EXP lead acetate affects the expression of GPX4 mRNA CTD PMID:15014207 NCBI chr 7:12,516,357...12,519,154
Ensembl chr 7:12,516,352...12,519,154
JBrowse link
G Grb10 growth factor receptor bound protein 10 increases expression ISO lead acetate results in increased expression of GRB10 mRNA CTD PMID:25270620 NCBI chr14:92,021,851...92,122,249
Ensembl chr14:92,021,851...92,117,923
JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 increases expression ISO lead acetate results in increased expression of GREB1 mRNA CTD PMID:20542052 NCBI chr 6:41,932,941...42,002,770
Ensembl chr 6:41,932,244...42,002,819
JBrowse link
G Grem1 gremlin 1, DAN family BMP antagonist increases expression ISO lead acetate results in increased expression of GREM1 mRNA CTD PMID:27562236 NCBI chr 3:105,203,309...105,214,989
Ensembl chr 3:105,203,309...105,214,989
JBrowse link
G Gria1 glutamate ionotropic receptor AMPA type subunit 1 affects expression ISO lead acetate affects the expression of GRIA1 mRNA CTD PMID:24260418 NCBI chr10:42,441,723...42,760,200
Ensembl chr10:42,614,713...42,760,200
JBrowse link
G Gria2 glutamate ionotropic receptor AMPA type subunit 2 decreases expression ISO lead acetate results in decreased expression of GRIA2 mRNA CTD PMID:24260418 NCBI chr 2:179,584,302...179,704,629
Ensembl chr 2:179,584,308...179,704,629
JBrowse link
G Gria3 glutamate ionotropic receptor AMPA type subunit 3 decreases expression ISO lead acetate results in decreased expression of GRIA3 mRNA CTD PMID:24260418 NCBI chr  X:127,561,843...127,829,763
Ensembl chr  X:127,562,660...127,829,753
JBrowse link
G Gria4 glutamate ionotropic receptor AMPA type subunit 4 decreases expression ISO lead acetate results in decreased expression of GRIA4 mRNA CTD PMID:24260418 NCBI chr 8:1,548,145...2,045,874
Ensembl chr 8:1,548,146...2,045,817
JBrowse link
G Grik1 glutamate ionotropic receptor kainate type subunit 1 decreases expression
increases expression
ISO lead acetate results in decreased expression of GRIK1 mRNA
lead acetate results in increased expression of GRIK1 mRNA
CTD PMID:24260418 NCBI chr11:27,811,954...28,213,940
Ensembl chr11:27,811,957...27,971,359
JBrowse link
G Grik2 glutamate ionotropic receptor kainate type subunit 2 increases expression ISO lead acetate results in increased expression of GRIK2 mRNA CTD PMID:24260418 NCBI chr20:53,791,428...54,517,691
Ensembl chr20:53,789,760...54,517,709
JBrowse link
G Grik3 glutamate ionotropic receptor kainate type subunit 3 affects expression ISO lead acetate affects the expression of GRIK3 mRNA CTD PMID:24260418 NCBI chr 5:143,500,441...143,715,546
Ensembl chr 5:143,500,441...143,715,546
JBrowse link
G Grik5 glutamate ionotropic receptor kainate type subunit 5 decreases expression ISO lead acetate results in decreased expression of GRIK5 mRNA CTD PMID:24260418 NCBI chr 1:81,885,516...81,946,731
Ensembl chr 1:81,885,521...81,946,714
JBrowse link
G Grin1 glutamate ionotropic receptor NMDA type subunit 1 multiple interactions
decreases expression
EXP
ISO
[lead acetate promotes the reaction [GRIN1 protein binds to GRIN2B protein]] which results in decreased phosphorylation of CREB1 protein; Choline analog inhibits the reaction [lead acetate results in decreased expression of GRIN1 mRNA]; Choline analog inhibits the reaction [lead acetate results in decreased expression of GRIN1 protein]; lead acetate promotes the reaction [GRIN1 protein binds to GRIN2B protein]
lead acetate results in decreased expression of GRIN1 mRNA; lead acetate results in decreased expression of GRIN1 protein
CTD PMID:12480136 PMID:20381573 PMID:22160880 PMID:24260418 PMID:25242007 NCBI chr 3:2,507,745...2,534,664
Ensembl chr 3:2,506,896...2,534,663
JBrowse link
G Grin2a glutamate ionotropic receptor NMDA type subunit 2A multiple interactions
affects expression
decreases expression
increases expression
EXP
ISO
Choline analog affects the reaction [lead acetate results in decreased expression of GRIN2A mRNA]
lead acetate affects the expression of GRIN2A mRNA
lead acetate results in decreased expression of GRIN2A mRNA; lead acetate results in decreased expression of GRIN2A protein
lead acetate results in increased expression of GRIN2A mRNA
CTD PMID:15973774 PMID:20381573 PMID:22160880 PMID:22362014 PMID:24260418 NCBI chr10:5,707,806...6,123,568
Ensembl chr10:5,930,298...6,119,990
JBrowse link
G Grin2b glutamate ionotropic receptor NMDA type subunit 2B multiple interactions
decreases expression
increases expression
EXP
ISO
[lead acetate promotes the reaction [GRIN1 protein binds to GRIN2B protein]] which results in decreased phosphorylation of CREB1 protein; Choline analog affects the reaction [lead acetate results in decreased expression of GRIN2B mRNA]; lead acetate promotes the reaction [GRIN1 protein binds to GRIN2B protein]
lead acetate results in decreased expression of GRIN2B mRNA; lead acetate results in decreased expression of GRIN2B protein
lead acetate results in increased expression of GRIN2B mRNA
CTD PMID:12480136 PMID:20381573 PMID:22160880 PMID:22362014 PMID:24260418 PMID:25242007 NCBI chr 4:169,541,620...170,000,216
Ensembl chr 4:169,560,387...169,999,873
JBrowse link
G Grin2c glutamate ionotropic receptor NMDA type subunit 2C increases expression ISO lead acetate results in increased expression of GRIN2C mRNA